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CHAPTER 1. INTRODUCTION 
One of the most important factors to consider when assessing the overall productivity of 
the swine enterprise is the number of pigs marketed per sow per year. Of course, many factors 
are involved in such a number, but reproductive performance and mortality during the growth 
phase have the largest impact. Thus, the objective of a swine interprise is to maximize 
reproductive performance and minimize mortality during the growth phase of the swine life cycle. 
Many different approaches to the problem have been investigated by university and 
industry researchers. Regarding mortality during the growing phase, factors such as infections, 
infestations, management problems, nutritional deficiencies, and their combinations are among its 
most relevant causes. The economical impact of vitamin E-Selenium deficiency has been 
identified by the swine industry and, therefore, parenteral supplementation of vitamin E is now a 
common practice. Moreover, parenteral administration provides a quick and powerful means to 
improve vitamin E status in the growing pig and therefore, to eliminate the possibility of vitamin 
E-Selenium deficiency. 
Although enteral tocopherol absorption and distribution has been studied considerably, 
little information is available regarding the kinetics of tocopherol compounds, dosage regimens 
and product formulation of parenteral vitamin E preparations for monogastric animals. For these 
reasons, the experiment reported in Chapter 3 was undertaken to investigate the plasma 
pharmacokinetics of two sources of d-a-tocopherol (free and acetylated ester) and two routes of 
administration (i.m. and i.v.) in gilts. 
At weaning, pigs have a good vitamin E status which is a reflection of the tocopherol 
concentration of colostrum and milk. For two weeks after weaning, serum vitamin E declines 
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because of reduced feed intake and poor development of digestive enzymes. For those reasons, 
parenteral supplementation is likely to be better utilized than dietary vitamin E supplementation. 
The experiment reported in Chapter 4 was conducted to investigate the tissue and serum 
pharmacokinetics of four different injectable sources of vitamin E, two alcohols and two acetates, 
in weanling pigs. 
There are two critical periods in the reproductive cycle of a sow: those 12 to 18 d after 
breeding when most of the embryonic mortality occurs, and the first few days after farrowing 
because most of the pig mortality occurs at this time. In recent years, an increased interest in 
supplementation of specific vitamins at levels higher than those previously thought to be adequate 
has emerged. Tocopherol is one of those vitamins, and there has been an interest in the effect of 
supranutritional supplementation of vitamin E on reproductive performance of sows. Besides this 
eifort, there still is not a definitive answer to whether or not those supranutritional levels improve 
reproductive performance. The experiment in Chapter 5 was conducted to investigate the effect 
of dietary and/or injectable d-a-tocopherol supplementation on sow reproductive performance and 
tocopherol status of the dam and her litter over three parities. 
Dissertation Organization 
The thesis is divided into a Literature Review, three papers, and a General Summary. 
The papers were prepared in the style appropriate for submission to die Journal of Animal 
Science. Each paper includes abstract, introduction, materials and methods, results, discussion, 
implications, and literature cited sections. The general summary is intended to present the major 
findings and conclusions of the research performed to partially fulfill the requirements for the 
Ph.D. degree. 
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CHAPTER 2. LITERATURE REVIEW 
Vitamin E and its Pharmacokinetics 
History of vitamin E 
In the early 1920s, several groups of researchers found that purified diets containing 
adequate protein, carbohydrate, and known required minerals supplemented with the newly 
discovered vitamins A, C, D and thiamine markedly improved the performance of animals 
(Combs, 1992). Evans and Bishop (1922) observed tiiat in rats fed such supplemented 
semipurified diets, fetal resorption occurred during late gestation in females and testicular 
degeneration occurred in males. They reported that the addition of yeast or fresh lettuce to the 
diet restored fertility in the female and prevented infertility in the male. Evans and Bishop 
concluded that the diet was missing an unknown fertility factor termed "factor X". 
Evans and Bishop (1922) tested numerous feedstuffs, using the prevention of fetal 
resorption as the bioassay, and found "factor X" activity in dried alfalfa, oats, wheat germ, milk 
fat, and meats. The active factor was extracted by organic solvents. They showed that daily 
supplementation with single droplets of wheat germ oil completely prevented fetal resorption, 
whereas diets that contained cod liver oil, a source high in vitamin A and D, did not. Sure 
(1924) concluded that the fat-soluble factor was a new vitamin and he proposed the name "vitamin 
E", the next serial alphabetical designation. This is the currentiy accepted designation for 
tocopherols active in preventing certain types of infertility and myopathies in animals. 
Olcott and Mattill (1931), at the University of Iowa, found that those preparations which 
prevented fetal resorption had antioxidant properties. Evans et al. (1936) isolated an alcohol from 
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unsaponifable wheat-genn lipids that had considerable vitamin E activity. They proposed the 
name "alpha-tocopherol". The term was derived from the Greek words tokos (offspring) and 
pherein (to bear), and they used the -ol suffix to indicate that the factor was an alcohol. Emerson 
et al. (1937) isolated /S and 7-tocopherol from vegetable oils. The chemical structure of this new 
vitamin was proposed one year later (Femholz, 1938). The same year, the synthesis of a-
tocopherol was achieved (Karrer et al., 1938). A decade later, 6-tocopherol was isolated (Stern et 
al., 1947). In the 1960s, the tocotrienols were isolated from different vegetable oils. 
Structure of vitamin E 
The multiplicity of vitamin E structures has been historically defmed over the years. 
Eight naturally occurring compounds, four tocopherols (a, /5, y, and S) and four tocotrienols (a, 
jS, 7, and 6), have been isolated. Tocopherols are derived from tocol, hydroxychroman, 
substituted with a 16-carbon isoprenoid side chain at the 2- position (Figure 1). The full chemical 
name of a-tocopherol is 2, 5, 7, 8-tetramethyl-2-(4', 8', 12'-trimethyl-tridecyl) chroman-6-ol 
(lUNS Committee on Nomenclature, 1978). Differences between a, /3, 7, and 8 are in the 
number and placement of the methyl groups on the ring. Thus, d-a-tocopherol is 2R-(4'R,8'R)-
5,7,8-trimethyl-tocol, jS-tocopherol is 2R-(4'R,8'R)-5,8-dimethyl-tocol, 7-tocopherol is 2R-
(4'R,8'R)-7,8-dimethyl-tocol and 6-tocopherol is 2R-(4'R,8'R)-8-methyl-tocol (Lynch, 1991). 
Tocotrienols (Figure 1) have the same structure as tocopherols widi the exception of 
three double bonds occurring at positions 3',7' and 11' (unsaturated). The full chemical name for 
a-tocotrienol is 2, 5, 7, 8-tetramethyl-2-(4', 8', 12'-trimethyl-trideca-3', T, ll'-trienyl) chroman-
6-0I (lUNS Committee on Nomenclature, 1978). The a, jS, 7, and 8 tocotrienols have methyl 
groups located on the same position as the tocopherol counterparts. 
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All-rac- or dl-a-tocopherol is a synthetic compound that is a condensation product of 
racemic isophytol and trimethylhydroquinone. The result is a totally synthetic mixture of the four 
possible enantiomeric pairs of the eight diasterisomers (Ullrey, 1981). The d-a-tocopheryl acetate 
results from the extraction of natural tocopherols from vegetable oils. Those natural tocopherols 
are then acetylated to produce the ester (Lynch, 1991). 
CH3 
HO 
a-Tocopherol 
CHa 
HO 
o-Tocotrienoi 
Figure 1. a-tocopherol and a-tocotrienol structure. 
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In the vitamin E molecule, the chroman ring is responsible for the antioxidant activity, 
whereas the phytyl group determines its transport, and retention within membranes. 
Function of vitamin E 
Vitamin E is essential for the integrity and optimal function of the reproductive, muscular, 
circulatory, nervous, and immune systems. The most important function of vitamin E is as a 
biological antioxidant when the phenolic hydroxyl of its chromanol ring is free (unesterified). 
The free hydroxyl at the sixth position of the chroman ring can function as a scavenger of free 
radicals, usually being oxidized to the semiquinone or quinone. The active group can be 
protected from oxidation by esterification with the carboxyl group of organic acids forming esters 
such as the acetate or succinate derivatives. The esters do not have antioxidant activity (Ullrey, 
1981; McDowell, 1989). 
Stability of vitamin E 
Alpha-tocopherol is a yellow oil that is soluble in organic solvents. Tocopherols are 
readily oxidized. Natural vitamin E is subject to destruction by oxidation, which is accelerated by 
factors such as heat, moisture, rancid fat, storage time, presence of mold, presence of trace 
minerals, and storage of feedstuffs. Vitamin E is a natural antioxidant and acting as such is 
destroyed (Roche, 1991). Placing acetate or succinate in the sixth position of the chroman ring, 
where the hydroxyl with antioxidant activity is located, leaves the molecule without antioxidant 
properties, but it is protected against stressors that destroy the vitamin during storage. Therefore, 
the ester form of vitamin E is the source of choice when formulating dietary vitamin E 
supplements. 
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In the diet, the alcohol form of vitamin E is less stable and declines in activity over time 
(Dove and Ewan, 1987; Chung et al., 1992). Dove and Ewan (1991a) concluded that high levels 
of Cu, Fe, Zn, or Mn in the diet increased the rate of oxidation of natural tocopherols. Anderson 
et al. (1995) showed a dramatic decrease in vitamin E content of swine diets supplemented with d-
or dl-a-tocopherol after five days of storage, whereas the diets supplemented with acetate forms 
were stable over the 28-daystudy. 
Data on swine liver and serum showed that a-tocopherol remains stable for at least 12 
hours after sample collection when maintained at to 23°C. (Fredrickson, 1990). He concluded 
that to minimize vitamin E loss between sample collection and further analysis, tissue should be 
stored at either -20° or -70 °C. 
Vitamin E acts as an antioxidant in feedstuffs and biological samples. Supranutritional 
levels of vitamin E in the diet increase vitamin E in muscle and improve the oxidative stability of 
lipids and color, and recuce drip loss of raw and cooked pork (Monahan et al., 1990; Asghar et 
al., 1991). 
Vitamin E deficiency 
Vitamin E deficiency may result from impaired absorption or insufficient dietary intake of 
the vitamin. Selenium and polyunsaturated fatty acids are the most important factors that can 
affect the need for vitamin E. This vitamin has a large range of deficiency signs that differ 
among species and even among animals within the same species. In swine, most vitamin E 
deficiency signs have been associated with selenium (Se) deficiency. Vitamin E-Se deficiency is 
an important cause of sporadic mortality in growing swine. 
Vitamin E-Se deficiency is expressed as one or several complex lesions in growing swine. 
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including hepatic necrosis (hepatosis dietetica), myocardial necrosis and hemorrhage (mulberry 
heart disease or dietetic microangiopathy), skeletal muscle degeneration (white muscle disease), 
esophagogastric ulceration, and steatitis (yellow fat disease) (Ewan et al., 1969). Other symptoms 
of vitamin E-Se deficiency that have been reported in swine herds are mastitis-metritis-agalactia 
complex, spraddle rear legs in newborn, infertility, susceptibility to swine dysentery, and poor 
skin condition (Ullrey, 1981; McDowell, 1989; Roche, 1991; Combs, 1992). A rise in activity 
of specific enzymes may be measured before any clinical signs are observed. Lactic acid 
dehydrogenase can be used to provide the pre-clinical diagnosis of vitamin E/Se deficiency 
(Hyldgaard-Jensen, 1973). 
Vitamin E hvpervitaminosis 
The manifestation of hypervitaminosis E in rats, chicks and humans indicates a maximum 
tolerable level of 1000 to 2000 lU of vitamin E per kilogram of diet (NRC, 1987). Dietary 
supplementation with an excess of vitamin E can interfere with the utilization of other fat-soluble 
vitamins and produce impaired bone mineralization, reduction in hepatic storage of vitamin A, 
and coagulation disorders (McDowell, 1989; Combs, 1992). 
Assay methods for vitamin E 
There are two major assay methods for vitamin E. The first is the chemical assay which 
is used for qualitative and quantitative analysis. Extraction, purification, and detection are the 
three basic steps to perform when conducting the analysis. High performance liquid 
chromatography coupled with fluorescence detection is simple, fast, accurate, and very sensitive 
techique. There are two common methods of detection: spectrophotometric, and 
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spectrofluorometric. Fluorometric methods use an activation wavelength of 295 r/m and an 
emission wavelength of 323 i;m (Machlin, 1984). The second method of analysis of vitamin E is 
the biological assay, and monitors the biological activity of vitamin E to reverse or alter 
symptoms of vitamin E deficiency. Prevention of fetal resorption in rats, encephalomalacia in 
chicks, nutritional muscular dystrophy, red blood cell hemolysis, plasma concentration, and liver 
storage tests are the most common forms of bioassay (Coelho, 1991). 
Pharmacokinetics; general concepts 
Pharmacokinetics describes what the body does to a drug and is the mathematical 
relationship that exists between the dose of a drug and the concentration of the drug in a readily 
accessible site in the body (i.e., plasma or blood). Several factors determine how rapidly, at what 
concentration, and for how long the drug will appear at the target organ. Bioavailability, 
distribution, and clearance represent three major pharmacokinetic variables (Niazi, 1979). 
Enteral or parenterally administered vitamin E must reach the general circulation to be 
distributed throughout the body, and the active form needs to be present at the site of action to 
exert its effect. The change of vitamin E concentration with time in the blood is a function of the 
absorption, distribution, and elimination. 
Absorption of vitamin E can be defined as the fraction of the dose reaching the systemic 
circulation as unchanged vitamin E following administration by any route. The specific 
characteristics of vitamin E absorption will be presented later in this dissertation in the section 
dealing with route of administration. In the blood, vitamin E distributes rapidly between the 
plasma and erythrocytes. The transfer of vitamin E between blood, extravascular fluids, and 
tissues is called distribution. Vitamin E is found bound to lipoproteins in lymph and blood 
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(Figure 2) and does not seem to have a specific carrier protein (Combs, 1992). About 20% of the 
tocopherol in blood is located within the erythrocyte membrane (Chow, 1975), but it is probably 
not a transport form. 
Most of the vitamin E in chylomicron and very low density lipoprotein (VLDL) is in the 
core and is located in the jS-lipoprotein fraction (Machlin, 1984). Plasma vitamin E is mainly 
cleared by the liver in association with chylomicron remnants (Bjomeboe et al., 1990). The 
majority of hepatic tocopherol in liver is in the parenchymal cells. Liver secretes VLDL, which 
contains tocopherol, into the circulatory system (Bjomeboe et al., 1990). 
The number and position of methyl groups on the chromanol ring influence the biological 
activity (a > jS > 7 > 5) of tocopherols and tocotrienols. Tocopherols have greater biological 
activity than tocotrienol counterparts (Machlin, 1984). 
The vitamin E International Unit (lU) was originally defined as the average amount of 
orally administered vitamin required to prevent fetal resorption in vitamin E-deprived rats, and its 
currently accepted definition is one mg of dl-a-tocopheryl acetate. The US Pharmacopeia and 
National Formulary (1980) uses USP units to define the weight/unit relationships for the isomers 
of vitamin E (Table 1). 
Sato et al. (1991) isolated and characterized a protein from rat liver cytosol that 
specifically binds a-tocopherol. This tocopherol binding protein has only been reported in liver 
cells. Yoshida et al. (1992) and Sato et al. (1993) suggested that in rats the liver takes up a-
tocopherol and preferentially transfers this isomer from the chylomicron to VLDL, discriminating 
against the 7-tocopherol. Then, 7-tocopherol is excreted in bile. This type of discrimination has 
also been reported in swine (Hoppe, 1991) and humans (Traber and Kayden, 1989). 
Discrimination between RRR-a-tocopherol and other steroisomers has been reported in humans 
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EXTRAHEPATIC TISSUES 
LDL 
Receptor 
Lipoprotein 
Lipase 
Lipoprotein 
Lipase FECES 
VLDL 
LDL 
CHY TBP 
Liver 
VITE 
Excess surface (VITE In surface) 
CHY-R HDL 
. (QUINONE, VITE) 
URINE 
Figure 2. Scheme for the intestinal absorption, transfer in plasma lipoprotein, and uptake of 
vitamin E (VITE) by tissues. Where chylomicron (CHY), chylomicron remnant (CHY-R), very 
low density lipoprotein (VLDL), low density lipoprotein (LDL), high density lipoprotein (HDL), 
tocopherol binding protein (TBP), and gastro-intestinal tract (GIT) are depicted. 
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Table 1. USP units per mg of vitamin E source" 
Source USP units/mg 
dl-a-tocopheryl acetate (all-rac) 1.00 
dl-a-tocopheryl acid succinate (all-rac) 0.89 
dl-a-tocopherol (all-rac) 1.10 
d-a-tocopheryl acid succinate (RRR) 1.21 
d-a-tocopheryl acetate (RRR) 1.36 
d-a-tocopherol (RRR) 1.49 
®US Pharmacopeia and National Formulary, 1980. 
(Acuff et al., 1994), cattle (Hidiroglou et al., 1988), rabbits (Fitch and Diehl, 1965), and rats 
(Ingold et al., 1987). 
Discrimination among steroisomers may affect die interconversion between mg and lU of 
the different vitamin E compounds. Machlin (1993) concluded that the values assigned to the 
RRR- and all-rac-forms of vitamin E are valid for farm animals and that tiaere is not advantage of 
supplementing animals with the natural form of vitamin E as long as the supplementation is 
measured in lU. Stuart (1993) questioned the interpretation of data regarding biopotency of the 
natural and synthetic vitamin E because they are normally expressed on a weight basis and not in 
lU. He concluded diat the actual equivalence of the natural vitamin E is greater than what is 
currentiy accepted and that all species cannot utilize the different forms of vitamin E in the same 
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fashion. Anderson et al. (1995) concluded that the actual bioavailability of d-a-tocopheryl acetate 
in swine is greater than the suggested values based on rat bioassays. 
The intestinal absorption of vitamin E, its transfer to and transport in blood lipoproteins, 
and its uptake by tissues are summarized on Figure 2. Machlin and Gabriel (1982) reported that 
it is difficult to saturate tissue with vitamin £ and that not only the concentration, but also the 
duration of supplementation may affect the concentration of vitamin E in the tissues. Two 
mechanisms of cellular uptake of vitamin E from plasma seem to be involved. The first is 
receptor-mediated uptake of low density lipoprotein (Traber and Kayden, 1984), and the second is 
the lipoprotein lipase-mediated release of lipid from chylomicron and VLDL (Traber et al., 1985). 
Vitamin E is stored in many tissues in the body and is concentrated in the cell membrane 
fractions such as those of the mitochondria and microsome (Diplock, 1985). Adipose tissue, liver 
and muscle are the major storage sites for this fat soluble vitamin (Bjomeboe et al., 1990). 
Pascoe and Reed (1987), using isolated hepatocytes in vitro, suggested that tocopherol 
esters may be more effective antioxidants than free tocopherol, because they can pass through the 
cell membrane and reach intracellular sites where they can be later hydrolyzed to the alcohol 
form. On the other hand, the highly lipophilic free tocopherol may be immobilized in the plasma 
membrane and may never reach the intracellular sites where it is needed. 
Most tissues serve as storage sites for vitamin E. However, not all stored tocopherol is 
accessible for use. In most non-adipose tissues, the location of vitamin E is almost exclusively in 
their membranes. Bieri (1972) reported that tissues have two pools of vitamin E: a labile pool 
that turns over rapidly, and a fixed pool that turns over slowly. Apparently, the labile pool is 
predominantiy in non-adipose tissues like plasma and liver. On the other hand, the fixed pool is 
predominantiy in the adipose tissue (Machlin et al., 1979). Burton et al. (1990) divided the 
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tissues of an animal in a steady-state into two kinetic groups. One tissue group included brain, 
testes, muscle and heart; this group had a slow, first order loss of old and gain of new 
tocopherol. The other tissue group included plasma, liver, lung, adrenal gland, and kidney; and 
this group had an initial, rapid change in vitamin E concentration compared with later stages. 
Therefore, the behavior of the fast tissues can be expressed as the sum of two (or more) first 
order processes. 
The body can be seen as a collection of separate compartments, each containing a fraction 
of the administered vitamin E (Figure 3). The transfer of vitamin E from one compartment to 
another is associated with a rate constant (K). The magnitude of the rate constant determines how 
rapidly the transfer occurs. Thus, vitamin E in plasma exists in equilibrium with vitamin E in 
erythrocytes, other body fluids, and tissues. Because of this equilibrium, changes in the 
concentration of vitamin E in plasma are indicative of changes in the concentration of this vitamin 
in other tissues. 
The first stage of vitamin E biotransformation is the oxidative conversion of tocopherol to 
tocopheroxy-radical. This is a reversible reaction, and further oxidation of the radical intermediate 
is unidirectional and results in tocopheryl-quinone. This tocopheryl-quinone can be reduced to 
tocopherol-hydroquinone in a reversible reaction. All the quinone metabolites have little vitamin 
E activity. The liver is able to conjugate tocopheryl-quinone for excretion in bile (Figure 2). 
Bjomeboe et al. (1987) observed that 24 h after i.v. administration of dl-a-['H] tocopherol in 
rats, 14% of the radioactivity was found in bile, and that only a fraction was unchanged a-
tocopherol. In sheep, only 3% of the total radioactivity found in bile was identified as unchanged 
tocopherol (Hidiroglou and Ivan, 1992). Lee-Kim et al. (1988) observed similar results, and also 
reported that in rats, the magnitude of enterohepatic circulation of vitamin E is very small. 
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a)TWO-COMPARTMENT MODEL 
DOSE 
b) THREE-COMPARTMENT MODEL 
DOSE 
SAMPLE 
Figure 3. a) Two- and b) three-compartment models. Compartments are shown as circles with 
their numbers inside. The Kjj represents the transfer rates from compartment j to compartment i. 
The elimination rates are depicted as Kqj. 
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The kidney degrades tocopheryl-quinone to tocopheronic acid and its derivative 7-lactone (Simon 
et al., 1956). Both acid and lactone metabolites can be excreted in urine or conjugated with 
glucuronic acid, resulting in a water soluble product of tocopherol that can follow the same route 
of excretion as the acid and lactone metabolites. Tocopheryl-quinone can also be reduced to a 
dimer and the dimer can be converted into a trimer (Gallo-Torres, 1980). 
The major route of excretion of vitamin E is through the feces, with urinary excretion 
representing a minor pathway. Dermal elimination has also been suggested to be significant 
because a large fraction of a-tocopherol can be found in the skin after injection (Combs, 1992). 
The shape of the concentration over time curve depends on the relative rates of absorption 
and elimination (Figure 4). For instance, an i.v. injection yields an earlier peak than does an i.m. 
injection due to fast or almost instantaneous absorption, whereas enteral, s.c., and other routes of 
administration may show delayed peaks due to slower rates of absorption. Generally, the 
concentration dependant elimination rate is considered to be constant for a given drug. Therefore, 
the peak in the concentration vs time curve is determined only by the rate of absorption. 
A higher or earlier peak in the curve does not necessarily mean larger absorption than a 
lower or delayed peak. The total absorption depends not only on the peak concentration 
achieved, but also on the persistence of the drug in the blood. The area under the curve better 
characterizes the total absorption of a drug. This area under the curve can not be used to 
determine the extent of absorption unless it is compared with a known standard or by some other 
method of administration such as i.v., which is assumed to be 100% absorbed (Niazi, 1979). 
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A. Absorption > Elimination 
B. Absorption = Elimination 
C. Absorption < Elimination 
D. Absorption = 0; Elimination > 0 
Time 
Figure 4. Phases of plasma concentration vs time profile. 
Approaches to pharmacokinetics studies 
Most of the studies done to date with the objective of better understanding the absorption, 
transport, and uptake by tissues of vitamin E in vivo have been conducted using one of the 
following three methods: 
Trace administration of vitamin E marked with radioactive isotopes. Most of the studies 
have used (Gallo-Torres and Miller, 1971; Hidiroglou and Karpinski, 1987) or ''•C-
(Krishramurthy and Bieri, 1963; Knight and Roberts, 1986) marked vitamin E given through a 
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enteral or parenteral route. Samples (blood, tissues) were collected at specific time intervals 
after vitamin E administration, and radioactivity was measured using a liquid scintillation counter. 
This method has the advantage that it distinguishes between endogenous and exogenous 
(radiolabelled) vitamin E in the system. On the other hand, radiolabeled vitamin E is not suitable 
for studies with humans, and it needs to be purified just before use due to its tendency to 
decompose. 
Trace administration of vitamin E marked with stable isotopes. The use of radioactive 
materials and radiation-producing devices has increased, and so has the understanding of the 
potential hazards associated with the use of those procedures. The use of stable isotopes 
eliminates the risk associated with the use of radioactivity. 
The use of stable isotopes allows the monitoring of unlabeled endogenous and labeled 
exogenous vitamin E by selected ion monitoring. Burton and Traber (1990) described the 
substitution of different amounts of deuterium on the chroman ring of vitamin E. This approach 
allows the administration of different steroisomers simultaneously. Furthermore, this technique 
allows the use of the same animal as its own control, and eliminates the need for crossover 
protocols. 
The procedure described by Burton and Traber (1990) involves the determination of the 
relative amounts of deuterated and nondeuterated a-tocopherol in the sample by silylating the 
tocopherol fraction purified by HPLC, and injecting the silyl derivative into a gas chromatograph 
mass spectrometer. 
Large dose of unlabeled vitamin E. This approach has the disadvantages that it does not 
distinguish between endogenous and exogenous vitamin E, it may not be physiologically relevant, 
because large doses are needed to distinguish any change relative to background levels, and it is 
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necessary to use crossover protocol or a relatively large number of experimental units to minimize 
the effects of individual variation. Levels used with this methodology are associated with the 
therapeutic or prophylactic treatment of deficiencies. Therefore, it has clinical significance. High 
performance liquid chromatography is generally used to determine vitamin E concentration (Cort 
et al., 1983). 
Pharmacokinetic parameters 
The equations and models used are always oversimplifications of the real system, and 
their appropriateness in a given experiment can be judged only by their ability to describe the 
observed data and the accuracy with which they make predictions of future results. 
For example, a single exponential curve generally does not best describe the shape of the 
curve following a bolus injection (Figure 4). This curve better fits by a multiexponential. 
Wolfe (1992) described the calculation of substrate kinetics for single- and multiple-pool 
models. The first step in calculating parameters in a multiple-pool model by noncompartmental 
modeling of bolus injection data is to fit a multiexponential curve of the form: 
Y(t) = 2 Kj e-'''' 
Where t, Kj and P; are time, intercept and slope, respectively, of the different components 
of the multiexponential curve. The values for K; and Pj are determined by the stripping technique 
or by nonlinear least squares estimation, using a curve-fitting program such as SAAM/CONSAM 
(Boston et al., 1981). The program determines the value for those parameters that minimizes the 
sum of squares of the residuals (SSR), defined as the deviation of the model-derived value from 
the measured value at an specific time ; 
SSR = E W[A - B]2 
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Where A is the observed value at time t, B is the expected value at time t derived from 
the function to fit the data, and W is the term to weight the data for experimental error. In 
general, each datum is weighted by a value inversely proportional to its variance. The evaluation 
of the best fit is done through the standard deviation of the estimated parameters, and by the 
goodness of fit (SSR, SD, CV, or R^), 
The area under the curve may be calculated by integration of the function or, 
alternatively, by the trapezoidal rule (Gibaldi, 1984). Other parameters such as pool size, mean 
residence time, and rates may be calculated. 
In compartmental modeling (Figure 3), compartments are used to model various 
components of the metabolic system. The development of the model is based on the exponential 
functions of the curve and an understanding of the metabolic system to be modeled. Generally, 
the number of compartments in the model is coincident with the number of exponential terms, 
^en using the slopes and intercepts of the exponential equation to calculate certain kinetic 
parameters, the compartmental analysis is called empirical modeling. If plasma data plus any 
other data (tissue, feces, urine, ...) from the same or another experiment are fitted to a 
hypothesized compartmental model and later adjusted to the model parameter, the compartmental 
analysis is called model-based compartmental analysis (Green and Green, 1990). 
Route of administration 
Enteral. Vitamin E absorption is dependent upon normal lipid digestion and absorption 
(Ullrey, 1981). Thus, normal pancreatic function, bile secretion, micelle formation, and 
penetration across intestinal membranes are needed. Humans and animals with lipid 
malabsorption syndromes (e.g., cystic fibrosis, premature infants, biliary atresia) have low 
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vitamin E status (Combs, 1992). 
Absorption is primarily in the medial small intestine following hydrolysis of the esterified 
forms of vitamin E to the alcohol form. No absorption occurs in the large intestine (Gallo-
Torres, 1980). The vitamin E alcohol is the main form which appears in mixed micelles, and is 
the predominant form of absorbed vitamin E (Combs, 1991) . Absorbed tocopherol is released 
into the lymphatic system in mammals, or into the portal system in fish, birds, and reptiles 
(Combs, 1992). 
Gallo-Torres (1980) reported that 20 to 40% of orally administered vitamin E is absorbed. 
D-a-tocopherol, when added to the diet of weanling pigs, may be better absorbed and retained 
than dl-a-tocopheryl acetate (Chung et al., 1992). Ingold et al. (1987) found that in rats, the 
discrimination between RRR- and SRR-a-tocopheryl acetate begins in the gut, due to the 
incomplete hydrolysis of the SRR- when compared to the RRR- steroisomer. Some minerals and 
lipids in the diet may cause vitamin E oxidation in the gastrointestinal tract, thus decreasing 
absorption (Burton et al., 1988). 
Factors affecting the bioavailability of oral drugs were reviewed by Wagner (1961) and 
Koch-Weser (1974). They listed and discussed the most important factors such as: 1) 
Characteristics of the drug, which included inactivation before gastrointestinal absorption, 
incomplete absorption, and biotransformation in the intestinal wall or liver, 2) Formulation of the 
drug product, which included state of the drug, and excipient, 3) Interaction with other 
substances, such as food and drugs, in the gastrointestinal tract, and 4) Characteristics of the 
patient which included genetics; hepatic function; and gastrointestinal pH, motility, perfusion 
flora, and structure. 
The delivery systems for oral dosing of vitamin E have been reviewed by Bauernfeind et 
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al. (1974) and include a sealed gelatin capsule, oil solution, water-dispersible liquid form, and 
water-emulsifiable fonn added to dry food or liquid. Bateman and Uccellini (1985) reported that 
vitamin E was better absorbed from a formulation containing surfactant than from an oily 
preparation following oral administration. 
After administration of a single capsule containing 500 lU of d-a-tocopherol in a water 
soluble base in humans fasted for at least 12 h, Bateman and Uccellini (1985) reported an 
absorption constant (Ka) of .87 h"', and an elimination constant (Ke) of .0032 h"'. They 
suggested that this high absorption constant was due to a rapid mechanism of absorption that did 
not require incorporation of vitamin E into micelles. 
Ferslew et al. (1993) reported that after oral administration of two 400 mg soft-gelatin 
capsules of either RRR- or all-rac-a-tocopherol to overnight fasted humans, natural and synthetic 
vitamin E had a similar lag time (3.2 h), half-life of absorption (tj/jj = 2.9 h), Ka (.454 h"'), 
maximum concentration (Cmax = 19.5 (ig/mL), time to reach Cmax (Tmax = 13.1 h), half-life 
of elimination (ti/2e = 76.9 h), and Ke = .017 h"'. The AUC from 0 to 96 h after administration 
of the dose (AUCo,96 h) ratio RRR/all-rac was 1.53. 
In chicks (Marusich et al., 1967), an oral dose of d- or dl-a-tocopheryl acetate in a water-
based formula; in human (Overman et al., 1954), an oral dose of an aqueous emulsion (capsule) 
of d-a-tocopheryl acetate; and in pigs (Hoppe, 1991), d-a- and d-7-tocopherol added to the feed 
reached Tmax 6 h after administration. The latest experiment, Hoppe (1991) reported that d-a-
tocopherol was 2.5 times more bioavailable, based on AUCo^gh, d-7-tocopherol. 
Hidiroglou and Karpinski (1988) reported Tmax at 40, 36, 26, and 32 h; Ke of .034, 
.016, .019, and .021 h"', and AUC0.320 h of 408, 420, 656, and 426 /ig/mL h after oral 
administration in gelatin capsule of 100 lU/kg BW of dl-a-tocopherol, dl-or-tocopheryl acetate, d­
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a-tocopherol, and d-a-tocopheryl acetate, respectively. 
Doncon and Steele (1988) reported Tmax between 8 and 24 h after oral administration of 
1000 or 2000 lU of a commercial a-tocopherol product (Rovimix E-20, Roche) in a study 
designed to investigate the effect of vitamin E supplementation on the mycotoxicosis lupinosis in 
sheep. 
In sheep, Hidiroglou and Ivan (1992) fitted the change in plasma concentration over time 
after oral administration of d-a-[^H] tocopherol in ethanol to a two exponential (Ct = Kj e'^'' -
K2 e'^'). Where the magnitude of the intercepts (dpm/g) were Kj = 419, and K2 = 438 and of 
the slopes (h"') were PI = .0027, and P2 =.31. The Tmax was reported between 32 and 48 h. 
In sheep, Hidiroglou and Karpinski (1987) expressed the change in plasma concentration 
with time after oral administration of d-a-[^H] tocopherol in capsule as two exponentials (Ct = 
Kj e'^'' - K2 e'^'). The intercepts (dpm//ig) were 3,000 for Kj, and 2,500 for K2; and for the 
slopes (h'^) were .008 for PI, and .25 for P2. The Tmax was reported at 16 h, and the 
bioavailability related to the i.v. administration was 28%. They also fitted the change in plasma 
concentration over time after intraruminal administration of d-a-[^H] tocopherol to a three 
exponential (Ct = Kj e'^'' + K2 e"'^' - K3 e'" ^ ). The intercepts (dpm//ig) were 2,000 for Kj 
and K3, and 1,500 for K2; and of the slopes (h"') were .01 for PI, .002 for P3,and .2 for P3. 
The Tmax was 16 h after administration and a relative bioavailavility of 21% compared with the 
i.v. administration. The same authors (Hidiroglou and Karpinski, 1988) reported Tmax at 28 h 
after intraruminal administration of dl-a-tocopheryl acetate, and a relative bioavailability (based 
on the AUCo.igoi,) of 82% compared with the i.p. route. 
Hidiroglou et al. (1994) estimated that the mean retention time of tocopherol in the rumen 
was between 15 to 19 h, and that a small fraction of the free tocopherol was absorbed by the 
24 
ruminal wall. Bioavailability of d-a-tocopherol was four times larger than that of its succinate 
ester because of the incomplete hydrolysis of the ester. 
After a single intraruminal administration of 100 mg of dl-a-tocopherol or dl-a-tocopheryl 
acetate per kg BW in sheep, Hidiroglou et ai. (1989) reported similar Cmax and final 
concentration (Cf) for the alcohol and ester sources of vitamin E. Tmax was faster for the free 
(27 h) than for the ester form (40 h) of synthetic vitamin E. The AUCo-288 h of free/ester 
was 1.12. They also reported similar Cmax, Cf, and Tmax (35-49 h) after a single oral 
administration of 50 mg of dl-a-tocopherol or dl-a-tocopheryl acetate per kg BW in cattle. The 
AUCo^go h ratio of free/acetate was 1.23. 
Parenteral. Parenteral administration of a drug is intended to go through or under one or 
more layers of skin. Subcutaneous, intramuscular, intravenous, intradermal, hypodermal, intra­
arterial, intrapleural, intraperitoneal, intra-articular, intracardial, intraspinal, and intracerebral are 
all parenteral administration routes that differ in the site of injection. 
Complications following the parenteral administration of drugs are not uncommon, and 
may include: pain or discomfort, skin pigmentation, hemorrhage, septic or sterile abscess, 
fibrosis, necrosis and gangrene in the site of injection (Ballard, 1968). 
Complete entry into the general circulation is assured only when the product is 
administered intravenously, intra-arterially, intraspinally, and intracerebrally. The other 
parenteral routes of administration only allow incomplete and variable bioavailability of the drug. 
Absorption rates after using any of the other routes of administration can be very different from 
the enteral administration (Wagner, 1961). Most of the factors influencing bioavailability of oral 
drugs also apply for parenteral administration. 
Koch-Weser (1974) remarked on the importance of the injection site on absorption rate. 
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particularly regarding perfusion at the injection site, circulatory disturbances, muscle activity, 
etcetera. Total surface area available for diffusion also influences the rate of absorption. High-
pressure injection devices and massage of the injection site after administration are effective 
means of spreading the solution (Greenblatt and Koch-Weser, 1976). 
Muscle has a rich supply of capillary vessels, but has a poor supply of lymph vessels. 
Lymph vessels exist where fascial planes enter the muscle. The subcutaneous region is well 
supplied by capillary and lymphatic vessels (Ballard, 1968). 
Lipid-soluble molecules diffuse through capillary walls (Ballard, 1968), but large lipid-
insoluble drug molecules depend on the lymphatic system to be removed from the injection site. 
The process is slow because the rate of lymph flow is less than .1% of the plasma flow 
(Greenblatt and Koch-Weser, 1976). 
The delivery systems for intramuscular administration of vitamin E have been reviewed 
by Bauemfeind et al. (1974) and include: water-dispersible, oil solution, and liquid emulsions. 
Drugs with low water solubility at physiologic pH may precipitate at the injection site and may be 
unable to diffuse into capillaries. In some parenteral preparations,the drug is in solution until it is 
placed under the skin, and then precipitation of the drug occurrs. This can explain some cases of 
partial bioavailability after parenteral administration. Precipitated compounds can gradually 
redissolve and be absorbed, or they can be removed by phagocytosis (Greenblatt and Koch-
Weser, 1976). 
Overman et al. (1954) reported that i.m. administration of 500 mg of dl-cx-tocopheroi in 
sesame oil did not increase the plasma tocopherol concentration in humans. Behrens et al. (1975) 
reported that the slow rate of release after i.m. administration of vitamin E in oil carrier (peanut 
or soybean oils) in sheep may be due to myositis and lymphadenitis. Similar clinical observations 
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were made by Dickson et al. (1986) also in sheep. The oil carrier itself was not responsible for 
such reaction. They also reported that lymph glands, where lymph drained from the site of 
injection, stored important amounts of vitamin £ for at least 4 months after i.m. administration. 
Chung (1993) also reported a continued and slow release of tocopherol, reflected as serum and 
tissue concentration, after i.m. administration of d-a-tocopheryl acetate with olive oil as a carrier 
in swine. In sheep; similar observation were made by Hidiroglou and McDowell (1987) after 40 
mg of d-a-tocopherol in sesame oil were i.m. injected per kg of BW, and by Judson et al. (1991) 
after s.c. administration of 15, 30, 60, or 120 mg of dl-a-tocopheryl acetate in an oily solution 
per kg of BW. 
Slow absorption can be obtained by the use of injection vehicles of various viscous 
organic solvents (glycerine, cotton-seed oil, sesame oil, or polyethylene glycol), or by the use of 
fatty acid ester derivatives. These complexes are gradually hydrolyzed, and slow release of the 
active drug to the circulatory system takes place. The rate of absorption, however, may be erratic 
and unpredictable (Greenblatt and Koch-Weser, 1976). 
The simplest model of drug absorption after i.m. administration is the first-order 
absorption, which assumes passive diffusion of the compound from the injection site into the 
capillary system. The concentration of the compound in the capillaries into which it diffuses is 
assumed to be negligible as compared to that at the place of injection. Therefore, this model 
assumes that the rate of absorption is proportional to the concentration (C) of the specific 
compound at the injection site: 
dC/dt = -Pi C 
Where t is the time after injection, and Pi is the apparent first-order absorption rate 
constant. After integration of the differential equation, the following relationship is obtained: 
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C = 
Indicating that the concentration at the site of injection, having an initial value Cj, at time 
zero, declines exponentially. The half-life of the absorption process is: 
ti/2 = In 2/Pi = 0.693/Pi 
When the rate of disappearance from the site of injection to concentration remaining at the 
injection site is not constant at all times after injection, die absorption is called nonlinear. This is 
a common situation, because local and systemic factors that influence the rate of absorption rarely 
remain constant while absorption takes place (Greenblatt and Koch-Weser, 1976). 
Hoppe (1991) reported in swine that after i.m. administration of equimolar doses of d-a-
or d-7-tocopherol in water based emulsion, Tmax was 4 and 8 h for a- and 7-tocopherol, 
respectively; and that based on the AUCo^g^ a-tocopherol was 2.1 times more bioavailable than 
7-tocopherol. He also stated that tocopherol was 4-5 times more bioavailable after i.m. 
administration than after oral administration. 
Hidiroglou and Karpinski (1991) noted that absorption (.174 h"') and elimination (.02 h ') 
rates of dl-a-tocopheryl acetate in liquid emulsion, after i.m. administration to sheep, are 
independent of dose, but that the extent of the absorption is parallel to dose. They also reported a 
lag phase following i.m. administration. Njeru et al. (1992) reported in sheep that a single i.m. 
injection of dl-a-tocopherol in an emulsifiable solution had an elimination rate independent of 
dose, whereas the absorption rate increased with increasing dose. They used a three-phase linear 
model to describe this results. 
In man (Rindi and Perri, 1958) and in dog (Bauemfeind et al., 1974; Fujii, 1980) after 
i.m. administration of dl-a-tocopheryl acetate, the peak of tocopherol in serum was always later 
than the peak of the acetate form (8 h). Therefore, hydrolysis of the tocopheryl ester was the 
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limiting step in bioavailability. 
Gallo-Torres and Miller (1971) reported hydrolysis of dl-a-tocopheryl acetate by the liver 
in rats. These authors found that, 30 min after i.v. administration, 79% of the radioactivity in the 
liver was due to quinone derivatives, 15% to the ester form, and only small quantities were due to 
the alcohol form. They also reported the same biotransformations in several other tissues and 
also indicated that blood contains enzymes capable of hydrolyzing esters of tocopherol. In 
contrast, Bauemfeind et al. (1974) reported that the blood does not have enzymes capable of 
hydrolyzing dl-a-tocopheryl acetate after an in vitro incubation of dog fresh blood at 37°C for up 
to 2 h. Newmark et al. (1975) reported similar results after incubation of human and dog blood 
at 37°C for up to 3 h. The same authors reported that 24 h after i.v. administration of dl-a-
tocopheryl acetate in dogs, 25% of the dose lost the acetate, whereas Ogihara et al. (1985) 
reported 36% in the case of rats. Therefore, differences seem to exist in the hydrolytic capability 
among species. 
Ogihara et al. (1985) also reported that 24 h after i.v. administration, the ester reached 
undetectable concentration in plasma, whereas 48 h were needed to reach those undetectable 
concentrations in red blood cells. Knight and Roberts (1986) observed that not all the a-
tocopheryl acetate was converted to tocopherol. This was probably due to the short duration of 
the experiment that did not allow total biotransformation of the ester. They also observed a-
tocopheryl acetate uptake by tissues. In premature infants receiving constant i.v. nutrition 
(including a fat emulsion supplemented with 4.5 mg of all-rac-a-tocopheryl acetate per kg of BW 
and day during 5 days), the ester form was readily hydrolyzed and the free form was released, 
resulting in good bioavailability (Schwalbe et al., 1992). These results indicated that premature 
infants had the enzymatic capability to hydrolyze the ester. 
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Hidiroglou and Atwal (1989) reported that the i.p. route was successfully used in cattle 
for administration of the free and acetylated forms of dl-a-tocopherol in emulsion, using 
polyoxyethylene sorbitan monooleate (Tween 80), and that the ester form resulted in higher milk 
tocopherol and lower plasma tocopherol content than the free form. Hidiroglou and Charmley 
(1990) reported that in sheep, after i.p. administration of 100 mg of dl-a-tocopheryl acetate per 
kg BW in Tween 80, Tmax was observed after 32 h. They also showed that, based on the AUQ). 
192 h, the i.p. route of administration was 1.2 times more bioavailable than the intraruminal route. 
Neither reference, however, reported the plasma tocopheryl acetate profile. Therefore, there was 
no information about whether the disacetylation process took place in the abdominal cavity or 
once absorbed in the blood stream. 
Hidiroglou and Karpinski (1987) studied the kinetics of 200 fiCi of d-a-[^H] tocopherol in 
ethanol of a physiological i.v. dose to sheep. The change in plasma tocopherol concentration with 
time was expressed as a sum of three exponentials (Ct = K, e"'''' + K2 e'^' + K3 e'*^ *), where 
the intercepts were: = 150,000, K, = 35,000, and K3 = 13,000 dpm/mL; and the slopes 
were: PI = .30, P2 = .48, and P3 = .014 h"\ Based on these estimates, a three compartmental 
model was proposed (Figure 3). In the case of i.m. administration, changes in plasma 
concentration with time (Figure 4) were characterized by a rapid absorption phase [Ct = Kj (1 -
e""'^')] and a slow absorption + elimination phase (Ct = K2 e"^' - K3 e""') The intercepts were 
K, = 1,700, Kj = 4,700, and K3 = 3,700 dpm/mL, and the slopes were PI = 1.73, P2 = 
.0042, and P3 = .13 h"'. The availability of tocopherol following i.m. administration, relative to 
the i.v. administration, was 51%. In this experiment, Tmax was detected 32 h after 
administration. 
Based on the AUC0.3191, [(/ig/mL) h], Hidiroglou and Karpinski (1988) reported that i.v. 
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administration of d-a-tocopheryl acetate (1120) was much better utilized by sheep than dl-a-
tocopherol (676) or dl-a-tocopheryl acetate (772). In this experiment, even though they injected 
the ester form, only the kinetics of the free tocopherol was reported. Therefore, after 
administration of the ester 62.4 and 28.4 h were needed to reach the maximum concentration of 
the free form, with a Ke of .028 and .045 h"' for the dl-a-tocopheryl acetate and the d-a-
tocopherol, respectively. When they i.v. injected dl-a-tocopherol, the profile was represented as 
a sum of three exponentials (Ct = Base + K, e"'''' -f- K2 e'^' + K3 e"'^'), where the intercepts 
were: K, = 46, Kj = 16, and K3 = 3 iig/niL h; and the slopes were: PI = 50, P2 = .6, and P3 
= .006 h-^ 
Hidiroglou et al. (1990) studied the kinetics of an i.v. dose of 2 nCi of d-Q:-[^H] 
tocopherol in emulsion per kg BW in sheep. The change in plasma concentration up to 56 h after 
administration was expressed as a sum of two exponentials (Ct = Kj e"'''' + Kj e'^')» where the 
intercepts were: Kj = 11,000, and Kj = 5,700 dpm//ig/mL; and the slopes were: PI = .7, and 
P2 = .02 h"'. Based on these estimates, they also were able to fit the data to a two 
compartmental model (Figure 3). 
Karpinski and Hidiroglou (1990) studied the kinetics of i.v. administration of 4 /nCi of d-
a-[^H] tocopherol in emulsion per kg of BW in sheep. The change in plasma concentration up to 
432 h after administration was expressed as a sum of three exponentials (Ct = Kj e"^'' + Kj e"*^ 
' -I- K3 e"'^ •), where the intercepts were; K, = 105,000, Kj = 28,000, and K3 = 4,000 dpm/ftg; 
and the slopes were: PI = 1.56, P2 = .062, and P3 = .006 h'^ 
Others. The percutaneous route of administration has been the focus of recent attention 
regarding topical therapy of the skin with vitamin E. Two routes of absorption of tocopheryl 
acetate by the skin have been proposed by Kamimura and Matsuzawa (1968). The first route is 
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from the stratum corneum into the epidermis and into the dermis, and the second route is through 
the hair follicles, by the way of the pilosebaceous canal into the dermal tissue and the connective 
tissue sheaths. 
Tocopheryl esters are hydrolyzed by enzymes in the gastrointestinal tract prior to 
absorption at the intestinal wall. In contrast, if absorbed through the skin, tocopheryl acetate is 
not exposed to hydrolytic enzymes. Tocopheryl acetate can diffuse across skin cell membranes, 
enter the cell, and be associated with mitochondria, endoplasmic reticulum and nuclear 
membranes. At this level, cellular esterases may release the free alcohol form of this vitamin 
(Trevithick et al., 1992; Trevithick and Mitton, 1993). These authors also reported that topical 
application of free tocopherol irritated the skin of mice. 
Sow Reproduction and Nutrition 
Reproductive performance is generally determined by the number of pigs weaned per sow 
per year and is affected by the number of pigs bom and weaned per litter and the number of 
litters per sow per year. For a meaningful between-herd comparison of number of pigs weaned 
per sow per year, it is necessary that gilts be considered to be a part of the breeding herd from 
the time they are selected for breeding and are withheld from market. Thus, to maximize 
reproductive efficiency, the objective is to mate gilts early and keep them producing healthy and 
large litters as frequendy and for as long as possible. 
The effect of nutrition on the reproductive performance of the sow is very difficult to 
measure because a variety of factors, including environmental and management systems, can mask 
the sow's responses, and her capability to cope with minor nutritional deficiencies. Nutrient 
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requirements are different for the various stages of the reproductive life of the sow, and this needs 
to be recognized to achieve maximal reproduction. 
Around 35% of the sows in a herd are culled each year and replaced with gilts. Gilts 
produce smaller litters than sows, and as a result, a high culling rate has a significant impact on 
the number of pigs weaned per breeding female. Therefore, the full expression of the 
reproductive performance of the gilt is important. Factors that may affect this include age, 
weight and body condition at mating, and the ability to be rebred after weaning. 
Age at puberty 
The mean age at puberty of gilts is about 200 days in breeds commonly available in the 
U.S. However, relocating gilts to another pen, mixing them with gilts from another pen, and/or 
exposing them to a mature boar can induce puberty about 30 days earlier than in non-induced gilts 
(Aheme, 1991). 
Conditions of management and nutrition that support acceptable growth rates during 
rearing are thought to be adequate for the proper development of the gilt and her subsequent 
reproductive performance (Close and Cole, 1986). Newton and Mahan (1993) reported that 
breeding weight from 120 to 150 kg at 8 mo of age does not affect the onset of puberty. 
Moderate protein restriction does not affect age at puberty. In contrast, severe protein restriction 
or amino acid imbalance does delay the age at puberty (Jones and Maxwell, 1974). Increasing 
energy intake of gilts for one estrous cycle prior to breeding (flushing) has been reported (Schultz 
et al, 1966) to result in an increase of 1.9 corpora lutea. Other factors, such as environment and 
management, have a greater impact on the onset of puberty than nutrition. 
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Bndv condition 
Minimum fat cover, at least 10 mm backfat, is required for successful reproduction. Gilts 
that are bred at younger ages and lighter weights widi lower backfat depths have higher 
subsequent culling rates. In spite of this, the same lean gilts can maintain their original backfat 
depth and productivity as long as can gilts bred at heavier weights with greater backfat depths if 
lean gilts are provided good nutrition and management (Aherne, 1991). 
Ovulation rate 
In swine, the main constraint on litter size is ovulation rate. Archibong et al. (1987) 
suggested that, when puberty occurs at a young age and low body weight, ovulation rate increases 
with successive estrous periods; thus, delaying mating until the second or third estrus increases 
the ovulation rate and embryo survival. However, beyond a minimum age and weight, neither 
age, weight, nor number of estrus periods exhibited influence ovulation rate or litter size 
(Kirkwood and Thacker, 1988). Flushing gilts for 11 to 14 d before mating increases the 
ovulation rate, but only to the levels achieved by ad libitum-fed gilts (Den Hartog and van 
Kempen, 1980). Flushing increases insulin concentration in blood. This elevation in insulin level 
has been reported to increase ovulation rate, but it is not always accompanied by increases in 
plasma gonadotrophin level (Robinson, 1990). Thus, ad libitum feeding during the growing-
fmishing phase and up to mating maximizes ovulation rate. 
Pregnancy and conception rate 
Pregnancy rate may be defined as the proportion of sows selected for breeding that 
become pregnant, and conception rate may be defined as the proportion of selected sows mated 
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that become pregnant. In sows fed for 35 days before mating at a level of 1.5 kg, conception rate 
was not affected, but pregnancy rate was lower than that of gilts fed 2.25 to 3.0 kg/day (Dyck, 
1988). Den Hartog and van Kempen (1980) reported that high or low levels of feed intake up to 
puberty or during the estrous cycle did not significantly affect conception rate. 
Nutrition of the embrvo 
Swine have epitheliochorial placentae in which the maternal blood supply is well separated 
from the absorptive surface of the chorion. Consequently, nutrients need to be transferred from 
the endometrial surface and glandular epithelium to the choricallantcis (Ashworth, 1991). The 
uterine milk (histotroph) secreted by the uterine glands furnishes, during early pregnancy, a good 
part of the nutrients that diffuse through the placental membranes and reach the fetuses. 
However, in advanced pregnancy, the nutrients come from the maternal circulatory system and 
are transported across the placenta into the fetal circulation. Different types of placentae have 
different degree of permeability to minerals, fats, carbohydrates, and proteins. The placental and 
fetal cells have a greater metabolic rate than the cells of the maternal tissues, and red blood cells 
from the fetus have a higher oxygen-carrying capacity than maternal ones (Nalbandov, 1976). 
Conceptus secretions 
Blastocysts secrete a variety of compounds prostaglandins, binding proteins for insulin, 
proteins with antiviral activity, and plasminogen activator. The roles of most of these secretions 
are not clear, but may increase endometrial prostaglandin synthesis and interact with estrogen to 
alter prostaglandin (luteolytic agent) movement into the uterine lumen. At 11 to 12 d of 
pregnancy, estrogen secretion by the pig conceptuses increases. It is at this stage of gestation that 
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the corpus luteum must be protected from luteolysis to establish pregnancy and maintain 
progesterone levels to term. Conceptus estrogens increase uterine arterial blood flow, uterine 
vascular permeability, and increase the concentrations of protein, calcium, prostaglandin, and 
plasmin inhibitor in uterine secretions (Ashworth, 1991). 
Embryo mortality 
In pigs, the fertilization rate is close to 100%, but only 60% of the ova shed culminate in 
the birth of living piglets (Ashworth, 1991). Many factors affect embryonic mortality in the pig, 
such as feeding, age of gilts at mating, weaning to remating interval, environment, mating sire, 
breed, level of inbreeding, immunological factors, age and parity of the sow, disease, hormone 
treatment, length of lactation, time of entry of embryos into the uterus, intra-uterine position and 
crowding of embryos, chromosomal abnormalities, and anesthesia [see reviews by Stone (1987) 
and Clark et al. (1988)]. 
At the time of implantation, when delicate hormonal changes occur, most of the embryo 
mortality takes place. Any disturbance to the dam at this stage will cause hormonal upset and 
increase the number of eggs which die (Varley, 1991). Early weaned sows have very high 
embryonic loss and also show disturbed hormonal profile. Sows injected with pregnant mare's 
serum gonadotropin, which can stimulate ovarian steroid secretion, on day 15 of pregnancy 
produced a high number of viable embryos (Stone, 1987). Sows fed progesterone orally for 4 
days after breeding had greater embryo survival than sows fed control diets (Schultz et al., 1966). 
Great variation exists in the developmental stage among littermate embryos, and a 
relatively advanced embryo has a greater chance of survival. The relatively advanced embryos 
secrete increasing quantities of estradiol from d 11 to 12, which alters uterine function in 
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accordance with their increasing requirements. The lesser developed embryos are consequently 
exposed to an uterine environment too advanced, from a biochemical point of view, for their 
needs, and this environment becomes embryocidal (Ashworth, 1991). 
Therefore, the increased survival at this early stage of the embryo life could be either the 
result of a better recognition of live embryos by the hormonal and autocrine mechanisms or the 
result of an increased viability of the embryos themselves (Buttle, 1991). Youngs et al. (1994), in 
a reciprocal embryo transfer study involving Meishan and Yorkshire pigs, suggested that the 
higher prolificacy of Meishan pigs compared with that of Yorkshire pigs may be due not only to 
the slower growth rate of the embryos and an associated more gradual change in estradiol 
secretion, but also to uterine factor(s) with a suppressive effect on embyonic growth and estradiol 
secretion. 
The incidence of mununified fetuses increases in sows carrying 10 or more fetuses after 
50 d of gestation. This has been associated with a lack of uterine space resulting in intra-uterine 
crowding. Other factors implicated in such fetal mortality include maternal nutrition, thermal 
effects, and limitations of blood flow (Ashworth, 1991). 
During the first half of pregnancy, a low plane of nutrition does not affect fetal weight 
adversely if dietary intake is adequate during the second half. An inadequate plane of nutrition 
during the second half of pregnancy, or competition for available nutrients in polytocous species 
like swine, reduces the size of the pigs at birth. On the other hand, excessive food intake by the 
dam does not cause fetal growth beyond the normal size. Thus, fetal size and weight at birth, up 
to the normal size and weight, depends on the plane of nutrition of the female during the second 
half of pregnancy (Kirkwood and Thacker, 1988). 
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Nutrition for gestation 
The major energy source in the newborn pig is glycogen. Nevertheless, an increase in 
glycogen quantity through the diet does not necessarily improve piglet survival. Muscle fiber 
hyperplasia ceases between 85 and 95 d of gestation, and a reduction in the total number of fibers 
in muscle of the smallest fetus as compared with the largest one in a litter has been observed. As 
a consequence, undernutrition of the sow at that time can have a detrimental effect on subsequent 
performance of the litter (Robinson, 1990). 
Feed intake by gestating sows should be limited to control weight gain during pregnancy. 
Sows should gain a total of 45 kg during the whole gestation period for at least the first three or 
four parities, 20 kg for the increase in weight of the placenta and other products of conception, 
and 25 kg for body weight gain. To achieve this goal, gestation feed intake should be maintained 
between 1.7 and 2.3 kg per day (6.1 Meal of metabolizable energy per day) (NRC, 1988). 
Fasting gilts for 10 days during late gestation after feeding a high-fat diet results in an 
increase in plasma fatty acid concentration of the dam, but the use of fatty acids by the fetus is 
limited (Ruwe et al., 1991) by the poor utero-placental fatty acid transfer (Thulin et al., 1989; 
Ramsay et al., 1991). Overfeeding during pregnancy reduces voluntary feed intake during 
lactation and seems to impede mammary development (Pettigrew and Tokach, 1991). The 
nutritional objective during gestation is to conserve body condition, and, as a consequence, sows 
should gain 1 to 2 mm of backfat in this period and not should lose more than 1 to 2 mm during 
lactation (Aherne, 1991). 
Diets low in protein (.5% to 2%), protein-free diets, or even periods of complete 
inanition of sows did not adversely affect embryo or fetal development or litter size, but did 
reduce birth weight of the pigs (Speer, 1982). 
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Feeding fat during late gestation increases glycogen and fat content of the liver and 
skeletal muscle of newborn pig. Adding fat, butanediol, fructose, or starch to the gestation diet 
has minor effects on sow reproductive performance, pig survival, or litter growth (Aheme, 1991). 
Milk production 
There are three important aspects of the lactation period. First, antibodies are transfered 
via the colostrum during the first 24 hours post-parturition; second, the sow lets down 20 to 25 
mL of milk once every 40 min or so for the duration of lactation; and third, the composition of 
the milk is rich in fat and protein. From a endocrinological point of view, lactation is 
characterized by elevated prolactin concentrations, and a suppression of gonadotropin secretions 
(Buttle, 1991). 
In pigs, active mammary growth is restricted to the last third of pregnancy. The complex 
of hormones that stimulate mammary growth consists of the anterior pituitary gland hormones 
(prolactin and growth hormone), the steroid hormones (estrogen and progesterone), as well as 
metabolic hormones (e.g., adrenal steroids and insulin). Pigs do not produce a placental lactogen, 
but their placentae do produce estrogens in large amount, coincident with mammary growth. In 
ovariectomized pregnant pigs, the administration of relaxin stimulated mammary growth. Relaxin 
is a hormone similar in structure to insulin, it is formed in the corpora lutea of pigs during 
pregnancy and plays an important function in mammogenesis, parturition, and lactogenesis of pigs 
(Buttle, 1991). 
The function of the sow is not only to produce large litters of viable pigs, but also to 
ensure their survival and rapid growth. The most important factors affecting milk yield of the 
sow are her genetic potential, nutrient and energy intake, body condition, and the demands made 
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by the Utter. The average milk yield of sows ranges from 5 to 10 kg/d, but gilts produce less 
milk than sows. Milk yield increases up to the third parity after which it plateaus and then 
declines at the fifth or sixth parity. Milk yield increases gradually postpartum and reaches a peak 
at about d 21 of lactation (Aheme, 1991). Estimation of milk yield can be made by assuming that 
each gram of litter weight gain up to 21 days of age requires about 4 g of milk (Noblet and 
Etienne, 1986). 
The composition of milk from the sow varies with nutrient and energy intake in gestation 
and lactation, and the stage of lactation. The composition of colostrum changes rapidly during the 
first 12 hours after farrowing. The gannma globulin fraction of colostral protein declines from 
8.6% at farrowing to 2% at 12 hours postpartum. After 48 hours postfarrow, the composition of 
the sow's milk changes little (Aheme, 1991). 
Nutrition for lactation 
Daily feed intake of 4.4 to 6.1 kg of a corn-soybean meal diet containing 3.34 Meal of 
DE/kg, 13% CP and 0.6% lysine allows the production of average milk yield of 5 to 7 kg/day, 
and enable a minimal loss in sow weight or condition throughout lactation. Sows producing 
greater milk yields than 5 to 7 kg/day require additional feed. A considerable percentage of sows 
do not consume or obtain the levels of feed recommended by NRC (1988), causing them to 
mobilize their body reserves, both protein and fat, to maintain milk production (NRC, 1988). 
Factors affecting feed intake have been reviewed by Aherne (1991), and include appetite, milk 
yield, gestation-lactation feed intake interactions, temperature, and system of feeding. 
Energy intakes of less than 12 Meal DE per day for first-litter gilts has been reported to 
increase weight and condition loss, as well as reduce conception rate, embryo survival, and 
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subsequent litter size. These effects are less obvious in multiparous sows (Reese et al., 1984). 
Digestible energy intake of a lactating sow can be increased by supplementation of her diet with 
fat. This supplementation increases litter weaning weights, but a clear benefit on reproductive 
function has not been shown. Excessive energy intake during pregnancy interferes with mammary 
development (Pettigrew and Tokach, 1991). In general it is advisable to add fat or oil to the 
lactating sow diet during the summer, when hot weather can decrease feed intake. 
No significant differences in the productivity of the sows fed isonitrogenous and isocaloric 
diets with or without cereals were found by Van der Peet-Shwering and der Hartog (1991). 
Feeding sows diets deficient in amino acids resulted in great mobilization of body protein, and 
this condition has been associated with prolonged weaning-to-estrus interval because of lower 
mean plasma concentration of luteinizing hormone (Jones and Stahly, 1995). 
Excessive loss of either fat or protein body reserves reduces sow reproductive 
performance. At this point, the critical factor seems to be the amount of body reserves at 
farrowing and weaning, rather that the amount of tissue that has been mobilized during lactation. 
As a consequence, weight loss in a thin sow may be more serious than a large weight loss in a 
sow in good condition (Esbenshade et al., 1986). 
There is no reason to think that lactating sows have larger calcium and phosphorus 
requirements than the levels suggested by NRC (1988). The milk of the sow is rich in calcium 
and phosphorus, so the requirement for those minerals is high during lactation. Demineralization 
of the bones is needed to maintain adequate concentration of calcium and phosphorus in milk, but 
this demineralization does not cause problems unless it reaches an excessive level (Aherne, 1991). 
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Weaning-to-rebreeding interval 
Delay of estrus activity is one of the main reasons for early culling of sows in the herd. 
Protein or energy intake depression during lactation can delay the return to estrus after weaning. 
This is more evident in gilts than in multiparous sows, and even more accentuated in those gilts 
mated for the first time at a young age (Robinson, 1990). 
Vitamin E and Reproduction in Swine 
In recent years, an increased interest focus on supplementation of sow diets with specific 
vitamins at levels higher than those previously thought to be adequate has emerged. Special 
attention has been paid to six vitamins. 
Choline is found at high level in soybean meal, and for many years this level was thought 
to be adequate for optimal production. Feeding grain-soybean meal diets supplemented with 438 
to 800 mg/kg of choline increased litter size and weight of the pigs at farrowing (NRC, 1988). 
Biotin supplementation of sow diets (.20 mg/kg) improved litter size at farrowing and 
weaning, litter weight at weaning, and weaning to estrus interval (NRC, 1988). 
Parenteral administration of folic acid increased prolificacy of multiparous sows 
(Friendship and Wilson, 1991). On the other hand, Matte et al. (1993) showed that reproductive 
capacity of gilts was not affected by dietary supplementation of folic acid. Lindemann (1993) 
concluded that the positive effect of folic acid during gestation seems to be a consequence of 
improved embryo or fetal survival rather than an increase in ovulation rate. Supplementation of 
folic acid in gestation diets could be beneficial for high reproductive capacity animals. 
Weekly injection of jS-carotene improved embryo survival and litter size in pigs (Brief and 
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Chew, 1985). Injection of /S-carotene or vitamin A at weaning time improved subsequent litter 
size (Coffey and Britt, 1991). Chew (1993) concluded that /3-carotene can affect reproductive 
performance in swine by influencing ovarian steroidogenesis or changing the uterine environment. 
The route of administration for (3-carotene needs to be studied, because swine absorb little or none 
of this provitamin from the diet. 
Bazer and Zavy (1988) reported that a daily dose of 110 mg of riboflavin from d 4 to 10 
of pregnancy produced a transitory increase in riboflavin concentration in uterine flushing, and 
this event was accompanied by a improvement in litter size. Wiseman et al. (1991) failed to 
confirm these observations when gilts were treated with 65 or 150 mg of riboflavin per d for 28 
consecutive d beginning 5-10 d before breeding. 
Vitamin E is the sixth of this group of vitamins and is the subject of the present 
dissertation. The benefit of supplemental vitamin E in addition to what is contained naturally in 
the swine diet is unclear (for review see Pharazyn et al., 1990). 
Vitamin E requirement of swine 
Recommendations for vitamin E supplementation of sow diets vary among countries. 
The NRC (1988) requirement, used in USA and Canada for bred and lactating sows, is 22 lU/kg 
of diet. In the UK, the ARC (1981) recommendation is 9 lU/kg of diet. In the case of the 
Netherlands, dietary supplemental levels of vitamin E vary from 10 to 30 lU/kg (Pharazyn et al., 
1990). On the other hand, the level of vitamin E used in Denmark is as high as 37 lU/kg of diet. 
Many factors need to be considered when assessing vitamin E requirements for animals. 
The term vitamin E is a generic name, representing the eight structural isomers previously 
discussed. In the pig, a-tocopherol has the greatest biological activity (McMurray et al., 1983). 
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There are other dietary, physiological, genetic (Less, 1990), and environmental factors that can 
affect the requirement of vitamin E for animals of reproductive age. 
Vitamin E. Se and dietary fat 
Many of the experimental studies reported in the literature have evaluated the combination 
of dietary Se, vitamin E and fat. 
Chavez and Patton (1956) considered levels in a basal diet of .1 ppm Se and 15 lU 
vitamin E/kg of diet to be adequate. In this single parity study, thirty-one sows were assigned to 
three groups: the basal diet, basal diet plus injection of 3 ml of Dystocel (total 3 mg Se and 408 
lU vitamin E) at d 30, 60, and 100 of gestation, or the second treatment provided with an 
additional injection of Dystocel at weaning of the previous litter. No significant differences in 
reproductive performance were found among injected groups, but when compared with non-
injected animals, the injected ones had a greater litter size at birth, at weaning, and a lower 
mortality of the pigs prior to weaning. Van Vleet et al. (1973) reported a reduction in perinatal 
mortality in pigs from Se-vitamin E injected sows within 2 to 3 wk of farrowing and fed a 
deficient diet in vitamin E. In contrast, Malm et al. (1976) fed a control or a semi-purified diet 
containing .3 lU per kilogram of vitamin E and .05 ppm as Se supplementation to gestating gilts, 
and found no evidence of decreased reproductive performance or signs of clinical deficiency. 
Piatkowski et al. (1979) used a 2x2 factorial design and initiated dietary treatments at 150 days 
before breeding and continued over one gestation. The semi-purified basal diet contained .02 
ppm Se and 6 mg of a-tocopherol/kg of diet and it was supplemented with 0 or 0.1 ppm Se 
and/or 0 or 22 mg of vitamin E/kg of diet. At 105 days post-coitus, gilts were slaughtered, and 
no response in litter size and weight was found to dietary vitamin E supplementation. The 
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conflicting results in the above studies may be due to the differences in dietary level of Se. 
The results from the experiment of Piatkowski et al. (1979) indicated that vitamin E and 
Se, provided by both the semi-purified basal diet and tissue reserves, were adequate for the first 
parity, but .1 ppm Se and 22 lU vitamin E/kg were necessary to maintain tissue levels. Glienke 
and Ewan (1977) demonstrated the presence of vitamin E deficiency symptoms in pigs from sows 
during the second and subsequent parities that were fed a vitamin E-deficient diet for five parities. 
No symptoms were observed in the sows. Sows were able to buffer short-term deficiencies of 
vitamin E in the diet for a limited period of time, but deficiency symptoms appeared in the 
offspring. 
The metabolism of vitamin E and its requirement by mammals is affected by the type of 
dietary fat. The use of fat, especially polyunsaturated fat, in late gestation and lactation to 
increase the energy intake of the animal (Pettigrew, 1981) may increase the requirement of the 
sow for vitamin E. As dietary intake of polyunsaturated fatty acids increases, the requirement for 
tissue antioxidant and, therefore, for vitamin E, increases. Tissue levels of a-tocopherol are 
reduced with high dietary intake of polyunsaturated fats (Bieri et al., 1978). For growing pigs, 
the ARC (1981) suggested an increase of .25 mg of d-a-tocopherol per gram of polyunsaturated 
fat added in the diet. A trend was observed for lower serum a-tocopherol when corn oil rather 
than lard (both stripped of vitamin E) was provided in the diets of gilts at the same levels (Malm 
et al., 1976). Two experiments were conducted by Babinszky et al. (1992a) to asses the effect of 
fat and tocopherol levels in the lactation diet on the performance and milk production of pigs. In 
Experiment 1, they used two different levels of animal fat, low (43 g/kg of DM) and moderate 
(75 g/kg of DM) with tapioca starch, and two levels of vitamin E, low (13 to 16 mg/kg of diet) 
and high (117 to 135 mg/kg of diet). In Experiment 2, the two different levels of animal fat 
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were: low (37 g/kg DM) and high (125 g/kg DM) with com starch, and two levels of vitamin E 
were; low (21 to 24 mg/kg of diet) and high (140 to 163 mg/kg of diet). They concluded that the 
different fat levels did not affect liver weight, backfat thickness, or milk production of the sows, 
and utilization of dry matter, fat, protein and energy of milk for baby pig growth. The high 
dietary fat with corn starch increased the dry matter, fat, and energy content of the milk and the 
daily gain of piglets between d 18 and 25 of lactation. The dietary vitamin E levels had no affect 
on any of the variables under investigation. In a different study (Babinszky et al., 1992b), gilts 
were fed two different sources of fat (animal fat or sunflower oil) with three levels of vitamin E 
in the diet during gestation and lactation. No effect of the type of fat on reproductive 
performance was reported. Also, milk production was not affected by the different levels of 
vitamin E: Low (12 to 16 mg/kg of feed), medium (45 to 50 mg/kg) ,or high (117 to 140 
mg/kg). The authors concluded that colostral vitamin E concentration may increase with 
increasing levels of vitamin E combined with animal fat, and milk vitamin E concentration at 
weaning was higher when the diet contained animal fat. 
Vitamin E and tissue concentration in post-puberal female pigs 
The time necessary to develop deficiency symptoms after feeding a diet deficient invitamin 
E and Se is longer in gilts or sows than in younger animals (Mahan et al., 1974; Piatkowski et 
al., 1979). Sows fed a corn-soybean meal diet without supplemental vitamin E or Se did not 
show any sign of myopathies until after the second parity (Mahan et al., 1974). 
The status of vitamin E and Se in an animal reflects the amount provided by the diet and 
body reserves. During the growth phase, the vitamin E and Se requirement is high, but during 
the reproduction process this requirement is increased. The contribution of these two nutrients 
46 
from the feedstuff can vary and consequently can affect the body pool size of each nutrient. 
These stores can be mobilized when reproductive demands exceed the supply from the diet. As a 
result, the concentration of these nutrients accumulated in the tissue during the growth of the 
animal, the vitamin E and Se levels in the diet, and the reproductive capacity of the female will 
dictate whether an animal will show deficiency during her life. 
Vitamin E transfer to the progeny 
Placental. The nutrients present in the maternal blood reach the fetal blood after crossing 
the epitheliochorial placenta in swine. Beside this anatomical barrier, there are many other 
factors that affect the rate of maternal-fetal transfer such as uterine-placental blood flow, the size 
and chemical characteristics of the compound to be transported, the metabolic activity of the 
placenta, and the fetal circulation. The concentration of lipid-soluble vitamins in the fetal 
bloodstream is lower than that in the maternal blood. Passive diffusion has been suggested to be 
the transport mechanism of vitamin E by the human placenta (Rosso, 1990). 
Pigs are born with a poor vitamin E status, whereas their Se status reflects the level of Se 
fed to the sow (Malm et al, 1976; Mahan et al., 1977; Young et al., 1977; Loundenslager et al., 
1986). Mahan (1991b) reported that placental transfer of vitamin E is poor but reflects the level 
in the diet of the sow. Placental transfer of vitamin E is lower than for Se. Consequently, 
increasing the levels of tocopherol and/or Se in the pregnant animal diet increases fetal Se 
reserves but has little effect on fetal vitamin E status (Mahan et al., 1977; Mahan, 1991b). This 
effect on Se status of neonates was not found when an injectable Se and vitamin E was 
administered along the gestation period of sows fed a diet supplemented with 0.1 ppm Se and 15 
lU vitamin E/kg (Chavez and Patton, 1986). Therefore, newborn pigs are dependent on 
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colostrum and milk intake or any other exogenous sources to balance this low vitamin E status. 
Fetal serum Se was negatively correlated with fetal serum vitamin E concentration, and 
fetal whole blood glutathione peroxidase activity was correlated negatively with maternal serum 
vitamin E concentration, leading Van Saun et al. (1989) to the conclusion that Se spares the 
requirement of vitamin E in die fetus. Newborn infants are similarly born with low plasma 
vitamin E levels. Those levels are difficult to increase by maternal supplementation during 
pregnancy (Mino and Nishino, 1973). The levels of plasma |8-apolipoprotein, which transports 
tocopherol, are low in the human fetus (Kayden, 1983) and as a result may limit the capacity for 
transport of vitamin E across the placenta. Kelly et al. (1992) reported that significant tocopherol 
storage takes place in the fetal liver of guinea pigs by the end of gestation. They concluded that 
the newborn guinea pig utilized liver stores to increase plasma tocopherol concentration after 
birth. 
Colostrum and milk. Vitamin E and Se effectively traverse manunary tissue. Schweigert 
(1988) reported that low-density lipoprotein receptors increase in mammary tissue during the 
formation of colostrum, and that they may help transfer lipophilic substances into the colostrum. 
Colostrum has a higher concentration of Se and vitamin E than does milk, and both nutrients are 
elevated in mature milk secretions as the dietary concentrations are increased (Piatkowski et al., 
1979; Loudenslager et al., 1986; Mahan, 1991b). Therefore, the requirement of the dam during 
lactation is greater for these nutrients, and this is accentuated when the sow has a larger litter size 
and for a longer lactation period. Older sows had a lower vitamin E and Se concentration in the 
milk than younger sows, suggesting a depletion of those nutrients with age. There is no depletion 
of vitamin E in milk associated with parity if vitamin E is supplemented ( Mahan, 1991b; Mahan 
et al., 1974, 1977). Furthermore, over one parity, tissue reserves of vitamin E are adequate to 
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meet demands for secretion into both colostrum and milk (Hardy and Frape, 1982). 
Newborn pigs have low circulating levels of vitamin E. Subsequent changes in plasma 
vitamin E and Se concentration after birth are influenced by the vitamin E, Se and 
polyunsaturated fatty acid contents of milk, the daily milk intake, and the efficiency of intestinal 
fat absorption. Greater tissue reservoirs of those nutrients in pigs at weaning time are a reflection 
of those factors, and this condition is beneficial in preventing the onset of deficiency later in the 
growth phase (Cline et al., 1974; Mahan et al., 1977). This greater colostrum and milk 
tocopherol may be even more beneficial to pigs when they are housed in a dirty environment 
(Mahan, 1994). 
Vitamin E and parturition problems 
In dairy cattle, retained placenta has been reported as a sign of Se-vitamin E deficiency; 
however, this has not been demonstrated in swine. Signs of this deficiency in reproducing sows 
are an inadequate prostaglandin production resulting in an impaired smooth muscle contraction 
that is expressed as extended parturition time, poor milk letdown, weak newborn pigs, and pigs 
with spreadlegs (Mahan, 1991a). Mastitis, metritis, and agalactia (MMA) in sows are a complex 
syndrome. Sows in poor sanitary conditions are exposed to a greater concentration of pathogens 
and toxic substances. Consequently, those sows have a high incidence of MMA. Sows in poor 
sanitary conditions tend to respond more positively to dietary vitamin E supplementation than 
sows in good sanitary conditions (Mahan, 1994). 
49 
Vitamin E and Fe tolerance in voune pie 
Low Fe reserves found in neonatal pigs lead to anemia if iron is not available (ARC, 
1981). To prevent the development of anemia, the newborn piglet is injected i.m. with iron-
dextran. In vitamin E and Se-deficient pigs, an i.m. injection of Fe-dextran may lead to severe 
bruising, high serum aspartate amino transferase, and in some cases, death 8 to 12 h post-
injection. Synthetic antioxidants are able to prevent the Fe-induced myopathy and bruising 
observed in vitamin E-deficient pigs. The prevention of this symptom by vitamin E is attributable 
to its antioxidant function in cell membranes (Tollerz, 1973). Loudenslager et al. (1986) 
conducted an experiment to assess the biological antioxidant status of neonatal pigs and their 
subsequent tolerance to parenteral Fe. The biological antioxidant status of the newborn unsuckled 
piglets, measured by serum a-tocopherol concentration and glutathione peroxidase (GSH Px) 
activity, was low and unaffected by the maternal diet during gestation. Symptoms of Fe toxicity 
were not observed, but injection of Fe altered the antioxidant status of the neonates by decreasing 
plasma tocopherol, increasing plasma Se concentration, and increasing plasma GSH Px activity. 
Vitamin E and immunltv 
There is little placental transfer of immunoglobulins to the fetus; consequently newborn 
pigs are essentially devoid of circulating antibodies. Antibodies in colostrum are derived from the 
serum of the dam and provide systemic immunity to the newborn pig. Immunoglobulin G is the 
main component of the colostrum immunoglobulin fraction. Milk provides local immunity to the 
intestinal tract of the pig during the lactation period. Antibodies present in milk are produced in 
the mammary tissue, with immunoglobulin A as the main component (Bourne and Curtis, 1973; 
Bourne, 1976). Therefore, piglets are dependent on the sow for both systemic and intestinal tract 
50 
immunity during the first few weeks of life. 
Inunune system function and disease resistance are impaired in vitamin £ deficiency. 
Moreover, vitamin E supplementation may improve disease resistance and immune system 
function (Nockels, 1983; Tengerdy, 1990). Vitamin E supplementation has been shown to 
enhance tumor immunity, reduce and (or) delay the growth of tumors, improve protection against 
infections, increase vaccination responses, abolish radiation-induced immunosuppression, and 
improve wound healing (Bendich, 1990). 
Cell-mediated immunity was impaired in weanling pigs inoculated with Salmonella 
typhisuis and fed a vitamin E-Se-deficient diet (Lessard et al., 1991). Hayek et al. (1989) 
reported that sows fed the NRC (1988) requirement and injected with 5 mg of Se and (or) 1,000 
lU of vitamin E as a single injection at d 100 of gestation transferred more antibodies to their 
offspring. An earlier study by Teige et al. (1978) showed that the combination of vitamin E and 
Se increased resistance of pigs to swine dysentery. Further studies demonstrated that most of the 
beneficial effect was due to supplemental Se rather than vitamin E (Teige et al., 1978). In 
another study with weanling pigs, Peplowski et al., (1981) suggested an additive effect of Se and 
vitamin E, provided either via injection or in the diet, in increasing the humoral response against 
sheep red blood cells. Spallholz (1990) reviewed the role of Se in immunity. 
Dove and Ewan (1991b), in a 2 x 2 factorial arrangement of two levels of Cu (5 or 250 
ppm) and two levels of a-tocopheryl acetate (0 or 22 lU/kg) added to the diet of growing pigs, 
reported no effect of vitamin E on antibody production against sheep red blood cells. 
Diets unsupplemented with Se during gestation and up to d 4 of lactation in sows impaired 
neutrophil function when compared with diets supplemented with .3 ppm. Moreover, diets 
unsupplemented with vitamin E during the same time-period depressed the number of lymphocytes 
51 
and the phagocytic activity of blood, colostrum and milk when compared with dietary 
supplementation of 60 lU of vitamin E per kg (Wuryastuti et al., 1993). Nemec et al. (1994) 
studied the effect of dietary vitamin E supplementation above NRC recommendations and fat 
source (tallow or fish oil) of gestation and lactation diets on humoral and cellular immunity of 
gilts and their offspring. They reported that only the higher levels of dl-a-tocopheryl acetate 
supplementation (110 and 220 lU/kg) improved cellular immunity in newborn pigs. 
Babinszky et al. (1991) concluded that pigs from sows fed 136 mg of a-tocopherol/kg of 
diet increased their immune response after weaning when they were challenged with ovalbumin 
and tetanus toxoid, but that the fat source (5% sunflower oil or animal fat) had no consistent 
effect on immunity. All the weanling pigs received a diet containing 20 mg of a-tocopherol per 
kg of diet. 
The cost associated with dietary supplementation of vitamin E for effective disease 
protection is excessive in many situations. Alternate uses of vitamin E for this purpose are to 
feed the animal with a high dose of vitamin E for 3 to 4 wk prior to vaccination or the use of 
vitamin E in adjuvant vaccines for immunomodulation and increased disease protection, especially 
under stress conditions (Tengerdy, 1990). 
Vitamin E and reproductive performance 
There are many factors that can affect vitamin E status in swine. First, factors that can 
lower the vitamin E content of cereal grains include processing, storage and disease. Second, 
factors exist tfiat can lower the vitamin E content of the diet such as processing, addition of 
unsaturated fats, and (or) addition of excess trace minerals to the diets. Finally, there are some 
other factors that can increase the vitamin E requirements of the animal such as confinement, 
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genetics, early weaning, and intensified reproductive programs in the farm (Adams and 
Zimmerman, 1982; Mahan, 1991a). 
Litter size was not reduced in primiparous sows fed cereal grain-based diets 
unsupplemented with Se or vitamin E (Mahan et al., 1974; Wilkinson et al., 1977; Young et al., 
1977; Nielsen et al., 1979; Piatkowski et al., 1979; Chavez and Patton, 1986; Loudenslager et 
al., 1986), because of the high body reserves in gilts. But after the second parity litter size was 
smaller (Mahan et al., 1974; Chavez and Patton, 1986). This reduction in litter size has been 
attributed by Adamstone et al. (1949) to embryonic death rather than to impaired ovulation rate or 
implantation failure. Adamstone et al. (1949) reported muscular incoordination and necrosis of 
muscle fibers in pigs born from deficient sows. On the other hand, Piatkowski et al. (1979) did 
not report fetal atrophy in primiparous sows fed a vitamin E and Se-deficient diet 
Myer (1992) reported no effect of a single injection of vitamin E (500 to 600 lU) and Se 
(10 to 12 mg) at weaning time, or about 4 d before rebreeding on the farrowing rate, number of 
pigs bom alive, stillbirths, birth weight, or number of pigs at d 21 of lactation. No significant 
effect of vitamin E supplementation in the diet on reproductive performance was reported by 
Babinszky et al. (1992b). In both cases, the levels of vitamin E in the control diet were 
considered as normal. 
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CHAPTER 3. KINETICS OF ALCOHOL AND ACETATE FORMS OF VITAMIN E 
AFTER i.m. AND i.v. ADMINISTRATION IN GILTS 
A paper to be submitted to the Journal of Animal Science 
D. Carrion, R. C. Ewan, and J. Coma 
Abstract 
The objective of this study was to investigate the plasma pharmacokinetics of two sources 
of d-a-tocopherol (alcohol and ester) and two routes of administration (i.v. and i.m.) in gilts. 
After a 4-d adaptation period, eight crossbred (YxLxHxD) gilts (100 ± 4 kg) were surgically 
cannulated for chronic blood collection. After a 9-d recovery-period, gilts (105 + 3 kg) were 
used in two 4x4 Latin squares. Treatments were 20 lU/kg of BW of d-a-tocopherol or d-or-
tocopheryl acetate in an emulsion by i.m. injection (IMOL and IMAC), or i.v. administration 
through the cannula (IVOL and IVAC). Pigs were fed 2.5 kg of corn-soy bean meal diet fortified 
with vitamins (except vitamin E) and minerals to meet their requirements. Blood samples were 
collected at 0, 40, and 80 minutes; tiien at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 36, 42, 
48, 60, 72, 84, 96, 108, 120, 132, 144, 156, and 168 h after administration. Changes in plasma 
concentration over time profile was fitted to a sum of two exponentials (R^ = .996, .975, .980, 
and .879 for IVOL, IMOL, IVAC, and IMAC, respectively). IMAC failed to maintain plasma a-
tocopherol concentration for at least 7 d after administration. The absorption from the site of 
injection was calculated to be 43 (IMOL) and 40% (IMAC). Although the rate of elimination was 
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similar (.026 vs 0.029 h"'), the rate of absorption was greater for IMOL than IMAC (2.168 vs 
1.757 h ^). The AUCjyql^^^Cjvac 2nd AUCjj^ol^^^^imac '^^tios were 1,26 and 1.33, 
respectively. Under our experimental conditions, i.v. administration of vitamin E resulted in 
adverse systemic reactions, whereas the i.m. route did not. Therefore, the i.m. route is the 
therapeutic tool of choice to rapidly increase plasma a-tocopherol concentration of deficient 
animals. 
Key words; Pigs, Vitamin E, Tocopherol, i.m, i.v.. Kinetics 
Introduction 
Vitamin E is a fat soluble vitamin that is routinely supplemented in swine diets. There is 
a tendency by the industry to increase vitamin E supplementation above the NRC 
recommendations (Cousins et al., 1995). The reasons for the increase in supplementation are; 
partial destruction of tocopherol in dietary ingredients; changes in the production system, going 
from extensive (outdoor-pasture) to intensive (confinement) to more sophisticated schemes of 
production (segregated early weaning-medicated early weaning); and improvement in the growth 
and reproductive potential of the new genetic lines. Supplementation with vitamin E is not 
restricted to dietary addition. Parenteral supplementation at specific points of the life cycle are 
recommended by some practitioners under conditions that may decrease feed intake (weaning) and 
vitamin E content of the diet ingredients (storage, processing), or when poor tocopherol status is 
present. 
There is a variety of parenteral vitamin E products commercially available. Some 
products only provide tocopherol, whereas others are combination of tocopherol with selenium or 
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vitamin A. Most products are a liquid emulsion, while others use vegetable oils as a carrier. 
Although intestinal absorption, distribution, and elimination of vitamin E have been 
studied (Bjomeboe et al, 1990); little information regarding kinetics of tocopherol compounds, 
dosage regimens, and product formulation of parenteral vitamin E preparations is available for 
monogastric animals. 
Therefore, the objective of this experiment was to determine the effect of two sources of 
d-a-tocopherol, acetate ester and alcohol, and two routes of administration, i.m. and i.v. in gilts 
on serum tocopherol concentration. 
Materials and Methods 
Eight crossbred (YxLxHxD) gilts (100 ± 4 kg) were individually penned in a 
mechanically ventilated room. Room temperature was maintained at 20 ± 4 °C. Animals were 
individually fed 2.5 kg of a diet based on corn and solvent extracted soybean meal once a day 
(Table 1). The diet was formulated to be adequate in all nutrients and energy (NRC, 1988), with 
the exception of vitamin E. Gilts were allowed to consume water ad libitum. 
After a 4-d adaptation period, surgical cannulation of the vena cava for chronic blood 
collection was performed. Catheters (Tygon micro-bore tubing, .03 internal diameter x .09 outer 
diameter, medical grade) were heparinized and gas-sterilized prior to the surgical procedure. 
Animals were anesthetized with ketamine;xylazine (2:2 mg/kg of BW) given i.v. via marginal ear 
vein. The procedure has been described by Ford and Maure (1978). A nine d recovery-period 
was allowed. The catheters were filled with heparinized sterile saline (100 lU heparin/mL) 
containing 1.5% benzyl alcohol between sampling periods. 
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Treatments were an i.m. injection in the neck (.9 mm x 25 mm needle) or i.v. 
administration through the cannula of 20 lU of d-a-tocopherol or d-a-tocopheryl acetate per kg of 
BW. Ten minutes per animal were allowed for i.v. infusion of the calculated dose. The canula 
was flushed with sterile saline (5 mL) after the i.v. administration to insure complete infusion. 
Thus, the treatments were: i.m. administration of d-a-tocopherol (IMOL), i.v. administration of 
d-a-tocopherol (TVOL), i.m. administration of d-a-tocopheryl acetate (IMAC), and i.v. 
administration of d-a-tocopheryl acetate (IVAC). 
After the adaptation (4d) and recovery-periods (9d), gilts (105 + 3 kg) were used in two 
4x4 Latin squares. Treatments were assigned to four 7-d periods and to four gilts within square 
with the constraint that gilts were administered each treatment in only one period. Therefore, 
each gilt received all four treatments, and each animal within square received a different treatment 
in the same period. 
Both injectable vitamin E sources, d-a-tocopherol and d-a-tocopheryl acetate, were liquid 
emulsion products prepared by the procedure outlined in Table 2. The preparation contained 300 
lU of vitamin E per mL. The same product was used for i.v. and i.m. administration. 
Gilts were weighed each period, before administration of treatments. Then, exact amount 
(D) of vitamin E was calculated for each animal. Feed efficiency was also determined for the 41 
d that the animals were involved in the experiment. 
Blood samples were collected at 0, 40, and 80 minutes; then at 2, 4, 6, 8, 10, 12, 14, 16, 
18, 20, 22, 24, 30, 36, 42, 48, 60, 72, 84, 96, 108, 120, 132, 144, 156, and 168 h after 
administration of vitamin E. The exact time after administration of the treatments, when each 
sample was collected was recorded. Plasma samples were fi-ozen and stored at -20°C. The 
protocol was approved by the Committee on Animal Care and Use at Iowa State University. 
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Vitamin E was isolated from plasma (2 mL) by deproteinizing with redistilled absolute 
ethanol containing 1 % ascorbic acid (3 mL) and extracting with hexane (1 mL). Tocopherol 
isomers were separated by HPLC. The hexane extract was injected directly and separation 
achieved with silica gel column 25 cm x 4.6 mm CHROMAGESPHERE SI-60 with a particle 
diameter of 5 fim and a pore diameter of 60 A (ES Industries; Berlin, NJ 08009) with a mobile 
phase of 3.5% tetrahydrofuran (vol/vol) in HPLC-grade hexane with a flow rate of 2.0 mL/min. 
Tocopherol was detected fluorometrically with an excitation wavelength of 294 ijm and an 
emission wavelength of 323 Tjm. Peak areas were determined by integration and compared with 
standards for quantification. 
Plasma concentrations in mg/L were converted to lU/L to make both sources of vitamin E 
comparable: mg of d-a-tocopherol/L x 1.49 lU/mg, plus mg of d-a-tocopheryl acetate/L x 1.36 
lU/mg. 
Data were fitted to a multiexponential curve of the form; 
Ct = E Ki e-P'' 
Where Ct is the serum concentration at time t in lU/L, Kj is the intercept in lU/L, P; is 
the rate in h'\ and t is the time in h. The initial values for Kj and P; were determined by the 
stripping technique (Wagner, 1975). These estimates were refined by nonlinear least squares 
regression using the SAAM/CONSAM curve-fitting program (Boston et al., 1981). The program 
determined the value for the parameters that minimized the sum of squares of the residuals (SSR), 
defined as the deviation of the predicted concentration from the obsereved concentration at a 
specific time: 
SSR = E W[A - Bf 
Where A is the observed value at time t, B is the predicted value at time t, and W is a 
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term to weight the data for experimental error. 
The area under the curve (AUC) was calculated by the trapezoidal rule (Gibaldi, 1984). 
In compartmental modeling, compartments are used to represent components of the 
metabolic system. The development of the model was based on the exponential functions and an 
understanding of the metabolic system to be modeled. When using the slopes and intercepts of 
the exponential equation to calculate kinetic parameters, the compartmental analysis is called 
empirical modeling (Green and Green, 1990). 
For the empirical modeling, a two compartment open model after a single bolus i.v. 
injection (Figure 1), where elimination only takes place from the central compartment was used 
Wagner (1975): 
k,.2 = [(K, x P2) + (K2 x P,)] / (K, + K2) 
ke = Pi X P2 / k,,2 
k2.1 = Pi + P2-kl,2-ke 
One compartment open model with first order absorption and elimination was used for a 
single i.m. injection of a-tocopherol (Figure 1): 
ka = Pl 
ke = P2 
Where: k, is the absorption rate, h"'; kg is the elimination rate, h"'; and kj; is the rate of 
transfer from compartment i to j, hThe volume of distribution for the central compartment (V) 
was also calculated after i.v. administration of a-tocopherol: 
V = D/(K, + Kj) 
Observed pharmacokinetic parameters (initial concentration , maximum concentration, 
final concentration, time to maximum concentration, and AUC ) were analyzed as latin square 
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designs, with gilts as columns and time periods as rows using the GLM procedure of SAS (1988). 
The evaluation of the best fit was done by the for the regression of the observed vs predicted 
values. 
Results 
At the end of the experiment, animals weighed 127 + 7 kg, and had a G:F ratio of .26 
for the total 41 d-period. The initial plasma a-tocopherol concentration prior to dosing, during 
the first experimental period, was 1.55 ± .31 lU/L. Both sources of i.m. vitamin E (ester and 
alcohol) resulted in local reaction, characterized by transitory redness and induration at the site of 
injection, that generally disappeared by three days after administration. During i.v. inftision of 
both vitamin E sources, a systemic reaction was observed and was characterized by fainting, 
muscular spasms, and skin erythema. Shortly after infusion those symptoms disappeared, and the 
animals stood up and ate normally. The severity of the systemic reaction was greater after i.v. 
administration of d-a-tocopherol than of d-a-tocopheryl acetate. Once the experiment was 
completed, the vehicle without vitamin E, was infused i.v. in the gilts without any systemic 
reaction. 
Plasma a-tocopheryl acetate was under detectable limit (< .01 mg/L) in all animals at the 
beginning and end of each period. Only gilts injected with d-a-tocopheryl acetate had a-
tocopheryl acetate in plasma, and their concentration remained detectable for 5 h after i.v. and for 
24 h after i.m. administration. 
There was no effect of square (P > .05) for the observed pharmacokinetic values (Table 
3). Observed pharmacokinetic values represents outcome fi-om the experiment previous 
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mathematical approach. IVAC-treated pigs had lower initial observed concentration (Co) than 
pigs in the other treatment groups. IVOL-treated pigs had greater (P < .01) observed plasma 
maximum concentration (Cmax) than the rest of the animals. IMAC-injected gilts had lower (P 
< .01) final observed concentration (Cf) than that of animals in the other treatment groups. 
IVOL and IVAC-treated pigs reached Cmax earlier (P < .05) than IMAC-treated pigs. The time 
to maximum observed concentration (Tmax) was similar among IMOL and IMAC-treated gilts. 
Pigs injected with IVOL or IVAC had larger (P < .01) AUC than pigs that received IMOL or 
IMAC. IVOL-treated pigs had larger (P < .05) AUC than IVAC-treated pigs. 
Changes in plasma a-tocopherol concentration with time were fitted to a sum of two 
exponentials. Figures 2 to 5 represent observed and predicted concentration of the plasma a-
tocopherol with time after administration of IVOL, IMOL, IVAC, and IMAC, respectively. 
Those figures also show the equation; rates, slopes and for the best fit; and predicted half life, 
Co, Cmax, Cf, and Tmax. 
In the case of i.v. administration (IVOL, Figure 2; and IVAC, Figure 4), the exponential 
components of the equation (Kj e"*"^ ' + K2 e"'^ *) represent distribution and elimination. The 
second exponential term (K2 e'^ *) represents the terminal decay phase, which was evident when 
Kj e'^' ' become smaller than K2 e"'^ ', at about 2 to 3 h after dose. 
In the case of i.m. administration (IMOL, Figure 3; and IMAC, Figure 5), the first 
exponential component of the equation (Kj e"^' ') represents the first order absorption. The peak 
plasma concentration represents the time at which absorption becomes equal to distribution and 
elimination. As the amount of vitamin E remaining at the injection site decreases, the rate of 
absorption also decreases, until K, e"^' ' approximate zero. Thereafter, the plasma concentration 
is described only by the distribution and elimination portion of the equation (Kj e"^ •). 
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Results from the empirical compartmental model are presented in Table 4, whereas the 
scheme of the compartments is depicted in Figure 1. IMOL had a numerically greater absorption 
rate (kj and smaller distribution and elimination rate (kj than IMAC. Whereas IVOL had 
similar rate of transfer from compartment 2 to 1 (ki^2)» t)ut greater rates of transfer from 
compartment 1 to 2 (kj^i) and disappearance from the central compartment (k^) than IVAC. 
Discussion 
Plasma a-tocopherol concentration increased following i.v. or i.m. administration of d-a-
tocopherol or d-a-tocopheryl acetate in gilts. This is in agreement with reports using i.m. 
supplementation of liquid emulsion vitamin E products in human (Rindi and Perri, 1958), pig 
(Hoppe, 1991; Carrion et al., 1995), and sheep (Hidiroglou and Karpinski, 1991; Njeru et al., 
1992); and with studies using i.v. injection in human (Schwalbe et al., 1992), dog (Fujii, 1980), 
rabbit (Knight and Roberts, 1986), and rat (Gallo-Torres and Miller, 1971). 
Our results showed that IMAC was the only treatment where Cf was lower than Co. 
Therefore, IMAC was not able to maintain a-tocopherol concentration when supplemented at 20 
lU/kg of BW. As a consequence, Co for IVAC was significantly lower than in the other 
treatments, since randomization dictated for 6 out of 8 animals to receive IVAC after IMAC. 
Hoppe (1991) reported that, in swine after i.m. administration of equimolar doses of d-a-
or d-7-tocopherol in water based emulsion, the Tmax was 4 and 8 h for the a- and 7-tocopherol, 
respectively. They also observed that based on the AUCo^gh, a-tocopherol was 2.1 times more 
bioavailable than 7-tocopherol; and that i.m. administration was 4-5 times more bioavailable dian 
oral. 
Hidiroglou and Karpinski (1991) noted that absorption (.174 h"') and elimination (.02 h"') 
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rates of dl-a-tocopheryl acetate in liquid emulsion, after i.m. administration in sheep, are 
independent of dose, but that the extent of that absorption is parallel to dose. In our case, IMAC 
had a faster rate of absorption, and similar elimination rate than those reported in the former 
study. Njeru et al. (1992) reported that after a single i.m. injection of dl-a-tocopherol in an 
emulsifiable solution, sheep had elimination rate independent of dose, whereas the absorption rate 
increased with dose. They fitted their data to a three-phase linear model. 
IVAC had longer half life for the P, and P2 phases of the concentration vs time profile 
than IVOL, whereas IVOL had greater Cmax than IVAC, resulting in similar Cf among them. 
In man (Rindi and Perri, 1958), dog (Bauernfeind et al., 1974; Fujii, 1980) and pig 
(Carrion et al., 1995) the peak of tocopherol in serum was always later than the peak of the 
acetate form after i.m. administration of tocopheryl acetate. Therefore, once the ester leaves the 
place of injection and reaches blood, hydrolysis of tocopheryl ester is the limiting step in 
bioavailability. 
Gallo-Torres and Miller (1971) reported rapid hydrolysis of dl-a-tocopheryl acetate by the 
rat liver. Those authors found that, 30 min after i.v. administration, 19% of the 
chromatographed radioactivity in the liver was due to quinone derivatives, 15% to the ester form, 
and only small quantities due to the alcohol form. They also reported the same 
biotransformations in several other tissues and that the blood contains enzymes that hydrolyze 
esters of tocopherol. 
Ogihara et al. (1985) also reported that, 24 h after i.v. administration of 10 mg of dl-a-
tocopheryl acetate/kg of BW in rats, the ester reached undetectable concentration in plasma, 
whereas 48 h were needed to reach those undetectable concentrations in red blood cells. Under 
our conditions after IVAC administration, d-a-tocopheryl acetate was undetectable in plasma after 
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six h. 
Based on the AUCo.3,9h [(fig/mL) h], Hidiroglou and Karpinski (1988) reported that i.v. 
administration of d-a-tocopheryl acetate (1120) was much better utilized by sheep than dl-a-
tocopherol (676) or dl-a-tocopheryl acetate (772). In this experiment, even though they injected 
the ester form, only the kinetics of the free a-tocopherol was reported with an elimination rate 
(ke) of .028 and .045 h"' for the dl-a-tocopheryl acetate and the d-a-tocopherol, respectively. 
When they i.v. injected dl-a-tocopherol, the profile was represented as a sum of three 
exponentials (Ct = Base + K, e'^'' + K2 ' + K3 '), where the intercepts were: K, = 46, 
K2 = 16, and K3 = 3 /xg/mL h; and the slopes were: PI = 50, P2 = .6, and P3 = .006 h"'. 
The lower calculated Cmax after IVAC (35.78 lU/L) compared to IVOL (124.84 lU/L) 
may be explained by the larger volume of distribution for d-a-tocopheryl acetate (64.28 L) 
compared to d-a-tocopherol (18.76 L). In both cases the volume of distribution was larger than 
plasma volume for the size of animals used. Therefore, the central compartment (Ql, Figure 1) 
after i.v. administration includes non-plasma sources of vitamin E with which plasma a-
tocopherol can exchange rapidly. The larger V observed for d-a-tocopheryl acetate may also 
explain the milder systemic reaction observed after IVAC compared to IVOL. 
Hidiroglou et al. (1990) studied the kinetics of an i.v. dose of 2 /xCi (.036 ng)  of d-a-[^H] 
tocopherol in emulsion per kg of BW in sheep. The plasma data were expressed up to 56 h as a 
sum of two exponentials (Ct = Kj e'^'' -f- K2 e'^ •), where the intercepts were of the magnitude: 
Ki = 11,000, and K2 = 5,700 dpm/;ig/mL; and the slopes were: PI = .7, P2 = .02 h"'. Based 
on these estimates, they were also able to fit the data to a two compartmental model. 
Karpinski and Hidiroglou (1990) studied the kinetics of i.v. administration of 4 fiCi (.072 
Hg) of d-a-[^H] tocopherol in emulsion per kg of BW in sheep. The plasma data were expressed 
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up to 432 h as a sum of three exponentials (Ct = Kj e"'''' + K2 e"^' + K3 e"'^ *), where the 
intercepts were: Kj = 105,000, Kj = 28,000, and Kj = 4,000 dpm/;ig; and the slopes were of 
the magnitude: PI = 1.56, P2 = .062, and P3 = .006 h"^ 
Hidiroglou and Karpinski (1987) studied the kinetics of 200 fiCi of d-Q:-[^H] 
tocopherol(.077 /ig/kg of BW) in 2 mL ethanol of a physiological i.v. dose in sheep. They fitted 
the plasma profile to a sum of three exponentials (Ct = Kj e'^'' + K2 ' + K3 e'*^ •), where 
the intercepts were of the magnitude; Kj = 150,000, K2 = 35,000, and K3 = 13,000 dpm/mL; 
and the slopes were: PI = .30, P2 = .48, and P3 = .014 h"'. Based on these estimates, they 
were also able to fit the data to a three compartmental model. In the case of i.m. administration, 
a more complicated profile had to be divided in a rapid absorption phase [Ct = Kj (1 - e"''' *)] and 
a slow absorption + elimination phase (Ct = Kj e'^' - K3 e'^'), where the intercepts were: K, 
= 1,700, K2 = 4,700, and K3 = 3,700 dpm/mL; and the slopes were of the magnitude: PI = 
1.73, P2 = .0042, and P3 = .13 h'^ 
All these studies using trace administration of vitamin E marked with radioactive isotopes 
resulted in slopes of the same magnitude as the ones reported herein using large dose of unlabeled 
vitamin E. Our conditions resulted in a plasma profile that was described by a sum of two 
exponentials. Consequently, two compartment open model after a single bolus i.v. injection or a 
one compartment open model with first order absorption and elimination after a single i.m. dose 
of vitamin E were developed. 
Intravenous, intra-arterial, intraspinal, and intracerebral route of administration allows 
total entry of any compound into the general circulation (Wagner, 1961). This author also 
reported that the other parenteral routes only allow incomplete and variable degree of 
incorporation into the blood stream. Absorption rates may be affected by different factors such as 
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specificities in formulation of the parenteral product and injection site. For those reasons, the rate 
of appearance into blood may vary to a larger extent than the rate of disappearance from the 
general circulation, where conditions are more homogeneous, although individual dii¥erences in 
metabolic states always exist. 
Based on the AUQ nj./AUCj y. ratio, 43 and 40% of the original dose was absorbed from 
the place of injection after administration of d-a-tocopherol and d-a-tocopheryl acetate, 
respectively. Hidiroglou and Karpinski (1987), using trace of radioactive isotopes of d-a-
tocopherol, reported 51% availability of tocopherol following i.m. administration relative to the 
i.v. in sheep. 
From our experiment, we can also estimate the relative availability of the free:acetate 
ester sources of d-a-tocopherol. The AUCjvol/AUCjvac and AUCjmol^AUCij^c ratios were 
1.26 and 1.33, respectively. The slight difference observed among the i.v. and the i.m. ratios 
may be attributed to the difference in absorption rate observed between the acetate ester and the 
free a-tocopherol. This ratio is slightly higher than what we expected based on molecular weight 
(472 g d-a-tocopheryl acetate / 430 g d-a-tocopherol = 1.10) or lU (1.49 lU/mg d-a-tocopherol/ 
1.36 lU/mg d-a-tocopheryl acetate = 1.10). 
Implications 
Under our experimental conditions, i.v. administration of vitamin E resulted in adverse 
systemic reactions, whereas the i.m. route did not. Therefore, the i.m. route is the therapeutic 
tool of choice to rapidly increase a-tocopherol status of deficient animals. Single i.m. dose of 20 
lU of d-a-tocopherol per kg of BW improves vitamin E status of pig for at least 7 d after 
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administration when no dietary vitamin E supplementation is provided. 
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Table 1 Composition of the diet (as-fed basis) 
Item % 
Ingredients: 
Com 81.73 
Soybean meal, solvent 15.00 
Dicalcium phosphate 1.50 
Calcium carbonate .94 
Vitamin premix" .20 
Trace mineral premix*" .05 
Salt .50 
Calculated analysis: 
CP 13.57 
ME, kcal/kg 3,302 
Ca .75 
P .60 
Lysine .64 
"Contributed the following per kilogram of diet: vit. A, 4,400 lU; vit. Dj, 1,100 lU; vit. B,2, 
0.022 mg; riboflavin, 6.6 mg; niacin, 33.1 mg; d-pantothenic acid, 18 mg. 
•'Contributed the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg; Cu, 
8.8 mg; and I, 1 mg. 
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Table 2. Formulation of the parenteral vitamin E products"'' 
Product 
Item d-a-tocopherol d-a-tocopheryl acetate 
d-a-tocopherol, mg 
d-a-tocopheryl acetate, mg 
Polyoxyethylated fatty 
acid derivative®, mg 
Benzyl alcohol, mL 
Sterile saline, mL 
Total volume, mL 
40,268 
30,000 
2 
up to volume 
200 
44,118 
30,000 
2 
up to volume 
200 
'Vitamin E was added to the polyoxyethylated fatty acid derivative and the mixture was 
shaken and sonicated for 15 minutes. Benzyl alcohol was added and diluted to volume with 
sterile saline. The mixture was shaken and sonicated until total emulsified. 
''300 lU per mL. 
'^Tween 80 (Fisher Sci. Co.). 
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Table 3. Observed plasma vitamin E pharmacokinetic values in gilts after administration of 
20 lU of vitamin E/kg BW 
Treatment" 
Item'' IVOL IMOL IVAC IMAC SEM 
Co, lU/L 2.2T 2.60^ 1.79'' 2.50= .12 
Cmax, lU/L 64" 9c 25= T 7 
Cf, lU/L 3.02=8 2.64f 2.86^8 2.09' .10 
Tmax, h .85' 6.87'f .65' 10.44^ 2.62 
AUC, (lU/L) X h 446' 190^ 3538 143^ 25 
'IMOL = i.m. d-a-tocopherol, IVOL = i.v. d-a-tocopherol, IMAC = i.m. d-a-tocopheryl 
acetate, and IVAC = i.v. d-a-tocopheryl acetate. 
•"Co = initial concentration, Cmax = maximum concentration, Cf = final concentration, 
Tmax = time to maximum concentration, and AUC = area under the plasma concentration vs 
time curve, calculated by the trapezoidal rule and corrected for Co. 
"'Means in a row with different superscripts differ (P < .01). 
®^®Means in a row with different superscripts differ (P < .05). 
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Table 4. Parameters for the empirical compartmental model of a single parenteral injection 
of 20 lU of vitamin E as d-a-tocopherol or tocopheryl acetate" 
Treatment'' 
Item'= IVOL IMOL IVAC IMAC 
K - 2.168 _ 1.757 
^1,2 .092 - .091 -
^^2,1 1.169 - .580 -
K .234 .026 .084 .029 
V 18.76 - 64.28 -
"Calculated using slopes and intercepts of the exponential equations. were .996, .915, 
.980, and .876 for IVOL, IMOL, IVAC, and IMAC, respectively. 
•"IVOL = i.v. d-a-tocopherol, IMOL = i.m. d-a-tocopherol, IVAC = i.v. d-a-tocopheryl 
acetate, and IMAC = i.m. d-a-tocopheryl acetate. 
= rate of absorption, h"'; kj 2 = rate of transfer from compartment 2 to compartment 1, 
h"'; k2,i = rate of transfer from compartment 1 to compartment 2, h"^; k^ = rate of elimination, 
h"'; and V = volume of distribution, L. 
S6 
a) 
D Ke 
K2,1 K1,2 
Q2 
b) 
FD Ka Ke 
Figure 1. a) two compartment open model with single bolus i.v. injection, where elimination 
occurs from compartment number one, b) one compartment open model with first order 
absorption and elimination after a single i.m. dose, = absorption rate, h"'; = elimination 
rate, h"'; D = dose, lU; F = fraction of dose; Q = size of compartment, lU; l^j = rate of 
transfer from compartment i to j, h"^ 
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140 
Cmax = 124.84 lU/L 
120 
T.meix = 0 h 
Co = 2.27 lU/L 
100 Cf = 2.84 lU/L 
K1 = 116.12 lU/L 
K2 = 6.46 lU/L SO 
PI = 1.48 1/h 
P2 = .015 1/h 
T1/2 = .47 h 
T1/2 = 47.73 h v 
60 
40 
20 
-20 O 20 40 eO SO 100 120 140 160 
Hours 
-PI t -P2 t 
Ct = Co + K1 • -t- K2 « 
Figure 2. Concentration of a-tocopherol vs time observed (•) and predicted (-) values after a 
single i.v. injection of 20 lU of d-a-tocopherol per kg of BW. Tmax = time to maximum 
concentration, half life, t = time, Co = initial concentration, Cmax = maximum 
concentration, Cf = concentration at 168 h, Ct = concentration at time t, Kj = intercept, and Pj 
= rate. 
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R = .975 
Cmax = 6.95 lU/L 
T.max = 2.07 h 
Co = 2.60 lU/L 
Cf = 2.66 lU/L 
K1 = 4.64 lU/L 
PI = 2.168 1/h^ 
P2 = .026 1/h 
.32 h 
26.96 h 
-20 20 40 60 80 100 120 140 ISO 
Hours  
Ct = Co + K1 ( e -P2 t -PI 
- e 
Figure 3. Concentration of a-tocopherol vs time observed (•) and predicted (-) values after a 
single i.m. injection of 20 lU of d-a-tocopherol per kg of BW. Tmax = time to maximum 
concentration, T1/2 = half life, t = time, Co = initial concentration, Cmax = maximum 
concentration, Cf = concentration at 168 h, Ct = concentration at time t, K; = intercept, and P; 
= rate. 
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40 R = .980 
30 
O 
20 
Cmax = 35.78 lU/L 
T.max = 0 h 
Co = 1.79 lU/L 
Cf = 2.50 lU/L 
K1 = 31.85 lU/L 
K2 = 3.93 lU/L 
P1 = .745 1/h ^ T1/2 
P2 = .010 1/h T1/2 
.93 h 
67.81 h 
10 
-20 O 20 40 60 80 100 120 140 160 
Hours 
-PI t -P2 t 
Ct = Co + K1 « -I- K2 • 
Figure 4. Concentration of a-tocopherol vs time observed (•) and predicted (-) values after a 
single i.v. injection of 20 lU of d-a-tocopheryl acetate per kg of BW. Tmax = time to maximum 
concentration, T1/2 = half life, t = time, Co = initial concentration, Cmax = maximum 
concentration, Cf = concentration at 168 h, Ct = concentration at time t, Kj = intercept, and P; 
= rate. 
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8 
6 
2 
R = .876 
Cmax = 6.12 lU/L 
T.max = 2.38 h 
Co = 2.50 lU/L 
Cf = 2.53 lU/L 
K1 = 3.936 lU/L 
PI = 1.757 l/hi^ 
P2 = .029 1/h ^ 
T1/2 = .39 h 
T1/2 = 24.20 h 
G> o O 
-20 O 20 40 60 80 100 120 140 160 
Hours 
-P2 t -P1 Ct = Co + K1 ( e - e 
Figure 5. Concentration of a-tocopherol vs time observed (•) and predicted (-) values after a 
single i.m. injection of 20 lU of d-a-tocopheryl acetate per kg of BW. Tmax = Time to 
maximum concentration, Tj/j = half life, t = time, Co = initial concentration, Cmax = 
maximum concentration, Cf = concentration at 168 h, Ct = concentration at time t, Kj = 
intercept, and P; = rate. 
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CHAPTER 4. PHARMACOKINETICS OF INTRAMUSCULARLY INJECTABLE 
SOURCES OF VITAMIN E IN WEANLING PIGS 
A paper to be submitted to the Journal of Animal Science 
D. Carrion, R. C. Ewan, and J. Coma 
Abstract 
An experiment was conducted with weanling pigs to investigate the pharmacokinetics of 
four different injectable sources of d-a-tocopherol, two alcohols and two acetates, in tissue and 
serum. Three groups of six littermate crossbred (YxLxHxD) pigs (6.36 ± .40 kg) were used. 
After a 14-d adaptation period, pigs within littermate groups were randomly assigned to one of six 
groups. One group was killed and used as base line. The other 5 groups were the treatments: 
i.m. injection in the right ham of either saline or 138 lU/kg BW of one of two sources of d-a-
tocopheryl acetate (A-act and B-act) or d-a-tocopherol (A-ol and B-ol). Both of the d-a-
tocopherol and one of the d-a-tocopheryl acetate sources of injectable vitamin E were products 
prepared as emulsions, whereas, the other d-a-tocopheryl acetate (A-act) was prepared with olive 
oil as a carrier. Similar serum and tissue tocopherol concentrations were detected among A-ol 
and B-ol treated pigs. Therefore, the data were pooled for animals injected with d-a-tocopherol 
(01). Pigs injected with A-act did not show a response in the serum tocopherol concentrations. 
For B-act (R^ = .93 and .65 for serum tocopheryl acetate and serum tocopherol respectively) and 
01 (R^ = .96 for serum tocopherol), the serum profiles were characterized by exponential 
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equations. Based on the half life of the curve and the absorption rates of the compartmental 
approaches, the tocopheryl acetate was absorbed faster from the site of injection than the free 
form. In animals receiving the acetate sources, serum and tissue vitamin E concentrations were 
only detected as alcohol 336 h after administration. B-act and 01 had similar tissue tocopherol 
concentrations, with the exception of spleen. However the injection of the alcohol increased total 
muscle vitamin E content. These results indicate that: pigs were able to hydrolyze the acetate to 
alcohol vitamin E; olive oil was not a good carrier for i.m. vitamin E preparations; and when 
vitamin E was formulated with an adequate carrier, it was readily available. 
Key words: Pigs, Vitamin E, Tocopherol, Intramuscular Injection, Kinetics 
Introduction 
Serum vitamin E declines for approximately two weeks after weaning (Chung, 1993) 
because of reduced feed intake and poor development of digestive enzymes (Leibbrandt et al., 
1975). Therefore, an injectable form of vitamin E may be utilized more elficiently than an equal 
amount given orally (Caravaggi et al., 1968; Reddy et al., 1985), providing a quick and powerful 
method of improving vitamin E status in weanling pigs and eliminate the possibility of vitamin E-
Se deficiency. Although intestinal tocopherol absorption and distribution has been studied in 
monogastric animals (Gallo-Torres, 1980), very little information is available for parenteral 
administration. Most of the studies regarding disposition kinetics of dosage regimens and vitamin 
E compounds following their administration by parenteral routes have been performed in ruminant 
animals (Hidiroglou and Karpinski, 1987). Studies of the bioavailability of different sources of 
vitamin E in swine are essential for prevention and therapy of vitamin E deficiency. This 
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experiment was undertaken with weanling pigs to investigate the pharmacokinetics of four 
different injectable sources of vitamin E, two alcohols and two acetates, in tissue and serum. 
Materials and Methods 
Three groups of six littermate crossbred (YxLxHxD) pigs were weaned at an average age 
of 25 days and weight of 6.36 + .40 kg. Pigs were housed in individual pens, and allowed to 
consume feed and water ad libitum. After weaning, the pigs were fed a basal diet (Table 1) for a 
two-week adaptation period and a two-week experimental period. 
After the adaptation period, pigs within littermate groups were randomly assigned to one 
of six groups. One randomly selected animal per littermate group was killed on the day of 
injection, and their tissue tocopherol concentrations used as base line. Treatments consisted of an 
i.m. injection in the right ham of either saline or one of two sources of d-a-tocopheryl acetate (A-
act and B-act) or d-a-tocopherol (A-ol and B-ol). The amount of a-tocopherol that was injected 
(138 lU/kg of BW) was equivalent to the amount that would have been consumed if a diet 
supplemented with 50 lU of a-tocopherol/kg of diet were fed during a 4-wk period after weaning. 
Both of the d-a-tocopherol and one of the d-a-tocopheryl acetate sources of injectable 
vitamin E were commercially available liquid emulsion products. The other d-a-tocopheryl 
acetate (A-act) was prepared with olive oil as a carrier (300 lU/mL) as follows; The d-a-
tocopheryl acetate (Sigma Chemical) was weighed (5.51 g) in a 25 mL volumetric flask 
containing 5 mL of absolute ethanol. Then, the solution was brought up to volume (25 mL) with 
olive oil. The new solution was transferred to a serum bottle, sealed and stored in a refrigerator 
until used. 
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Pigs were weighed at weaning, and at two, three, and four weeks after weaning. Feed 
intake and efficiency were determined. Blood samples were obtained from the orbital sinus at 0, 
2, 4, 8, 16, 24, 48, 72, 96, 120, 144, 168, 192, 216, 240, 288, and 336 h after injection. At the 
end of the experimental period, pigs were electrically stunned and killed by exsanguination. 
Psoas muscle, longissimus muscle, left ham, heart, adrenal gland, kidney, liver, lung, pancreas, 
and spleen were excised and weighed. Serum and tissues samples were frozen and stored at 
-20°C until analysis. The protocol was approved by die Committee on Animal Care and Use at 
Iowa State University. 
Tissues were prepared for tocopherol analysis by homogenizing 2 to 3 g of tissue in 10 
mL (wt/vol) of phosphate-EDTA-buffer (ph 7.0). Serum and tissue homogenates (2 mL) were 
deproteinized with redistilled absolute ethanol (3 mL) and tocopherols were extracted with hexane 
(1 mL). The hexane extract was injected directly and separation achieved with silica gel colunm 
25 cm X 4.6 mm CHROMAGESPHERE SI-60 with a particle diameter of 5 /xm and a pore 
diameter of 60 A (ES Industries; Berlin, NJ 08009) with a mobile phase of 3.5% tetrahydrofuran 
(vol/vol) in HPLC-grade hexane with a flow rate of 2.0 mL/min. Tocopherol was detected 
fluorometrically with an excitation wavelength of 294 ijm and an emission wavelength of 323 -qm. 
Peak areas were determined by integration and compared with standards for quantification. 
Data were fitted to a multiexponential curve of the form: 
Ct = E Kj e-P'' 
Where Ct is the serum concentration at time "t" in mg/L, K; is the intercept in mg/L, Pj 
is the rate in h"\ and t is the time in h. The initial values for Kj and Pj were determined by the 
stripping technique (Wagner, 1975). These estimates were refined by nonlinear least squares 
regression using the curve-fitting program SAAM/CONSAM (Boston et al., 1981). The program 
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determines the value for those parameters that minimize the sum of square of the residuals. 
The area under the curve (AUC) was calculated by integration of such a function or by 
the trapezoidal rule (Gibaldi, 1984). 
In compartmental modeling, compartments are used to model various components of the 
metabolic system. The development of the model is based in the exponential functions of the 
curve and an understanding of the metabolic system to be modeled. When using the slopes and 
intercepts of the exponential equation to calculate certain kinetic parameters, the compartmental 
analysis is called empirical modeling. When fitting plasma data plus any other data from the 
same or other experiment (tissue, feces, urine, ...) to a hypothesized compartmental model and 
later adjusting the model parameter, the compartmental analysis is called model-based 
compartmental analysis (Green and Green, 1990). 
For the empirical modeling, we used the equations given by Wagner (1975) for one 
(serum d-a-tocopheryl acetate) and two (serum d-a-tocopherol) compartment open model with 
first order absorption and elimination after a single dose (Figure 1): 
a) Serum d-a-tocopheryl acetate: 
k. = P, 
ke = P2 
b) Serum d-a-tocopherol: 
ka = Pl 
ki.2 = [(K2 X P2 X P,)+(K, X P3 X Pi)-l-(-K, X P3 X P2)] / [Kj x (Pj - P3)-hK, x (Pj - Pj)] 
Kj = P3 X P2 / kj 2 
^2,1 = P3 + P2 + ^1,2 - It* 
Where Kj = absorption rate, h"^; = elimination rate, h"'; and = rate of transfer 
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from compartment i to j, h'^ 
Data were analyzed by the GLM procedure of SAS (1988). Growth data were analyzed by 
analysis of covariance using initial body weight (weight at injection time) as a covariate. For 
tocopherol concentration in tissues and observed pharmacokinetic values, non-orthogonal contrasts 
were performed. The evaluation of the best fit was done through the fractional standard deviation 
(FSD) defined as the standard deviation/mean ratio of the estimated parameters or by the for 
the regression of the observed vs predicted values. 
Results 
Growth Performance 
Growth performance for the two week experimental period was not affected by treatment 
(P >.1). Average daily gain, ADFI, and gain:feed ratio were .52 + .07 kg, .81 + .08 kg, and 
.65 ± .07, respectively. Pigs weighed 7.6 + 1.1 kg at 14 d post-weaning (day of injection), and 
14.9 + .8 kg at the end of the experimental period. 
Vitamin E in Serum 
During the first two weeks after weaning, there were some problems with diarrhoea and 
low feed intake. One animal in the B-ol treatment had low feed intake during the experimental 
period and was culled out. Similar serum and tissue tocopherol concentrations were observed 
among pigs injected with A-ol and B-ol. Therefore, the data were pooled (01). A local reaction 
occurred at the injection site of animals injected with the alcohol form of vitamin E. 
The initial (Co) and final (Cf) concentrations of d-a-tocopheryl acetate in serum were 
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below the detectable limit (< .01 mg/L) in all treatments. Animals injected with B-act had 
greater serum tocopheryl acetate concentration (Cmax = 301 ±52 mg/L) at 16 h after injection 
and area under the concentration vs time curve [AUC = 10,257 ± 2099 (mg d-a-tocopheryl 
acetate/L) x h] than animals in the other treatment groups. Nine per cent of this AUC for 
tocopheryl acetate represented the AUC for tocopherol in serum. 
Observed pharmacokinetic values (Table 2) represents outcome from the experiment 
previous mathematical approach. All the treatment groups had similar Co of serum a-tocopherol. 
Pigs injected with d-a-tocopherol had greater (P < .001) serum observed d-a-tocopherol Cmax 
and AUC, calculated by the trapezoidal rule, than pigs that received saline or d-a-tocopheryl 
acetate. The time to maximum observed d-a-tocopherol concentration in serum (Tmax) occurred 
significantly later (P < .001) for the A-act treatment than for the other treatment groups. All 
sources of injectable vitamin E (alcohol and acetate) increased (P < .01) the observed Cf of a-
tocopherol at the end of the experimental period when compared with saline. There were no 
differences among the Cf of the vitamin E injected pigs. The average concentration of a-
tocopherol detected at this time in serum was 1.44 mg/L for pigs injected with any of the vitamin 
E sources, and .56 mg/L for pigs injected with saline. 
There was no peak (Cmax) in the serum observed a-tocopherol with time profile for 
saline and A-act treatments. Therefore, we only attempted to fit the serum a-tocopherol profile to 
a sum of exponentials in those cases where a clear response to injectable vitamin E was observed 
(Table 3). Those cases were: a) serum a-tocopheryl acetate concentration after injection of B-act 
(Figure 2); b) serum a-tocopherol concentration after injection of B-act (Figure 3); and c) serum 
a-tocopherol concentration after injection of 01 (Figure 4). 
In the case of serum a-tocopheryl acetate concentration vs time, the profile was best fitted 
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to a sum of two exponential, whereas serum a-tocopherol concentration vs time profile was best 
represented as a sum of three exponentials. 
The estimated concentration at time zero for the best fit was always negative and far fi-om 
the observed value. Therefore, a lag phase between injection time (t = 0) and the time at which 
first-order absorption began (t = T), was hypothesized. Because the observed Co was subtracted 
from the concentration at each specific time when modeling, Co was equal to zero. Therefore, T 
was calculated for the best fit as the time at which Ct was equal to zero, and the final model fit in 
the form: 
For t < T, then 
Ct = Co 
For serum d-a-tocopheryl acetate and t S T, then 
Ct = Co - K, e-Pi + Kj e-P2 C-t) 
If serum d-a-tocopherol and t ^ T, then 
Ct = Co - Ki e-P' + K, e-*^ + Kj e*" 
Parameter estimates for B-act and 01 are presented in Table 3. Figures 2 to 4 represent 
observed and predicted profiles of the serum concentration vs time curve. 
The predicted lag phase was shorter in animals injected with 01 than with B-act, reflecting 
the early appearance of the first-order absorption. 
The first exponential component of the equation (K, e"^^ represents the first order 
absorption. The peak plasma concentration represents the time at which absorption becomes equal 
to distribution and elimination. As the amount of vitamin E remaining at the injection site 
decreases, the rate of absorption also decreases until Kj e'®*' approximates zero. Thereafter, 
the plasma concentration is described only by the distribution and elimination portion of the 
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equation: Kj in case of serum d-a-tocopheryl acetate, or Kj + Kj e"'^ in 
case of d-a-tocopherol. The terminal decay phase was Kj e"" , which was evident when K, 
g-P2 (t-T) became smaller than K2 e'" 
Predicted serum pharmacokinetic values calculated from the exponential equation are 
displayed in Table 4. The absorption rate constant, Pj, was always larger than the distribution 
and elimination rate constants, P2 and P3. The faster vitamin E is absorbed (Pj T1/2), the higher 
is the serum maximum concentration (Cmax), and the shorter is the time to maximum 
concentration after administration (Tmax, Table 4). 
Based on equimolar equivalence, 91% of the ester corresponds with the free form, and 
expressing the total observed AUC in (mg of a-tocopherol per liter) x hour: 
a) Observed values (Table 2). 
B-act = [10,257 (mg of d-a-tocopheryl acetate / L)x h] x .91 + 912 (mg of d-a-
tocopherol / L) X h = 10,246 (mg d-a-tocopherol / L) x h. 
01 = 4,872 (mg of d-a-tocopherol / L) x h 
b) Predicted values (Table 4). 
B-act = [8,156 (mg of d-a-tocopheryl acetate / L)x h] x .91 + 939 (mg of d-a-
tocopherol / L) x h = 8,361 (mg d-a-tocopherol / L) x h. 
01 = 4,914 (mg of d-a-tocopherol / L) x h 
In this way, the AUC for the B-act was between 2.1 (observed) and 1.7 (predicted) times 
greater than 01. 
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Vitamin E in Tissues 
At the end of the 14 d experimental period, a-tocopherol concentration of all tissues, 
except adrenal gland and lung, were similar among Saline and A-act treated pigs (Table 5). 
Tocopherol concentrations of lung and adrenal gland from pigs injected with A-act were greater 
(P < .05) than those of pigs injected with saline, but lower (P < .06) than those of pigs injected 
B-act or 01. B-act and 01 treated pigs had similar tissue a-tocopherol concentration (P > .05). 
Pigs receiving B-act or 01 had greater (P < .05) longissimus muscle, heart, adrenal gland, 
kidney, and pancreas a-tocopherol concentration than pigs receiving no supplemental vitamin E. 
Ham and psoas muscle a-tocopherol concentration of B-act injected pigs were similar to that of 
saline and A-act injected pigs, but lower (P < .06) than a-tocopherol concentration of 01 injected 
pigs. Pigs injected with B-act had extremely high (P < .01) spleen tocopherol concentration (62 
mg/kg), compared with the rest of the animals (3 mg/kg). 
Total a-tocopherol content of organs (Table 6) followed the same pattern observed for 
their respective a-tocopherol concentrations (Table 5), with a few exceptions: 1) pigs receiving 
injectable A-act had similar total a-tocopherol content in adrenal gland and liver as pigs receiving 
saline and B-act; and 2) pigs receiving injectable A-act had similar total a-tocopherol content in 
lung than pigs receiving saline, but lower (P < .01) vitamin E concentration than pigs receiving 
B-act and 01 treatments. 
Total a-tocopherol content of the organs were similar (Table 6) at the beginning (basal) 
and the end of the experimental period when no supplemental vitamin E was administered 
(saline), but tissue a-tocopherol concentrations were generally lower (Table 5) in the animals 
injected with saline than the ones used as basal line. 
Tocopherol content of injectable origin (Table 7) was similar among B-act and 01 treated 
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pigs with the exception of that of spleen and muscle. Total and muscle a-tocopherol content of 
injectable origin were greater (P < .03) for 01 than for B-act treated pigs. 
Results from the empirical compartmental model are presented in Table 8, whereas the 
scheme of the compartments is depicted in Figure 1. Similar absorption rate (kj and rate of 
transfer from compartment 2 to 1 (k, j) were observed for serum a-tocopherol after injection of 
either B-act or 01 treatment. On the other hand, rate of transfer from compartment 1 to 2 (k^ i) 
and elimination rate (kg) were smaller for the B-act than for the 01 treated pigs. Faster absorption 
rate for B-act than 01 was observed (.15 vs .08 h"'). 
The rate of disappearance from the central compartment of a-tocopheryl acetate after B-
act administration (k^ = .081 h"') was similar to that for a-tocopherol after injection of 01 
(k,-l-k2,i = .06+.023 = .083 h"'). 
Figures 5 and 6 depict the model-based compartments for i.m. d-a-tocopheryl acetate and 
d-a-tocopherol respectively. Values for the parameters defined in those figures are reported in 
Tables 9 and 10. As a result, the size of the different pools over time can be predicted (Figures 7 
and 8). 
Discussion 
Serum a-tocopherol concentration of the saline-injected pigs was similar for all periods, 
and within the normal range for pigs of the same age fed a corn-soybean-whey starter diet 
meeting the NRC (1988) nutrient recommendations. 
In spite of the relatively large amount of d-a-tocopheryl acetate (138 lU/kg of BW) in 
olive oil (A-act), no detectable changes in the serum vitamin E concentration with time were 
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observed until the end of the experiment. Similar results were obtained in our laboratory by 
Chung (1993) when studying the effect of source and method of administration of vitamin E on 
weanling pigs. He used d-a-tocopheryl acetate in olive oil as one of the injectable sources. In 
the present experiment, a slight but significant increment of serum a-tocopherol was detected in 
A-act injected pigs as compared to Saline injected pigs at 336 h, suggesting an initial sequestration 
phase, followed by a very slow rate of release. Another explanation for this is an interaction 
between the carrier (olive oil) and the vitamin E that impeded the distribution of the vitamin into 
the blood at high rate immediately after injection. The use of high viscosity injection vehicle 
(glycerin, cottonseed oil, sesame oil, or polyethylene glycol) slows the absorption of i.m. 
administered drugs (Niazi, 1979). The same author also indicated that after i.m. administration, 
small molecules are reported to be absorbed directly into the capillary system, while large 
molecules (vitamin E-oleate complex) follow the lymphatic system before reaching the general 
circulation. At this point, the limiting factor would be the slow flow rate of lymph (. 1 % of the 
plasma flow). Hidiroglou and McDowell (1987) also observed a similar delay (Tmax = 254 h) 
after 40 mg of d-a-tocopherol in sesame oil per kg of BW were i.m. injected in sheep. Njeru et 
al. (1994) observed no response of serum vitamin E concentration to i.m. injection of dl-a-
tocopheryl acetate in sesame oil in wediers. Behrens et al. (1975) reported that in sheep the slow 
rate of vitamin E release after i.m. administration of vitamin E in oil carrier (peanut or soybean 
oils) may be due to myositis and lymphadenitis. Similar clinical observations were made by 
Dickson et al. (1986). The oil carrier by itself was not responsible for the myositis and 
lymphadenitis. They also reported that lymph glands, where lymph drained from the place of 
injection, stored important amounts of vitamin E for at least 4 months after i.m. administration. 
In our experiment, there was no attempt to make histopathological observations, but we were able 
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to detect local swellings in the place of injection when both sources of vitamin E as alcohol (A-
and B-ol) were administered. Topical application of free tocopherol irritated the skin of mice, 
whereas the acetylated form did not (Trevithick et al., 1992). 
In the cases where a clear response to injectable vitamin E administration was observed, 
serum profiles were characterized by exponential equations. Absorption was represented by a 
single exponential term, whereas elimination + distribution was represented by a single 
exponential term in case of serum a-tocopheryl acetate, or two exponential terms in the case of a-
tocopherol. The single elimination + distribution exponential term in B-act is explained because 
after the j-iak, serum a-tocopheryl acetate declined quickly to non detectable levels. Hidiroglou 
and Karpinski (1991) reported similar absorption and elimination rates after fitting plasma a-
tocopherol to a two exponential equation following a single i.m. injection of dl-a-tocopheryl 
acetate in sheep. They also reported a lag phase between the injection time and the beginning of 
the first-order absorption. 
Vitamin E, either as acetate or as alcohol, was released at very rapid rates fi-om the 
injection site into the blood stream (absorption > distribution + elimination), peaking between 10 
and 24 h after injection (absorption = distribution + elimination). Within the next 48 h, there 
was a rapid removal of the vitamin from blood for either utilization and (or) storage by the 
tissues, or excretion as metabolites (absorption < distribution + elimination). After 72 h post-
injection, the concentration of vitamin E in blood decreased (absorption = 0, distribution + 
elimination > 0) at slow rate (Figures 2 to 4). 
In animals receiving the A-act treatment, the vitamin E was only detected in serum in the 
alcohol form, indicating hydrolysis of the ester by muscle esterases before its release fi-om the 
place of injection, and/or by plasma and/or tissue esterases immediately after its slow release rate 
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from muscle. In contrast, when B-act was i.m. administered, the ester form rapidly increased in 
serum (Figure 2), and this increment was followed by a slight rise in the alcohol form of vitamin 
E in serum (Figure 3). The peak of the alcohol form in serum was always later than the peak of 
the acetate form (Table 4). Similar results have been reported after i.m. administration of dl-a-
tocopheryl acetate in man (Rindi and Perri, 1958), and in dogs (Bauemfeind et al., 1974; Fujii, 
1980). The differences observed in the AUC data between the free and the ester sources of 
vitamin E (Tables 2 and 4), were partially explained by the rate of absorption from the injection 
site (Tables 8 to 10). 
Gallo-Torres and Miller (1971) reported rapid hydrolysis of dl-a-tocopheryl acetate by the 
rat liver. They found that, 30 min after i.v. administration, 79% of the chromatographed 
radioactivity in the liver was due to quinone-derivatives, 15% to the ester form, and only small 
quantities were due to the alcohol form. They also reported the same biotransformations in 
several other tissues, and that the blood contained enzymes able of hydrolyzing esters of 
tocopherol. In contrast, Bauemfeind et al. (1974) reported that the blood does not have enzymes 
capable of hydrolyzing dl-a-tocopheryl acetate after an in vitro incubation of dog fresh blood at 
37°C for up to 2 h. The same results were reported by Newmark et al. (1975) after incubation of 
human and dog blood at 37°C for up to 3 h. These authors reported that, 24 h after i.v. 
administration of dl-a-tocopheryl acetate in dogs, 25% of the dose was hydrolyzed, whereas 
Ogihara et al. (1985) reported 36% in the case of rats. Therefore, there seem to be differences in 
the hydrolytic capability among animal species. 
Ogihara et al. (1985) also reported that at 24 h after i.v. administration in rats, the ester 
reached undetectable concentrations in plasma, whereas 48 h were needed to reach those 
undetectable concentration in red blood cells. In rabbits. Knight and Roberts (1986) observed that 
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not all the a-tocopheryl acetate was converted to tocopherol and that there was some a-tocopheryl 
acetate uptake by tissues. Our observations showed a total conversion of a-tocopheryl acetate to 
a-tocopherol, because by the end of the experiment, the acetate was not observed in serum and 
tissues. A possible reason for these differences may be the short duration of the experiment 
carried out by Knight and Roberts (1986), that did not allowed total biotransformation of the 
ester. From our observations, there seems to be an enzymatic machinery in the organism able to 
convert the acetate to alcohol. Fujii (1980) reported that as much as 10% of the acetate ester of 
vitamin E is hydrolyzed to the free form after i.m. administration of dl-a-tocopheryl acetate in 
dogs. 
Pancreas and adrenal gland had the greatest a-tocopherol concentrations of all tissues 
analyzed (Table 5), but the lowest total a-tocopherol content (Table 6). Similar results were 
observed by Karpinski and Hidiroglou (1990) in sheep. 
Immediately after parenteral administration of radiolabeled a-tocopheryl acetate, most of 
the recovered radioactivity was present in spleen, lung, and liver of rats (Gallo-Torres and Miller, 
1971) and rabbits (Knight and Roberts, 1986). Therefore, most of the biotransformations leading 
to excretion (quinones) or utilization (free alcohol) of the ester may take place in those three 
tissues belonging to the reticuloendothelial system. Our results showed that spleen, lung, and 
liver were the organs with the greatest content of a-tocopherol 14 d after i.m. injection of B-act, 
whereas only liver and lung were the tissues with the greatest content of a-tocopherol in the case 
of 01 administration (Table 6). 
Of those three organs, concentration of a-tocopherol in spleen of B-act injected pigs was 
17-fold greater than in the rest of the animals, and about 10-fold greater than that of the other 
tissues analyzed. Hidiroglou and Karpinski (1991) also reported a 66-fold increase in a-
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tocopherol concentration in the spleen of sheep 80 h after i.m. administration of 60 mg of dl-a-
tocopheryl acetate per kg BW, compared to control sheep. Spleen is considered as the main filter 
for foreign substances present in blood, whereas lymph glands are the filters for foreign 
substances present in lymph. If the acetate form of vitamin E were considered as a foreign 
substance, it would be retained by the lymph glands if its absorption from the place of injection 
were via the lymphatic pathway (Dickson et al., 1985), or by the spleen if the absorption were via 
blood. In our experiment, the lymphatic pathway has been hypothesized as the via of absorption 
for treatment A-act, but we did not collect lymph or lymph gland samples to confirm the data 
reported by Dickson et al. (1985). In contrast, for treatments B-act, and 01, in which a quick 
response in serum vitamin E concentration was observed (Figure 2 to 4), the absorption from the 
place of injection was hypothesized to be via blood. The slow lymph flow rate preclude such a 
rapid response. 
For all the tissues analyzed but spleen, tocopherol concentration was similar among B-act 
and 01 treated pigs. Therefore, swine seem to have the enzymatic capability to effectively 
hydrolyze d-a-tocopheryl acetate to a-tocopherol and make the biologically active form of this 
vitamin available for the site of action. 
Physicochemical and technologic implementations in the design of the dose forms may 
result in differences in the bioavailability of drugs (Niazi, 1979). The principal factors 
controlling the bioavailability of drugs from the site of injection are; 1) the vascularization of the 
injection site, 2) the lipid solubility and ionization of the drug, and 3) the volume of the injection, 
and the osmolality of the solution (Greenblatt and Koch-Weser, 1976). Therefore, the release of 
a parenterally administered drug and the subsequent shape of the serum concentration vs time 
profile can be controlled by the type of administration (i.m., i.v., i.p.), the type of salts (ether, 
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ester, or complexes of the active ingredient with low solubility), the type of vehicle used, etc. 
Njeru et al. (1992) reported that after a single i.m. injection of dl-a-tocopherol in an emulsifiable 
solution, sheep had elimination rate independent of dose, whereas the absorption rate increased 
with dose. They fitted the data to a three-phase linear model. Our results suggest faster 
absorption of vitamin E firom the place of injection when i.m. supplementation was done as the 
acetylated ester, compared to the free form [P1T1/2, Table 4; kg. Table 8; k(8,7), Table 9; and 
k(6,l). Table 10]. And that once the acetylated ester is hydrolyzed to free the form, serum a-
tocopherol is maintained longer than when d-a-tocopherol is i.m. injected as such (P3T,/2, Table 
4). This was probably because, when d-a-tocopheryl acetate was injected, larger and more 
sustained inputs than outputs into compartment q3 (serum d-tx-tocopherol) occurred, compared 
with i.m. administration of d-a-tocopherol (Tables 9 and 10). Reasons for this, may be: first, 
that die esterified source (Table 10 and Figure 6) is absorbed from the place of injection [k(6,l)], 
distributed by the circulatory system (92), and taken up by different tissues [k(4,2) and k(9,2)]; 
second, that the hydrolysis of d-a-tocopheryl acetate to free tocopherol may have taken place at 
the injection site [k(7,l)], circulatorj' system [k(3,2)], and tissue level [k(5,4)]; and third, that 
once hydrolysis took place, d-a-tocopherol had the same behavior as when it was directly injected 
into the system [k(8,7), k(5,3), k(3,5), and k(3,9)]. 
The anatomical distribution of die pools for the model-based compartmental analysis was 
based on actual knowledge of vitamin E metabolism, experimental results, and some assumptions. 
This distribution was as follows; q, = d-a-tocopheryl acetate in place of injection, = d-a-
tocopheryl acetate in serum, q3 = d-a-tocopherol in serum, = d-a-tocopheryl acetate in 
extrahepatic tissues, q5 = d-a-tocopherol in extrahepatic tissues, qy = d-a-tocopherol in place of 
injection, qg = vitamin E and its metabolites in liver, q,o = vitamin E and its metabolites in bile. 
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dg and dg = delays. 
Even though tocopherol concentration of tissues (Table 5) and tocopherol content of 
organs (Table 6) 336 h after application of the treatments were similar among B-act and 01 treated 
pigs, with the exception of spleen; total and muscle a-tocopherol content of injectable origin 
(Table 7) was greater for 01 than for B-act treated pigs. Muscle had the largest contribution to 
total analyzed vitamin E content. The total amount of tissues analyzed for tocopherol content of 
injectable origin accounted for about 56% of BW. 
Results from the model-based compartmental analysis showed similar total content of cx-
tocopherol in extrahepatic tissue (05) in B-act and 01 treated pigs (48.9 vs 48.6 mg respectively) 
at 336 h after injection. This may suggest preferential uptake of the acetylated form of vitamin E 
by specific tissues, such as spleen (Table 5). Hidiroglou and Atwal (1989) reported that, after 
parenteral administration of an ester or free vitamin E to dairy cows, the acetate ester resulted in 
greater milk tocopherol concentration than the free form. This result may also be due to a 
preferential uptake of tocopheryl acetate by the mammary gland. Njeru et al. (1994) observed 
that after i.m. administration of dl-a-tocopheryl acetate in sheep, an increase in tocopherol 
concentration in liver and pancreas but not in diaphragm, kidney, heart, and neck. 
Total analyzed liver a-tocopherol content of injectable origin (Table 7) was similar in B-
act and 01 treated pigs and this results were in agreement with the output from the model-based 
compartmental analysis (qg). 
The existence of a tocopherol binding protein (TBP) in rat liver has been reported (Murphy and 
Mavis, 1981). This protein is able to discriminate between a- and 7-tocopherol. This could be 
the reason why, even though 7-tocopherol is predominant in the diet, a-tocopherol is more 
abundant in blood and tissue. Although TBP has not been reported in swine, Hoppe (1991) found 
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that weanling pigs fed a single dose of a 1:1 mixture of a-tocopherol and 7-tocopherol lost the 7-
isoraers more r^idly that the a-isomers. Discrimination between RRR- and other steroisomers 
has been reported. Hidiroglou and Karpinski (1988) reported that i.v. administration of d-a-
tocopheryl acetate was much better utilized by sheep than i.v. administration of dl-a-tocopherol or 
dl-a-tocopheryl acetate. 
The volume of distribution of the central compartment for B-act injected pigs (Table 10) 
was similar to the calculated serum volume of a 15 kg-pig (.84 kg). In contrast, 01 injected pigs 
(Table 9) had greater volume of distribution of the central compartment than the calculated serum 
volume. This implies that pool q3 must include non-serum sources of vitamin E rapidly 
exchangeable with serum tocopherol. 
When using the empirical compartmental model, we fitted one compartmental model for 
every exponential curve defined. In cases such as B-act treated pigs, two equations were needed 
to describe vitamin E vs time profile, one for the acetylated and the other for the free tocopherol, 
and therefore, two different empirical compartmental models were developed based on those 
equations (Figure 1 and Table 8). In biological systems, serum tocopheryl acetate and free 
tocopherol are not unrelated, they are metabolically interconnected. For that reason, even though 
the empirical model may be a good start-point, model-based compartmental analysis would be the 
method of choice (Figure 6). Besides, model-based compartmental analysis is more flexible 
dealing witii non-steady state conditions, allows us to include information from other sources 
(literature,...) in the model, and allows us to generate new hypothesis and develop new 
experiments (Green and Green, 1990). For instance, based on the information provided by 
model-based compartmental analysis, it would be possible to define the best protocol (route, 
source, preparation, dose, and time of vitamin E application) to obtain the a tocopherol 
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concentration in muscle at slaughter time that would optimize meat quality, or to maintain optimal 
vitamin E status to prevent the onset of deficiency in the herd. 
In the current study, we only used the d-a isomers of vitamin E, either as acetylated ester 
or alcohol. When d-a-tocopheryl acetate was used in conjugation with an adequate carrier, and 
given equal amounts based on lU of vitamin E activity, both sources (acetate and alcohol) of the 
same isomer (d-a-) had similar responses regarding ce-tocopherol concentration in tissues, with the 
exception of spleen; but the alcohol source had greater total muscle vitamin E content of 
injectable origin. 
Implications 
Vitamin E dissolved in olive oil was poorly utilized after i.m. administration. However, 
when an adequate carrier was used in the formulation of i.m. injectable preparations, the acetate 
and alcohol sources of the same vitamin E isomer (d-a-) resulted in similar serum and tissue a-
tocopherol concentrationsn of pigs 336 h after administration, except in spleen. The alcohol 
form was superior to the acetate source in increasing the total muscle vitamin E content of 
injectable origin. The a-tocopheryl acete has greater stability during storage, greater serum 
AUG, and maintains serum tocopherol longer than the alcohol. The a-tocopheryl acete was not 
an irritant when i.m. administered. Regarding the different approaches to compartmental 
modeling, model-based compartmental analysis is the method of choice. 
Ill 
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Table 1. Composition of the basal diet 
Ingredients % 
Ingredients; 
Com 55.93 
Soybean meal, dehulled, solvent 29.10 
Whey 10.00 
Soybean oil 1.00 
Dicalcium phosphate 1.51 
Calcium carbonate .76 
Vitamin premix" .20 
Trace mineral premix'' .05 
Salt .25 
Antibiotic*^ 1.00 
L-lysine-HCl .20 
Calculated analysis; 
CP 20.19 
ME, kcal/kg 3,280 
Ca .86 
P .70 
Lysine 1.30 
'Contributed the following per kilogram of diet; vit. A, 4,400 lU; vit. D3, 1,100 lU; vit. E, 
22 lU; vit. B,2, 0.022 mg; riboflavin, 6.6 mg; niacin, 33 mg; d-pantothenic acid, 17,6 mg. 
•"Contributed the following per kilogram of diet: Zn, 75 mg; Fe, 87.5 mg; Mn, 30 mg; Cu, 
8.75 mg; I, and 1 mg. 
''Contributed .9 mg of carbadox per kilogram of diet. 
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Table 2. Observed serum a-tocopherol pharmacokinetic values in pigs after a single i.m. 
injection of 138 lU of vitamin E/kg of BW 
Treatments" 
Item*" Saline A-act B-act 01 SE 
Co, mg/L .60 .54 .54 .68 .12 
Cmax, mg/L 1"= r 14= 129" 11 
Cf, mg/L .56= 1.21'' 1.58" 1.43" .16 
Tmax, h 96= 272" 24= 10= 31 
AUC, (mg/L) X h 5= 114= 912= 4,872" 418 
"Saline = Injection of saline. A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act 
= Injection of d-a-tocopheryl acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion. 
•"Co = Initial concentration. Cmax = Maximum concentration. Cf = Final concentration. 
Tmax = Time to maximum cocentration. AUG = Area under the serum concentration vs time 
curve. Calculated by the trapezoidal rule and corrected for Co. 
^''Means in a row with different supperscripts differ (P < .01). 
Table 3. 
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Exponential equation parameters estimated for serum vitamin E in pigs after a 
single i.m. injection of 138 lU of vitamin E/kg of BW®*' 
Serum Serum 
a-tocopherol a-tocopheryl acetate 
Item B-act 01 B-act OF 
T, h 2.97 .62 1.24 
K„ mg/L 35 1580 1440 
Kj, mg/L 2.46 4.68 -
P„ h-i .077 .086 .151 
P2, h-' .04 .07 .08 
P3, h-' .003 .006 -
R2 
.65 .96 .93 
'Saline = Injection of saline. A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act 
= Injection of d-a-tocopheryl acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion. 
Saline and A-act treatments did not show a response. 
•"If t < T, then: Ct = Co. If serum d-a-tocopheryl acetate and t ^ T, then: Ct = Co - Kj 
g-pi (t-T) 4. g-P2 (t-T) sefum d-a-tocopherol and t ^ T, then: Ct = Co - K, e"''' + Kj e" 
P2 (t-T) ^ g-P3 (t-T) -J- _ jjjjjg which first-order absorption begins; t = time; Ct = 
concentration at t time; Co = initial concentration; Kj = intercept; and Pj = rate. 
''Serum d-a-tocopheryl acetate was not detected (< .01 mg/L) after injection of d-a-
tocopherol (01). 
Table 4. 
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Predicted serum pharmacokinetic values calculated from exponential equations 
after a single i.m. administration of 138 lU of vitamin E/kg of BW" 
Serum Serum 
a-tocopherol a-tocopheryl acetate 
Item'' B-act 01 B-act 01"= 
Co, mg/L .54 .68 0 -
Cmax, mg/L 10.42 124 325 -
Cf. mg/L 1.36 1.43 0 -
Tmax, h 20.01 13.45 10.14 -
TI/2. h 9.06 8.06 4.59 -
^2 Ti/2, h 16.42 9.90 8.56 -
P3 Ti/2, h 210 126 - -
AUC, (mg/L)xh 939 4914 8156 -
"Saline = Injection of saline. A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act 
= Injection of d-a-tocopheryl acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion 
Saline and A-act treatments did not show a response. For B-act (R^ = .93 and .65 for serum a-
tocopheryl acetate and serum tocopherol respectively) and 01 (R^ = .96 for serum a-tocopherol). 
•"Co = initial concentration; Cmax = maximum concentration; Cf = final concentration; 
Tmax = Time to maximum concentration; P; T,/2 = half life for the Pj phase; AUG = Area 
under the serum concentration vs time curve, estimated after integration of the exponential 
equation from time 0 to 336 h. 
®Serum a-tocopheryl acetate was not detected (< .01 mg/L) after injection of d-a-tocopherol 
(01). 
Table 5. 
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Concentration of a-tocopherol in tissues before and 336 h after a single i.m. 
administration of 138 lU of vitamin E/kg of BW (mg/kg) 
Basal" Treatments'" 
Item Mean SE Saline A-act B-act 01 SE 
Muscle 
Ham 3.1 2.2 i.r 2.1= 3.6=" 8.4" 1.7 
Longissimus 2.4 .6 1.2"= 1.3= 3.5" 4.4" .4 
Psoas 3.5 1.3 1.4= 1.9= 4.6=" 6.8" 1.2 
Heart 4.2 .6 2.2= 3.2= 7.2" 8.2" .4 
Adrenal gland 2.6 .8 2.7= 4.8" 9.5' 9.9= .6 
Kidney 2.0 .4 1.9= 2.6= 6.0" 5.9" .3 
Liver 1.4 1.0 2.0= 2.9= 5.6" 5.0" .7 
Lung 3.1 .6 1.9= 3.5" 6.5® 6.5= .4 
Pancreas 3.4 .6 2.8= 4.1= 11.8" 10.9" .5 
Spleen 7 14 2= 4= 62" 4= 11 
'Base line. One animal per littermate group was killed before i.m. administration of vitamin 
E. 
""Saline = Injection of saline. A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act 
= Injection of d-a-tocopheryl acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion. 
•^"^Means in a row with different superscripts differ (P < .06). 
119 
Table 6. Content of a-tocopherol in organs before and 336 h after a single i.m. 
administration of 138 lU of vitamin E/kg of BW (mg) 
Basal' Treatments'" 
Item Mean SE Saline A-act B-act 01 SE 
Heart .21 .05 .19= .25= .58" .63" .04 
Adrenal gland .007 .003 .006= .011"* .016"® .019= .002 
Kidney .10 .06 .22= .26= .55" .55" .05 
Liver .47 .29 1.04= 1.46=" 2.32"= 2.27= .28 
Lung .32 .07 .34= .56= .97" 1.05" .09 
Pancreas .07 .03 .12= .15= .40" .42" .04 
Spleen .03 .27 .06= .12= 1.80" .11= .27 
"Basal line. One animal per littermate group was killed before i.m. administration of vitamin 
E. 
''Saline = Injection of saline. A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act 
= Injection of d-a-tocopheryl acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion. 
=''®Means in a row with different superscripts differ (P < .06). 
Table 7. 
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Content of a-tocopherol of injectable origin' 336 h after a single i.m. 
administration of 138 lU of vitamin E/kg of BW (mg) 
Treatments'* 
Item A-act B-act 01 SE 
Heart .060^ .3848 .4378 .047 
Adrenal gland .005^ .OlO's .0138 .002 
Kidney .047^ .3358 .3298 .057 
Liver .419 1.273 1.250 .299 
Lung .222^ .6278 .6998 .095 
Pancreas .032^ .2788 .2988 .043 
Spleen .057' 1.7418 .031' .291 
Muscle® 3.380' 17.4338 34.877" 4.295 
Serum'' .552 .863 .736 .148 
TOTAL® 4.774' 22.9448 38.670'' 4.076 
"Calculated as follows: Tissue a-tocopherol content minus tissue vitamin E content of its 
littermate in the saline injected group. 
''A-act = Injection of d-a-tocopheryl acetate in olive oil. B-act = Injection of d-a-tocopheryl 
acetate as emulsion. 01 = Injection of d-a-tocopherol as emulsion. 
"^Calculated assuming that a 15 kg pig has 6.57 kg muscle, and using the average vitamin E 
concentration of the three skeletal muscle analyzed for each animal. 
''Calculated assuming that a 15 kg-pig has 0.84 kg serum, and using the a-tocopherol 
concentration in serum 336 h after i.m. administration. 
'Calculated adding up total a-tocopherol content of all the tissues anayzed for each animal. 
The total amount of tissues analyzed for a-tocopherol content of injectable origin accounted for 
about 56% ofBW. 
'^^''Means in a row with different superscripts differ (P < .07). 
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Table 8. Parameters for the empirical compartmental model of a single i.m. injection of 
138 lU of vitamin E as d-a-tocopherol or tocopheryl acetate® 
Serum 
a-tocopherol 
Serum 
a-tocopheryl acetate 
Item"" B-act 01 B-act 
.015 
.077 
.036 
.008 
.060 
.007 
.023 
.086 .151 
.081 
'Calculated using slopes and intercepts of the exponential equations. For B-act (R^ = .93 and 
.65 for serum a-tocopheryl acetate and serum a-tocopherol, respectively) and 01 (R^ = .96 for 
serum a-tocopherol). 
''kg = rate of absorption, kj 2 = rate of transfer from compartment 2 to compartment 1, k,, 
= rate of transfer from compartment 1 to compartment 2, and k^ = rate of elimination (h"*). 
"^Serum a-tocopheryl acetate was not detected (< .01 mg/L) after injection of d-a-tocopherol 
(01). 
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Table 9. Parameters for the model-based compartmental analysis of a single i.m. injection 
of 138 lU of vitamin E as d-a-tocopherol (01) 
Parameter' Characteristic Value FSD" 
k(8,7) Adjustable .060 .126 
k(3.5) Adjustable .004 .147 
k(5,3) Adjustable .022 .097 
lc(3,9) Adjustable .004 .688 
k(9,3) Adjustable .087 .181 
k(10,9) Adjustable .151 .618 
V Adjustable 1.490 .063 
d Fixed" .620 -
'k(j,i) = rate of transfer from compartment i to compartment j, h"'; V = volume of 
distribution, L; and d = delay or lag time, h. 
•"Fractional standard deviation (FSD) is defmed as the standard deviation/mean ratio. 
"Parameter from numerical model of 01 treatment. 
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Table 10. Parameters for the model-based compartmental analysis of a single i.m. injection 
of 138 lU of vitamin E as d-a-tocopheryl acetate (B-act) 
Parameter" Characteristic Value FSD" 
k(6,l) Fixed® .131 
k(7,l) & k(5.4) Fixed^ .010 -
k(4,2) Adjustable .013 .601 
k(3,2) Fixed® .002 -
k(9.2) Adjustable .071 .126 
k(5,3) Fixed^ .022 -
k(3,5) Fixed^ .004 -
k(9,3) Adjustable .157 .639 
k(3,9) Fixed^ .004 
-
k(8,7) Fixed^ .060 
-
k(10,9) Adjustable .156 .169 
V Adjustable .982 .065 
d6 Fixed® 1.700 
-
d8 Fixed® 2.970 -
®k(j,i) = rate of transfer from compartment i to compartment j, h"'; V = volume of 
distribution, L; and d; = delay or lag time, h. 
''Fractional standard deviation (FSD) is defmed as the standard deviation/mean ratio. 
+ k(7,l) = 0.143; FSD = 0.065. 
''Assuming that 1% of tissue tocopheryl acetate is hydrolyzed to free tocopherol per hour. 
®k(3,2) + k(4,2) + k(9,2) = 0.087; FSD = 0.014. 
'Parameter from compartmental model of 01 treatment. 
^Parameter firom numerical model of the B-act treatment. 
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a) 
Ka FD • Ke 
b) 
FD Ka Q1 = V1 X CI Ke F w 
K2,1 K1,2 
Q2 
Figure 1. a) One compartment open model with first order absorption and elimination of a-
tocopheryl acetate after a single i.m. dose of d-a-tocopheryl acetate (B-act), b) two compartment 
open model with first order absorption and elimination of a-tocopherol only from compartment 1 
after a single i.m. dose of d-a-tocopherol (01) or d-a-tocopheryl acetate (B-act). Ka = 
absorption rate, h"'; Ke = elimination rate, h"'; D = dose, mg; F = fraction of dose; Q = Size 
of compartment, mg; Kj,i = rate of transfer from compartment i to j, h ^ 
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Figure 2. Serum a-tocopheryl acetate concentration with time after a single i,m. injection of 138 
lU/kg of d-a-tocopheryl acetate (B-act). Observed (•) and predicted values (-). Co = initial 
concentration, Cmax = maximum concentration, Ct = concentration at time t, t = time, T = 
time at which first-order absorption begins, Tmax = Time to maximum concentration, Tj/j = 
half life, Kj = intercept, and P; = rate. 
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R = .65 
Cmax = 10.42 mg/L 
T.max = 20.01 h 
Co = .54 mg/L 
T = .54mg/L 
K1 = 35 mg/L 
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PI = .077 1/h ^ 
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I f t  < T ,  t h e n :  C t  =  C o  
-PI(t-T) -P2(t-T) -P3(t-T) 
If t > T, then: Ct = Co - K1 • + K1 e + K2 « 
Figure 3. Serum a-tocopherol concentration with time after a single i.m. injection of 138 lU/kg 
of d-a-tocopheryl acetate (B-act). Observed (•) and predicted values (-). Co = initial 
concentration, Cmax = maximum concentration, Ct = concentration at time t, t = time, T = 
time at which first-order absorption begins, Tmax = Time to maximum concentration, T,/2 = 
half life, Kj = intercept, and P; = rate. 
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Figure 4. Serum iHocophi 
of d-Qr-tocophcrol(31 = Poi 
concentration. Cm.s = ma 
time at which first-order ab 
half life, = intercept, an; 
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Cmax = 124.46 mg/L 
Tmax = ia45 h 
Co = .66 mg/L 
T = .62 h 
K1 = 1580 mg/L 
K2 = 4.68 mg/L 
PI = .086 1/h ^ 
92 = .07 1/h 
P3 = .0055 1/h 
O 50 10O 150 200 250 300 350 
Hours 
I f t  <  T ,  t h e n :  C t  =  C o  
-PI (t-T) -P2(t-T) -P3{t-T) 
I f t  > T .  t h e n :  C t = C o - K 1 e  +  K 1  e  +  K 2  e  
Figure 4. Serum a-tocopherol concentration with time after a single i.m. injection of 138 lU/kg 
of d-a-tocopherol(01 = Pooled A & B-ol). Observed (•) and predicted values (-). Co = initial 
concentration, Cmax = maximum concentration, Ct = concentration at time t, t = time, T = 
time at which first-order absorption begins, Tmax = Time to maximum concentration, T1/2 = 
half life, = intercept, and Pj = rate. 
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Figure 5. Model-based compartmental analysis of a single i.m. injection of 138 lU of vitamin E as d-a-tocopheryl acetate (B-act). 
q; = size of compartment i, mg; d^ and dg = delay or lag time, h; S; = sample; and k(j,i) = rate of transfer from compartment i 
to compartment j, h"'. 
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Figure 6. Model-based compartmental analysis of a single i.m. injection of 138 lU of vitamin E as d-a-tocopherol (01 = Pooled A 
«& B-ol). Qi = size of compartment i, mg; dg = delay or lag time, h; Sj = sample; and k(j,i) = rate of transfer from compartment i 
to compartment J, h'^ 
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Figure 7. Pool sizes vs time profile after model-based compartmental analysis was performed on 
a single i.m. injection of 138 lU of vitamin E as d-a-tocopheryl acetate B (B-act). 
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Figure 8. Pool sizes vs time profile after model-based compartmental analysis was performed on 
a single i.m. injection of 138 lU of vitamin E as d-a-tocopherol (01 = Pooled A & B-ol). 
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CHAPTER 5. EFFECT OF DIETARY AND INJECTABLE VITAMIN E ON 
REPRODUCTIVE PERFORMANCE AND TOCOPHEROL STATUS OF SOWS AND PIGS 
OVER THREE PARITIES 
A paper to be submitted to the Journal of Animal Science 
D. Carrion, R. C. Ewan, and J. Coma 
Abstract 
The effect of method of administration of vitamin E on reproductive performance and 
tocopherol status of the sows and their progeny was evaluated over three parities. Twenty 
Yorkshire x Landrace sows were allotted in a complete randomized design. Treatments were a 2 
X 2 factorial arrangement of none or 600 lU of d-a-tocopherol injected i.m. at breeding and at 
110 d of gestation and a corn-soybean diet or the diet supplemented with 50 lU of d-a-tocopheryl 
acetate per kilo. During gestation, sows were individually fed 1.8 kg per d and were full hand 
fed at least twice a day during lactation. Treatments had no effect on BW, ADFI, number of pigs 
born dead, number of mummies per litter, or percentage of mortality during lactation. The total 
number of pigs bom and pigs alive at 21 d of lactation per litter decreased (P < .01) in sows fed 
the vitamin E-supplemented diets, and increased (P < .01) by parity. The serum activity of 
glutathione peroxidase and lactic acid dehydrogenase were not affected by treatment and were 
within their respective normal ranges for sows and pigs. Sows fed diets supplemented with d-a-
tocopheryl acetate had greater serum (P < .05) and milk (P < .001) a-tocopherol 
concentrations, and their litters had greater (P < .05) serum and tissue a-tocopherol 
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concentrations than litters from sows fed the basal diet. Sows injected with supplemental d-a-
tocopherol had greater (P < .01) serum and milk a-tocopherol concentrations at farrowing, and 
their litters had greater (P < .05) a-tocopherol concentrations in kidney at 21 d of lactation than 
those from sows that did not receive the injection. Pigs were bom depleted of vitamin E, but the 
immediate uptake of colostrum repleted them. These results suggest that when sows fed diets 
containing .3 ppm of selenium for three consecutive parities and when reproductive performance 
is used as response criteion, 11 lU of vitamin E per kg of diet during gestation and 22 lU of 
vitamin E per kg during lactation was adequate. Moreover, dietary and injectable tocopherol 
supplementation of sows can improve the tocopherol status of both sows and their offspring. 
Key words: Pigs, Vitamin E, Tocopherol, Reproductive Performance 
Introduction 
Swine diets are generally supplemented with vitamin E because the vitamin E in 
ingredients is readily destroyed. Factors contributing to this destruction are: storage and 
processing of feedstuff's, and dietary factors such as presence of trace minerals or polyunsaturated 
fatty acids. Other factors affecting the requirement for vitamin E supplementation include the 
management system and the genetic background of the pigs (Adams and Zinmierman, 1982; 
Mahan, 1991a). 
Sows fed a vitamin E-deficient diet farrow fewer pigs because of embryonic death 
(Adamstone et al., 1949), occurring primarily between d 10 to 18 after breeding. Another critical 
time period during the reproductive process is the first few days after farrowing because most of 
the pig mortality occurs at that time. 
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Vitamin E supplementation through the diet (Babinszky et al., 1992) or through a single 
i.m. injection about 4 days before rebreeding (Myer, 1992) did not affect reproductive 
performance when the concentration of vitamin E in the control diets was normal. Mahan 
(1991b, 1994) reported an increase in litter size in response to dietary vitamin E supplementation 
above the NRC (1988) recommendation. 
Vitamin E is inefficiently transferred across the placenta, and low concentrations of 
vitamin E have been reported in pigs prior to first suckling (Malm et al., 1976; Mahan et al., 
1977; Young et al., 1977). However, vitamin E is effectively transported by mammary tissue 
with a greater concentration of vitamin E in colostrum than in milk. The concentration of vitamin 
E in milk can be increased by additional vitamin E supplementation (Mahan, 1991b; Babinszky et 
al. 1991; 1992). The following study was conducted to investigate the effect of dietary 
d-a-tocopheryl acetate supplementation and injectable d-a-tocopherol at breeding and at d 110 of 
gestation on sow reproductive performance and tocopherol status of the dam and its offspring over 
three parities. 
Materials and Methods 
Experimental Design and Management 
Twenty Yorkshire x Landrace primiparus sows were reared under common housing, 
environment, nutrition and management conditions. The sows were allocated in a complete 
randomized design. Treatments were a 2 x 2 factorial arrangement of none or 600 lU of d-a-
tocopherol injected i. m. at breeding and at d 110 of gestation, and of a corn-soybean meal diet or 
the diet supplemented with 50 lU of d-a-tocopheryl acetate per kilogram fed during the whole 
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experimental period. The procedures were approved by the Committee on Animal Care and Use 
at Iowa State University. 
Females eshibiting estrus were hand-mated to boars twice at 24 h intervals. During 
gestation, sows were housed in a naturally ventilated building in individual stalls on partly slatted 
concrete floor. They were individually fed once daily at 1.8 kg commencing at breeding. The 
gestation diets were based on com and solvent extracted soybean meal (Table 1). On d 110 of 
gestation, each sow was moved to a farrowing room and placed in a farrowing crate until 
weaning. The farrowing room was a completely closed facility with underslat waste storage. 
Fans and air inlets provided ventilation, and artificial cooling or heating was used. In the 
farrowing room, the animals received 1.8 kg/d of gestation diet until farrowing. During lactation, 
gilts were full hand fed, at least twice daily, a corn-soybean meal lactation diet (Table 1). The 
basal diets were formulated to meet or exceed the NRC (1988) recommendations. Pigs had no 
access to creep feed during lactation. Sows and pigs were allowed ad libitum access to water 
during the experimental period. 
Pigs were eamotched, tail docked and injected with iron dextran within 12 h of 
parturition. Male piglets were castrated at 14 d of lactation. 
Sample Collection and Measurements 
Diet. The vitamin E premix was prepared by adding 16.68 g of d-a-tocopheryl acetate 
(Sigma Chemical Co.) in 100 mL distilled ethanol to 25 kg of ground corn. Batches of 455 kg of 
gestation and lactation diets were mixed at least once per month for immediate consumption. A 
sample from each batch was taken and stored at -20 °C for determination of dry matter, energy, 
fat, protein, ash, selenium and tocopherol isomers. Feed samples were ground through a 1.0 mm 
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screen before analysis. 
Dry matter was determined by drying in an oven for 24 hours at 105°C, energy by an 
adiabatic calorimeter (Parr Instrument Co.), fat by the ether extract procedure (AOAC, 1990, 
method 920.39C), ash by using a muffle oven at 600°C for 3 h, and N by the Kjeldahl method 
(AOAC, 1990, method 954.01). 
Selenium was determined by the method of Olson et al. (1975). Selenium in the form of 
selenite reacts with aromatic orthodiamines to form piazselenols which fluoresce in certain organic 
solvents. Therefore, the sample was ashed under strong oxidizing conditions. When the Se was 
in the inorganic form, it was converted to the +4 oxidation state. It is then reacted witii 2,3-
diaminonaphthalene. The piazselenol was extracted into decahydronaphthalene and the 
fluorescence was measured. The calculations were done by linear regression based on standards. 
Tocopherol isomers and a-tocopheryl acetate were extracted with acetone in a soxhlet 
extractor. The extract was evaporated to dryness and dissolved in hexane. Tocopherol isomers 
were separate by HPLC. The hexane extract was injected directly and separation achieved with 
silica gel column 25 cm x 4.6 mm CHROMAGESPHERE SI-60 with a particle diameter of 5 /xm 
and a pore diameter of 60 A (ES Industries; Berlin, NJ 08009) with a mobile phase of 3.5% 
tetrahydrofuran (vol/vol) in HPLC-grade hexane with a flow rate of 2.0 mL/min. Tocopherol 
was detected fluorometrically with an excitation wavelength of 294 rjm and an emission 
wavelength of 323 Tjm. Peak areas were determined by integration and compared with standards 
for quantification. 
Weighing and reproductive performance. Data recorded included: weight of the gilts at 
breeding, at 110 d of gestation, within 12 h after parturition, and at 21 d of lactation, weight of 
the pigs within 12 h after birth, at 14 d, and at 21 d of lactation, number of stillborn and 
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mummies, pig mortality, feed consumption, and weaning to remating interval. 
Gestation weight gain was calculated as d 110 of gestation weight minus breeding weight, 
farrowing weight loss was calculated as d 110 of gestation weight minus weight within 12 h after 
parturition, and lactation weight change was calculated as 21 d of lactation weight minus within 
12 h after parturition weight. 
Colostrum and milk. Milk samples were obtained within 12 h of farrowing (colostrum) 
and at d 14 and 21 of lactation. An intravenous injection of oxytocin was used to stimulate milk 
let down. Milk samples were stored at -20°C until analyzed for tocopherol. Milk (2 mL) was 
deproteinized with redistilled absolute ethanol (3 mL), and tocopherols were extracted with hexane 
(1 mL). The hexane was injected directly into the HPLC using fluorescence detection as 
described for the feed analyisis. 
Blood. Blood samples were obtained from the vena cava of the sows at breeding, d 110 
of gestation, farrowing, and d 14 and 21 of lactation; and from the orbital sinus of one littermate 
pig within 12 h after birth, and at d 14 and 21 of lactation (at each lactation period the littermate 
pig was randomly selected among the pigs alive in the litter). Serum was frozen and stored at -
20°C until analysis. The analysis for tocopherol was performed using procedures identical to 
those described above for milk. 
Serum lactate dehydrogenase (LDH) was determined by the method of Amador et al. 
(1963). The conversion of lactic acid to pyruvic acid is catalyzed by LDH. In this conversion, 
/3-diphosphopyridine nucleotide (/3-DPN) is reduced to jS-DPNH. This reaction can be followed 
spectrophotometrically because j8-DPNH absorbs at 340 ijm wavelength, whereas /3-DPN does 
not. Thus, LDH activity can be measured. 
Serum glutathione peroxidase (GSH Px) activity was determined within 12 h of blood 
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collection by the method of Paglia and Valentine (1967). GSH Px catalyzes the conversion of 
hydrogen peroxide to water with the oxidation of glutathione. Oxidized glutathione is reduced by 
glutathione reductase. In diis conversion, jS-NADPH is oxidized to jff-NADP. This reaction can 
be followed spectrophotometrically because /3-NADPH absorbs at 340 7;m wavelength and /3-
NADP does not. Thus, GSH Px activity can be measured. 
Tissues. The pig randomly selected for bleeding within 12 h after parturition and at d 21 
of lactation was electrically stunned and killed by exsanguination. Liver, kidney, heart, 
longissimus muscle and psoas muscle were excised, weighed, frozen and stored at -20 °C. Ail the 
dissection work was performed by the same person and following anatomical references for 
consistency. Longissimus and psoas major muscles were excised from the intervertebral space 
between the IS"" thoracic and the first lumbar vertebrae to the intervertebral space between the 6"" 
and T'*" lumbar vertebrae. 
Tissue (2 to 3 g) were homogenized in 10 mL (wt/vol) of phosphate-EDTA-buffer (pH 
7.0) and deproteinized and extracted as described for milk. Tissues were analyzed for 
tocopherols by HPLC with fluorescence detection as described for feed. Liver GSH Px activity in 
the homogenate was determined as described for serum. 
Statistical Analysis 
Data were evaluated by the GLM procedure of SAS (1988). A complete randomized 
design with an split-split-plot analysis was performed. The whole-plot was treatment with the 
factorial arrangement of dietary and injectable vitamin E supplementation, the sub-plot was parity, 
and the sub-sub-plot was gestation and/or lactation stages. Variables measured in the same 
experimental unit, sow or litter, at different time intervals were analyzed as repeated measures. 
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Data are reported as least squares means. 
Results 
Three sows were removed from the experiment after completion of the first parity. Two 
of the sows were in the dietary vitamin E supplemented group and failed to conceive, whereas 
the other sow was in the vitamin £ unsupplemented group and presented legs problems. 
Performance of the Sows 
Gestation perfonnance of the sows. Treatments had no effect on the weight of the sows 
at breeding or 110 d of gestation (Table 2). Those weights increased by parity (P < .001). 
Weight gain during gestation was also similar among treatments and parities. 
Post-farrowing peiformance of the sows. No effect of vitamin E administration on post-
farrowing performance of the sows was observed (Table 2). The weight of the sows within 12 h 
after farrowing, and at 21 d of lactation increased by parity (P < .001). Sow weight change 
during lactation increased with parity (P < .01). Daily feed intake during lactation also increased 
(P < .001) by parity. Neither farrowing weight loss nor weaning to remating interval were 
affected by vitamin E administration or parity. 
Farrowing peiformance. The litter weight (live piglets only) and the pig weight at birth 
increased (P < .05) by parity, but was similar among treatments. The total number of pigs born 
and bom alive per litter decreased (P < .01) in sows fed supplemented diets, and increased (P < 
.001) with parity (Table 2). The number of bom dead and mummies per litter were similar 
among treatments and parities. 
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Lactation petformance. Neither treatment nor parity had an effect on the weight of the 
pigs at 21 d of lactation, growth rate to 21 d of lactation, or percentage of mortality during the 
same time interval (Table 2). Litter weight (P < .001) and the number of pigs alive at 21 d of 
lactation (P < .01) increased with parity. At 21 d of lactation, litter size decreased for sows fed 
unsupplemented diets with injectable d-a-tocopherol, whereas litter size was similar when sows 
were fed supplemented diets or supplemented diets plus injectable d-a-tocopherol, resulting in a 
diet X injection interaction (P < .05). 
Serum Enzymes of the Sows 
Treatment did not affect GSH Px or LDH (Table 3) activity (P > .1) of the sows. Serum 
GSH Px activity was greater at breeding than at d 110 of gestation, and serum LDH activity 
consistentiy increased at farrowing (P < .001). GSH Px activity at d 110 of gestation decreased 
(P < .001) with parity. GSH Px activity at d 14 of lactation increased (P < .01) with parity. 
LDH activity at d 14 of lactation (P < .05) and at d 21 of lactation decreased (P < .01) with 
parity. 
Tocopherol Status of the Sows 
Serum a-tocopherol concentration of sows fed a diet supplemented with d-a-tocopherol 
increased at breeding (P < .05), at d 110 of gestation (P < .001), at farrowing (P < .01), and 
at d 14 (P < .01) and d 21 (P < .001) of lactation when compared with that of sows fed 
unsupplemented diets (Table 4). Also, serum a-tocopherol concentration of sows injected with d-
o-tocopherol was greater (P < .01) at farrowing than that of sows that were not injected. Serum 
a-tocopherol concentration of first parity sows was greater than the concentration of second and 
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third parity sows at d 110 of gestation (P < .01), at farrowing (P < .05),and at d 14 (P < .001) 
and d 21 (P < .05) of lactation. Serum a-tocopherol concentration changed with the different 
stages (P < .01). Serum a-tocopherol concentration was greater at breeding than at d 110 of 
gestation, but subsequently increased from farrowing to d 21 of lactation. 
Concentration of a-tocopherol was 2- to 4-fold greater (P < .001) in colostrum than in d 
14 and 21 milk (Table 4). Concentration of a-tocopherol was greater in colostrum of sows 
supplemented with dietary (P < .001) and/or injectable (P < .01) vitamin E than in colostrum of 
non-supplemented gilts. The concentration of a-tocopherol in milk from sows fed diets 
supplemented with vitamin E was increased (P < .001) at d 14 and 21 of lactation as compared 
with that of sows fed basal diets. At d 14 and 21 of lactation, milk a-tocopherol concentration of 
the sows fed unsupplemented diets with injectable tocopherol was increased, whereas the 
combination of dietary and injectable tocopherol supplementation decreased vitamin E 
concentration, resulting in a diet x injection interaction (P < .05). First parity sows had lower 
milk a-tocopherol concentration than second and third parity sows at farrowing (P < .001), and 
d 14 (P < .01) and 21 (P < .001) of lactation. 
Enzymes of the Progeny 
The serum activities of GSH Px and LDH (Table 5) were not affected (P > .1) by 
treatment, but increased (P < .001) from birth to d 21 of lactation. Serum GSH Px activity at 
birth of pigs from second parity sows was greater (P < .01) than that of pigs from first and third 
parity sows, whereas GSH Px activity at d 14 of lactation of pigs from first parity sows was 
lower (P < .001) than that of pigs from second and third parity sows, resulting in parity x stage 
interaction (P < .01). Serum LDH activity at birth of pigs from first parity sows was greater (P 
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< .05) than that of pigs from second and third parity sows. In contrast, activity of LDH at d 21 
of lactation of pigs decreased (P < .01) with parity, resulting in parity x stage interaction (P < 
.05). 
GSH Px activity in liver (Table 5) was not affected by treatment (P > .1), but it 
increased (P < .001) from birth to d 21 of lactation. At birth, GSH Px activity in liver of pigs 
from second parity sows was greater (P < .05) than that of pigs from first and third parity sows, 
whereas at d 21 of lactation, liver GSH Px activity of pigs from first parity sows was lower (P < 
.001) than that of pigs from second and third parity sows, resulting in parity x stage interaction (P 
< .001). 
Tocopherol Status of the Progeny 
Serum. Serum a-tocopherol concentration (Table 6) increased over 10-fold from birth to 
d 14 and 21 of lactation. At birth, serum a-tocopherol concentration was low or not detectable in 
some samples. Serum a-tocopherol concentration of pigs from sows fed supplemented diets was 
increased at birth (P < .05) and at d 21 of lactation (P < .01) when compared with that of pigs 
from sows fed basal diet. On the other hand, serum a-tocopherol concentration of pigs from 
sows injected with vitamin E was lower (P < .05) than that of pigs from sows not injected with 
vitamin E only at birth. At d 21 of lactation, the serum a-tocopherol concentration of pigs from 
sows fed basal diets and injected with d-a-tocopherol was increased, whereas the combination of 
dietary and injectable supplementation did not increase serum a-tocopherol, resulting in diet x 
injection interaction (P < .05). At d 21 of lactation, serum a-tocopherol concentration of pigs 
decreased (P < .05) by parity. 
Tissues. Concentrations of a-tocopherol in tissues (Table 6) were lower at farrowing than 
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at d 21 of lactation (P< .001). At birth, dietary vitamin E supplementation of the sows increased 
a-tocopherol concentration of liver (P < .05), kidney, psoas muscle (P < .01), heart, and 
longissimus muscle (P < .001) as compared with feeding the control diets. At d 21 of lactation, 
tissue a-tocopherol concentrations in the offspring increased (P < .001) when sows were fed 
supplemental vitamin E, but were not affected by injection of vitamin E except for kidney (P < 
.05). 
Treatment and parity did not affect organ weight (Table 7) at birth and at d 21 of 
lactation, with the following exceptions at birth: psoas and longissimus muscle weights increased 
(P < .05) by parity, and longissimus muscle weight was similar when sows were fed the basal 
diets or basal diet plus injectable vitamin E, whereas dietary vitamin E supplementation increased 
its weight, resulting in a diet x injection interaction (P < .05). 
At birth and at 21 d of lactation, total liver, kidney, and heart a-tocopherol content of 
pigs (Table 8) from sows fed supplemental d-a-tocopheryl acetate was greater (P < .001) than in 
pigs from sows fed basal diets. At 21 d of lactation, liver a-tocopherol content of pigs decreased 
(P < .001) by parity. On the other hand, pigs from second parity sows had lower (P < .001) 
kidney a-tocopherol content than pigs from third parity sows, whereas pigs from second parity 
sows had lower (P < .001) heart a-tocopherol content than pigs from first and second parity 
sows. 
Discussion 
The weight of the sows increased by parity as a result of physiological growth of animals 
fed diets that met the NRC (1988) requirements which were placed in a sanitary and 
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environmental controlled facility. Average daily feed intake during lactation was similar among 
treatment groups, but increased by parity. Therefore, all the animal groups gained weight in a 
similar manner during lactation, and this weight gain increased by parity. 
The pharmacokinetics of the source of injectable vitamin E used in this experiment has 
been previously described in swine by our group (Carrion et al., 1995). Concentration of a-
tocopherol in serum reached a peak around 12 h after i.m. injection. By 72 h, a-tocopherol 
concentration in serum drastically declined, with a subsequent slow rate of disappearance from 
serum. Fairly high serum a-tocopherol concentrations were maintained for at least 14 d after 
i.m. injection. 
Ashworth (1991) reported that ovulation in swine takes place 24 to 48 h after the onset of 
estrus. Therefore, a-tocopherol concentration in serum after i.m. injection at breeding reaches a 
peak about ovulation time. Around 48 to 56 h after ovulation, the 4-cell embryos enter the 
uterus, where cell division continues. At d 5 to 6, the blastocyst stage of embryonic development 
is reached, and hatching of the pig embryo from the zona pellucida occurs 6 to 7 d after breeding. 
Migration of the embryo within the lumen of the uterus lasts up to 12 d after mating, and then 
elongation takes place. Most prenatal mortality in swine occurs before the attachment of the 
embryo in the uterus, when histotroph produced by the uterus is the only source of nutrients 
(Archibong et al., 1987). It is well established that high uterine blood flow is important for fetal 
growth during late pregnancy, and that the mammary system develops at the end of gestation. 
Therefore, i.m. injection of d-a-tocopherol at d 110 of gestation may improve vitamin E status in 
the neonate, and vitamin E contents of colostrum and milk. 
The number of pigs bom, and born alive per litter was decreased by dietary vitamin E 
supplementation of sows, but the number of mummies per litter was similar among treatments. 
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Therefore, the number of mummies, reflecting mortality of the fetuses after 50 d of gestation, 
cannot explain the differences found among dietary groups. Thus, these differences must be 
attributed to reasons such as low ovulation rate, low fertilization rate, or high embryonic death in 
sows fed the vitamin E supplemented diets, but because we did not estimate any of these traits, 
we can not conclusively determine which of these factors were responsible for such a response. 
Previous reports have suggested greater litter size (Adamstone et al., 1949; Cline et al., 1974; 
Mahan, 1991b, 1994) and lower mortality (Van Vleet et al., 1973; Mahan, 1991b) in response to 
supplemental vitamin E. Grandhi et al. (1993) recommended a minimum of 50 lU of vitamin E 
per kg during pre-breeding and gestation for improved ovulation rate. The same authors found a 
lack of effect of 50 or 100 lU of dl-a-tocopheryl acetate per kg of diet on progesterone-mediated 
embryo survival. Vitamin E supplementation in the diet (Babinszky et al., 1992) or through 
single i. m. injection about 4 days before rebreeding (Myer, 1992) did not affect reproductive 
performance when the level of vitamin E in the control diets was considered as normal. Feeding 
sows a cereal grain-based diet without vitamin E or selenium did not result in any sign of 
myopathies (Mahan et al., 1974) or reduction of litter size (Mahan et al., 1974; Young et al., 
1977; Nielsen et al., 1979) until the second reproductive cycle (Mahan et al., 1974). 
First parity sows had lighter litters at farrowing and at d 21 of lactation than second and 
third parity sows due to their smaller litter size. The lower number of pigs alive at d 21 of 
lactation for sows fed supplemented diets is the result of a reduction in litter size at birth by 
dietary vitamin E supplementation and no effect of treatment on litter mortality during lactation. 
Chavez and Patton (1986), Loudenslager et al. (1986), and Mahan (1994) reported no affect of 
vitamin E supplementation on mortality of pigs during lactation. In our experiment, vitamin E 
supplementation did not affect pig weight. This lack of response on pig weight is in agreement 
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with Malm et al. (1976) and Loudenslager et al. (1986). 
Plasma GSH Px activity correlates well with Se content of plasma (Meyer et al., 1981). 
The serum level of Se in the newborn pig reflected the Se content of the sow diet (Mahan et al., 
1977; Young et al., 1977; Piatkowski et al., 1979). Supplemental vitamin E had no effect on 
serum or liver GSH Px activities in our experiment. Serum and liver GSH Px activity of the pigs 
increased from birth to d 21 of lactation, probably as a consequence of a higher feed (Se) intake 
of the sows during lactation, and transfer of Se across mammary tissue. 
A rise in activity of specific enzymes can be measured before any clinical signs of vitamin 
E/Se deficiency are observed. Lactate dehydrogenase is one of the enzymes released from 
damaged cells of skeletal muscle, liver, or heart into the bloodstream. Therefore, LDH can be 
used to provide the preclinical diagnosis of vitamin E/Se deficiency (Hyldgaard-Jensen, 1973). 
The activity of LDH in serum of sows and pigs in the current trial suggested that vitamin E/Se 
deficiency was not present, and this finding was consistent with the studies of Less (1990) and 
Grandhi et al. (1993). Within those normal values, a consistent increase in serum LDH activity 
for all the treatments was observed at the time of parturition, coincident with cell damage in the 
reproductive tract. A similar increase was observed in first parity sows during lactation. On the 
other hand, serum LDH activity in the sows was lower than that in the pigs. The LDH activity 
values measured in the newborn pig indicated that the neonates did not have vitamin E/Se 
deficiency upon birth. These results are in agreement with those of Mahan (1991b). 
Serum a-tocopherol concentration of the pigs at birth was always less than that of the 
dam. Vitamin E concentrations in tissues and serum of the neonate suggest low quantitative 
transfer of vitamin E across the pig placenta even though 600 lU of d-a-tocopherol was injected 
at d 110 of gestation, coincident with the high placenta blood flow at the end of pregnancy. 
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Therefore, only a limited and saturated mechanism of vitamin E transport across placenta tissue 
can explain the lack of response to supplementation of the sow observed in the neonate. Fusion 
of the chorion and allantois in swine occurs between 30 and 60 d of pregnancy, forming an 
epitheliochorial placenta in which there is a good separation between maternal blood supply and 
the absorptive surface of the chorioallantois (Ashworth, 1991). Some studies have reported lower 
plasma a-tocopherol concentration in the newborn than in the dam (Mino and Nishino, 1973; 
Young et al., 1977; Loudenslager et al., 1986). In contrast. Malm et al. (1976) reported greater 
plasma a-tocopherol concentration of the neonate than in the dam. Mahan (1991b) showed lower 
liver tocopherol concentration in the newborn than in the dam, whereas Kelly et al. (1992) 
reported greater liver a-tocopherol concentration in the neonatal guinea pig than in the dam. 
They suggested that vitamin E stored in the liver could be utilized to increase plasma a-tocopherol 
levels in the neonate. In the present experiment, during dissection of the neonatal pig within 12 
h after birth, we recorded whether or not the stomach of the pig was ftill of colostrum. After 
comparing this record with the a-tocopherol concentrations in serum and tissues of the pigs, we 
can state that: first, all the pigs with an empty stomach had low a-tocophreol concentrations in 
serum and liver; and second, all the pigs with high serum and liver tocopherol concentration had 
a full stomach, but not all the pigs with a full stomach had high serum and liver a-tocopherol 
concentrations. This observation suggests that, in a matter of hours after nursing, vitamin E in 
colostrum would be absorbed, placed in the blood stream (probably in chylomicron), and taken up 
by the liver. This would imply that, depending on whether or not the neonatal animal nursed and 
on the time interval between nursing and killing for sample collection, different values would be 
obtained for a-tocopherol concentration, resulting in a higher variability in a-tocopherol values. 
Serum a-tocopherol concentration of sows declined ft^om breeding to parturition and was 
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associated with high a-tocophercl content of colostrum. This suggests efficent transfer of vitamin 
E by mammary tissue to colostrum at farrowing. It has been reported that low density lipoprotein 
receptors increase in mammary gland during formation of colostrum and may help transfer 
lipophilic substances into the first milk (Schweigert, 1988). Weiss et al. (1992) showed that in 
cows, this decline in vitamin E concentration in blood at the end of gestation was a result of 
plasma lipoprotein utilization by the mammary gland, and not a result of a selective removal of 
vitamin E from blood because the a-tocopherol:cholesterol ratio did not decrease. A similar 
decline in serum a-tocopherol concentration was reported by Malm et al. (1976), Mahan (1991b), 
and Grandhi et al. (1993). The concentration of a-tocopherol in colostrum was several fold 
greater than that in serum of the sows at 110 d of gestation or at parturition. Supplementation of 
injectable and dietary vitamin E increased colostrum and serum a-tocopherol concentration of the 
dam at farrowing. Therefore, the newborn pig is dependent on colostrum intake to establish an 
adequate antioxidant capacity. 
Serum a-tocopherol of the dam increased from parturition to d 14 of lactation because 
feed intake increased and perhaps lower permeability of the mammary tissue to vitamin E 
compared with parturition time. A decline in a-tocopherol content of milk from 14 to 21 d of 
lactation was observed, and this observation was consistent with those of Mahan (1994). Vitamin 
E content of the milk reflected the serum vitamin E concentration of the sow at 14 and 21 d post-
parturition. Transfer of vitamin E by mammary tissue to milk is lower in primiparous than in 
multiparous sows. This may be because the mammary system is immature. As serum and milk 
a-tocopherol increased, a decline in 7-tocopherol occurred (Loundenslager et al., 1986; Mahan, 
1991b). Although the incidence of mastitis, metritis, and agalactia was fairly low, it has been 
suggested that levels of supplemental vitamin E (44 to 66 lU/kg of diet) higher than the NRC 
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(1988) recommendations decreased the incidence of this syndrome (Mahan, 1994). 
Some of the differences observed between dietary and injectable vitamin E can be 
explained not only by the frequency of exposure via injectable (acute single dose) or dietary 
(chronic and continuous dose) treatment, but also by the total amount of vitamin E supplemented, 
which was 14 times larger for the dietary than the injectable route. 
Implications 
Vitamin E crosses placental tissue in limited quantities. Therefore, the neonatal pig is 
dependent on colostrum and milk intake to establish and maintain adequate antioxidant capacity 
and avoid vitamin E-Se deficiency after weaning. Colostrum and mature milk a-tocopherol 
content can be increased by dietary or injectable vitamin E supplementation of the sow. Eleven 
lU of vitamin E per kg of diet for gestating and 22 lU/kg for lactating sows may be adequate for 
animals in confinement with a good sanitary condition that are fed diets containing .3 ppm of Se 
for three consecutive parities, when reproductive performance is used as response criterion. 
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Table 1. Composition of the basal diets (as-fed basis) 
Item Gestation Lactation 
% -
Corn 82.20 74.30 
Solvent-extracted SBM 14.30 20.60 
Dicalcium phosphate 1.50 2.50 
Calcium carbonate .90 1.00 
Vitamin premix" .50 1.00 
Trace mineral premix*" .05 .05 
Selenium premix'^ .05 .05 
Salt .50 .50 
— Determined composition of the diet** -
GE, kcal/g 3762.01 3771.27 
Dry matter, % 87.48 88.24 
Protein, % 13.25 15.44 
Ether extract, % 3.30 3.26 
Ash, % 4.39 5.62 
Selenium, ppm .65 .60 
a-tocopherol, /ig/g 2.38 2.34 
"Vitamin composition per kg of diet. Gestation: 2,200 lU of vit. A; 550 lU of vit. D3; 11 
lU of vit. E; .011 mg of vit. 6,2; 3.3 mg of riboflavin; 16.5 mg of niacin; and 8.8 mg of d-
pantothenic acid. Lactation: 4,400 lU of vit. A; 1,100 lU of vit. D3; 22 lU of vit. E; .022 mg 
of vit. B,2; 6.6 mg of riboflavin; 33 mg of niacin; and 17.6 mg of d-pantothenic acid. 
'Trace mineral composition per kg of diet: 75 mg of Zn; 87.5 mg of Fe; 30 mg of Mn; 8.75 
mg of Cu; and 1 mg of I. 
Trovided .3 mg of Se per kg of diet. 
•"Values represent the mean of 18 batches of the diets that were analyzed. 
Table 2. Effect of treatment and parity on performance of the sows 
Treatment® Parity 
Item B B+I  D D+I  SE First Second Third SE 
Gestation 
Breeding wt, kg 150 153 161 147 3 128 154 177 
D 110 gestation wt, kg 197 198 202 189 4 171 203 216 
Gestation wt gain, kg 47 45 41 42 4 43 49 39 4 
Post-farrowing 
Post-farrowing wt, kg 180 187 189 177 3 161 191 199 2^ 
Farrowing wt loss, kg 17 11 13 12 3 10 12 17 2 
D 21 lactation wt, kg 183 197 200 184 3 165 197 211 2^ 
Lactation wt change, kg 3 10 11 7 2 4 6 12 2" 
ADFI lactation, kg 5.93 6.09 5.82 5.48 .22 4.71 5.80 6.98 .n^ 
Wean-remating interval, d 4.6 5.4 8.7 8.4 2.0 9.6 7.0 7.0 1.7 
Farrowing 
Total born alive wt, kg 16.0 13.5 13.7 12.1 1.0 11.5 14.6 15.4 .8= 
Avg. pig wt, kg 1.25 1.21 1.35 1.27 .04 1.25 1.34 1.22 .03'* 
No born/litter 12.9 11.2 10.1 10.7 .6® 9.4 11.1 13.2 .5*' 
No born alive/litter 12.8 10.8 9.2 9.9 .5® 8.8 10.7 12.5 .4" 
No born dead/litter .12 .40 .87 .80 .25 .60 .36 .70 .21 
No Mummies/litter .34 .34 .11 .53 .19 .25 .45 .29 .15 
Lactation, at 21 d 
Total litter wt, kg 53 42 42 42 3 35 48 51 2" 
Pig wt, kg 5.42 5.41 6.18 5.80 .19 5.42 5.95 5.74 .15 
Growth rate, g/d 199 200 230 216 9 198 220 215 7 
No pigs alive per litter 9.7 7.5 6.8 7.4 6.5 8.3 8.9 .5"= 
% Mortality 15 20 12 14 4 15 12 19 4 
"Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D -H I, Dietary supplementation -t- Injection of d-a-tocopherol. 
"•Effect of parity (P < .001). ""Effect of parity (P < .05). '^Effect of diet (P < .05). 
''Effect of parity (P < .01). ®Effect of diet (P < .01). ®Diet x injection interaction (P < .05). 
Table 3. Effect of treatment and parity on serum enzyme activity of sows 
Treatment® Parity 
Item B B+I  D D-t-I SE First Second Third SE 
GSH Px activity, units/mL''^' • 
Breeding 1.45 1.48 1.39 1.51 .11 1.68 1.32 1.37 .10 
D 110 gestation .98 1.13 .99 1.13 .05 1.16 1.11 .90 .05' 
Farrowing .81 .97 .95 1.03 .06 1.01 .96 .85 .05 
D 14 lactation .96 1.09 1.08 1.17 .05 .99 1.12 1.14 .05^ 
D 21 lactation 1.07 1.13 1.10 1.30 .06 1.15 1.18 1.12 .05 
LDH activity, units/mL'^'* 
Breeding 143 159 166 178 14 190 135 160 13 
D 110 gestation 131 165 199 125 28 150 140 174 24 
Farrowing 220 204 251 253 31 254 236 206 26 
D 14 lactation 190 145 168 148 15 192 161 135 138 
D 21 lactation 222 180 170 177 24 252 152 157 20^ 
^Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D + I, Dietary supplementation + Injection of d-a-tocopherol. 
''Glutathione peroxidase. One unit of activity was defined as the amount of enzyme that will convert 1 /imol of NADPH per 
min at pH 7.0 and 20°C. 
'^Lactic acid dehydrogenase. One unit of activity was defined as the amount of enzyme per mL of serum that will decrease 
optical density .001 units*min''cm"^ of light path at 340 T/m and 20°C. 
•"Effect of stage (P < .001). 
'Effect of parity (P < .001). 
^Effect of parity ^ < .01). 
^Effect of parity (P < .05). 
Table 4. Effect of treatment and parity on a-tocopherol concentration of sows (mg/L) 
Treatment® Parity 
Item B B-f-I D D-l-I SE First Second Third SE 
Serum''® 
Breeding 1.20 1.25 1.96 2.75 .49^ 1.05 2.44 1.88 .47 
D 110 gestation .91 1.04 1.92 2.22 .108 1.81 1.33 1.42 .09'' 
Farrowing .75 1.23 1.50 1.86 . lyi  1.58 1.31 1.12 .11' 
D 14 lactation 1.25 1.49 2.48 2.69 .15' 2.36 1.65 1.91 .13'^ 
D 21 lactation 1.30 1.53 2.42 2.41 .14^ 2.20 1.75 1.79 .12' 
Milk<=''® 
Birth (colostrum) 3.16 7.03 9.06 9.97 5.67 7.67 8.57 .60" 
D 14 lactation 1.14 1.75 3.44 2.79 .18''" 1.97 2.47 2.39 .168 
D 21 lactation 1.17 1.41 2.81 2.13 .12^ 1.37 2.13 2.13 .11'' 
"Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation -t-
No injection; and D 4- I, Dietary supplementation + Injection of d-a-tocopherol. 
''Effect of stage (P < .01). 
•^Parity x stage interaction (P < .001). 
•^Effect of stage (P < .001). 
'Treatment x stage interaction (P < .001). 
'^Effect of diet (P < .05). 
8Effectofdiet{P < .001). 
•"Effect of parity (P < .01). 
'Effect of diet (P < .01). 
JEfTect of injection (P < .01). 
''Effect of parity (P < .001). 
'Effect of parity (P < .05). 
"Diet X injection interaction (P < .05). 
Table 5. Effect of treatment and parity on enzyme activity of pigs 
Treatment® Parity 
Item B B+I  D D+I  SE First Second Third SE 
Serum GSH Px activity, units/mL'^® 
Birth .18 .19 .21 .17 .02 .18 .23 .16 .01" 
D 14 lactation .47 .45 .49 .46 .03 .37 .50 .53 .03' 
D 21 lactation .51 .50 .50 .57 .03 .50 .55 .50 .03 
Serum LDH activity, units/mL"*® 
Birth 294 215 244 216 41 311 195 220 36" 
D 14 lactation 333 329 312 315 19 313 338 317 17 
D 21 lactation 364 353 362 319 19 400 347 301 15" 
Liver GSH Px activity, units/g'*^'^ 
Birth 12.2 11.5 10.7 10.6 .9 10.2 13.0 10.6 .T 
D 21 lactation 20.4 19.3 19.9 19.4 .9 16.3 20.5 22.4 .T 
'Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D + I, Dietary supplementation + Injection of d-a-tocopherol. 
''Glutathione peroxidase. One unit of activity was defined as the amount of enzyme that will convert 1 /tmol of NADPH per 
min at pH 7.0 and 20°C. 
•^Lactic acid dehydrogenase. One unit of activity was defined as the amount of enzyme per mL of serum that will decrease 
optical density .001 units*min''*cm'' of light path at 340 ?jm and 20°C. 
•"Effect of stage (P < .001). 
^Parity x stage interaction (P < .01). 
•^Parity x stage interaction (P < .001). 
^Parity x stage interaction (P < .05). 
•"Effect of parity (P < .01). 
'Effect of parity (P < .001). 
^Effect of parity (P < .05). 
Table 6. Effect of treatment and parity on a-tocopherol concentration of pigs 
Treatment® Parity 
Item B B+I D D+I SE First Second Third SE 
Birth 
Serum, mg/L .63 .27 1.26 .54 .18'^ .61 .85 .57 .15 
Liver, mg/kg 1.39 .43 3.38 2.38 .90^ 2.19 2.30 1.20 .80 
Kidney, mg/kg .26 .12 .61 .47 .10^ .44 .26 .39 .09 
Heart, mg/kg .28 .19 .74 .63 .lOP .45 .38 .54 .08 
Psoas muscle, mg/kg .02 ND"* .14 .06 .03'' .02 .07 .07 .02 
Longissimus muscle, mg/kg ND ND .13 .05 .03"= .01 .05 .08 .03 
lactation 
Serum, mg/L 3.60 4.78 4.40 5.36 .53 4.56 4.34 4.71 .45 
lactation 
Serum, mg/L 3.69 4.92 6.22 5.24 .50^8 5.90 5.00 4.16 .43^ 
Liver, mg/kg 4.64 5.75 9.51 9.11 .72"= 10.88 7.74 3.14 .66 
Kidney, mg/kg 2.89 4.09 6.28 6.94 .32"=® 5.16 4.40 5.60 .27 
Heart, mg/kg 4.12 5.50 8.55 8.68 .34® 7.13 5.73 7.28 .28 
Psoas muscle, mg/kg 2.84 4.00 6.46 6.37 .34'' 4.54 4.50 5.71 .30 
Longissimus muscle, mg/kg 1.92 2.83 4.62 4.73 .23® 3.13 3.40 4.04 .19 
"Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D + I, Dietary supplementation + Injection of d-a-tocopherol. 
••Effect of diet (P < .05). 
''Effect of injection (P < .05). 
''Effect of diet (P < .01). 
^Effect of diet (P < .001). 
'^Effect of parity (P < .05). 
®Diet X injection interaction (P< .05). 
•"ND = none detected (< .01 mg/kg). 
Table 7. Effect of treatment and parity on organ weights (g) of pigs 
Treatment® Parity 
Item B B+I D D+I SE first Second Third SE 
Birth 
Liver 29 30 37 30 2 31 31 33 2 
Kidney 8.8 8.9 11.2 9.2 .6 9.5 9.7 9.3 .5 
Heart 8.9 9.2 11.1 8.6 .5 9.5 9.7 9.2 .5 
Psoas muscle 4.3 4.5 5.2 4.4 .3 3.7 4.9 5.1 .3'' 
Longissimus muscle 7.6 8.4 9.9 7.3 .6'' 7.2 8.5 9.1 .5' 
D 21 lactation 
Liver 129 140 133 139 10 136 136 134 9 
Kidney 37 36 37 35 3 35 35 38 2 
Heart 31 32 31 29 3 32 30 31 2 
Psoas muscle 24 25 25 24 2 22 25 26 2 
Longissimus muscle 54 59 53 58 5 56 55 57 4 
Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D + I, Dietary supplementation + Injection of d-a-tocopherol. 
•"Effect of parity (P < .01). 
^Effect of parity (P < .05). 
"•Diet X injection interaction (P < .05). 
Table 8. Effect of treatment and parity on organ a-tocopherol content Qig) of pigs 
Treatment® Parity 
Item B B-f-I D D+I  SE First Second Third SE 
Birth 
Liver 60 10 100 70 30" 70 80 40 30 
Kidney 3.3 1.0 6.7 4.8 1.2'= 4.5 3.3 4.1 1.0 
Heart 3.3 1.6 7.6 5.7 1.1= 4.5 4.1 5.0 .8 
D 21 lactation 
Liver 600 770 1,240 1,290 120= 1,460 1,040 420 90^* 
Kidney 105 146 230 239 19= 176 153 210 15® 
Heart 130 180 240 250 2(f 220 160 210 20® 
'Treatments: B, Basal diet + No injection; B + I, Basal diet + Injection of d-a-tocopherol; D, Dietary supplementation + 
No injection; and D + I, Dietary supplementation + Injection of d-a-tocopherol. ^ 
''Effect of diet (P < .05). S 
"^EffectofdietO* < .001). 
•"Effect of parity (P < .001). 
'Effect of parity (P < .05). 
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used as a response criterion, 11 lU of vitamin E per kg of diet during gestation and 22 lU/kg 
during lactation may be adequate. Moreover, dietary and injectable tocopherol supplementation 
of the sows can improve the tocopherol status of sows and their offspring. 
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